{"data": [{"source": "Loomly", "entities": {"annotations": [{"start": 80, "end": 84, "probability": 0.7153, "type": "Other", "normalized_text": "ASH22"}, {"start": 173, "end": 180, "probability": 0.3414, "type": "Other", "normalized_text": "ASHKudos"}], "hashtags": [{"start": 79, "end": 85, "tag": "ASH22"}, {"start": 139, "end": 150, "tag": "hematology"}, {"start": 172, "end": 181, "tag": "ASHKudos"}], "urls": [{"start": 183, "end": 206, "url": "https://t.co/aaBMI7Vzq9", "expanded_url": "https://twitter.com/ASH_hematology/status/1601306662794559488/photo/1", "display_url": "pic.twitter.com/aaBMI7Vzq9", "media_key": "3_1601306659984482304"}]}, "text": "Looking for a way to show appreciation &amp; admiration for your colleagues at #ASH22? Give them a special social media shoutout for their #hematology accomplishments with #ASHKudos! https://t.co/aaBMI7Vzq9", "conversation_id": "1601306662794559488", "created_at": "2022-12-09T20:03:53.000Z", "edit_history_tweet_ids": ["1601306662794559488"], "author_id": "84072624", "lang": "en", "id": "1601306662794559488"}, {"source": "Loomly", "entities": {"annotations": [{"start": 29, "end": 31, "probability": 0.5317, "type": "Other", "normalized_text": "ASH"}, {"start": 113, "end": 121, "probability": 0.8115, "type": "Other", "normalized_text": "ASH Booth"}, {"start": 169, "end": 171, "probability": 0.4752, "type": "Organization", "normalized_text": "ASH"}], "hashtags": [{"start": 59, "end": 70, "tag": "hematology"}]}, "text": "Starting tomorrow, check out ASH publications, learn about #hematology programs &amp; resources, and more at the ASH Booth (1333) \ud83e\udd13\ud83d\udcd6\ud83e\ude78 \n\nDon't forget to try your hand at ASH trivia to see if you can make it on our leaderboard &amp; win a special ASH-tastic prize!", "conversation_id": "1601276079678922755", "created_at": "2022-12-09T18:02:22.000Z", "edit_history_tweet_ids": ["1601276079678922755"], "author_id": "84072624", "lang": "en", "id": "1601276079678922755"}, {"source": "Loomly", "entities": {"annotations": [{"start": 44, "end": 58, "probability": 0.5851, "type": "Other", "normalized_text": "Immunotherapies"}, {"start": 64, "end": 83, "probability": 0.5246, "type": "Other", "normalized_text": "Hematologic Diseases"}, {"start": 206, "end": 218, "probability": 0.517, "type": "Other", "normalized_text": "Immunotherapy"}, {"start": 221, "end": 230, "probability": 0.7133, "type": "Other", "normalized_text": "MedTwitter"}], "hashtags": [{"start": 205, "end": 219, "tag": "Immunotherapy"}, {"start": 220, "end": 231, "tag": "MedTwitter"}], "urls": [{"start": 181, "end": 204, "url": "https://t.co/kkpY2BMQ4G", "expanded_url": "https://loom.ly/OD8PlHk", "display_url": "loom.ly/OD8PlHk", "status": 200, "title": "Call for Abstracts - Hematology.org", "description": "Call for Abstracts", "unwound_url": "https://www.hematology.org/meetings/summit-on-emerging-immunotherapies-for-hematologic-diseases/call-for-abstracts?utm_source=twitter&utm_medium=organic_social&utm_campaign=summit22_abstracts"}, {"start": 232, "end": 255, "url": "https://t.co/hMWQWJlsxr", "expanded_url": "https://twitter.com/ASH_hematology/status/1601261427276349440/photo/1", "display_url": "pic.twitter.com/hMWQWJlsxr", "media_key": "3_1601261424319369216"}]}, "text": "Submit your abstract for our 2023 Summit on Immunotherapies for Hematologic Diseases TODAY! Learn more about how your research can be featured at this unique meeting of the minds:  https://t.co/kkpY2BMQ4G\n#Immunotherapy #MedTwitter https://t.co/hMWQWJlsxr", "conversation_id": "1601261427276349440", "created_at": "2022-12-09T17:04:08.000Z", "edit_history_tweet_ids": ["1601261427276349440"], "author_id": "84072624", "lang": "en", "id": "1601261427276349440"}, {"entities": {"mentions": [{"start": 0, "end": 16, "username": "HowellJollyBody", "id": "603145861"}, {"start": 17, "end": 33, "username": "DrChrisHourigan", "id": "811643018025504768"}], "annotations": [{"start": 35, "end": 39, "probability": 0.6708, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 34, "end": 40, "tag": "ASH22"}]}, "source": "TweetDeck", "referenced_tweets": [{"type": "replied_to", "id": "1601243155109650437"}], "in_reply_to_user_id": "603145861", "text": "@HowellJollyBody @DrChrisHourigan #ASH22 will miss you!! We wish you a safe &amp; speedy recovery \u2764\ufe0f", "conversation_id": "1601243155109650437", "created_at": "2022-12-09T16:41:34.000Z", "edit_history_tweet_ids": ["1601255746813009921"], "author_id": "84072624", "lang": "en", "id": "1601255746813009921"}, {"entities": {"mentions": [{"start": 3, "end": 17, "username": "CarrawayHetty", "id": "3168040672"}, {"start": 63, "end": 78, "username": "ASH_hematology", "id": "84072624"}], "annotations": [{"start": 38, "end": 44, "probability": 0.6821, "type": "Other", "normalized_text": "ASH2022"}], "urls": [{"start": 84, "end": 107, "url": "https://t.co/KBB8oaWB0Q", "expanded_url": "https://twitter.com/CarrawayHetty/status/1601245405911683073/photo/1", "display_url": "pic.twitter.com/KBB8oaWB0Q", "media_key": "3_1601245400027090947"}]}, "source": "TweetDeck", "referenced_tweets": [{"type": "retweeted", "id": "1601245405911683073"}], "text": "RT @CarrawayHetty: Everyone ready for ASH2022!!? Let\u2019s Go!! \u2665\ufe0f\u2066@ASH_hematology\u2069 \ud83e\udd13\ud83e\udd13\ud83e\udd13 https://t.co/KBB8oaWB0Q", "conversation_id": "1601250213175480322", "created_at": "2022-12-09T16:19:35.000Z", "edit_history_tweet_ids": ["1601250213175480322"], "author_id": "84072624", "lang": "en", "id": "1601250213175480322"}, {"entities": {"mentions": [{"start": 171, "end": 184, "username": "JaneWinterMD", "id": "1433149659808247813"}], "annotations": [{"start": 0, "end": 2, "probability": 0.4124, "type": "Other", "normalized_text": "ASH"}, {"start": 60, "end": 66, "probability": 0.4949, "type": "Other", "normalized_text": "Palooza"}], "hashtags": [{"start": 215, "end": 221, "tag": "ASH22"}, {"start": 222, "end": 233, "tag": "ASHTrainee"}], "urls": [{"start": 234, "end": 257, "url": "https://t.co/MSE6iBVRpM", "expanded_url": "https://twitter.com/ASH_hematology/status/1601246478537744386/photo/1", "display_url": "pic.twitter.com/MSE6iBVRpM", "media_key": "3_1601246474616115204"}]}, "source": "Loomly", "text": "ASH Trainees \u2013 we better see you boogieing on down to ASH-a-Palooza! Don\u2019t miss out on learning sessions, mentorship opportunities, &amp; (most importantly) ASH President @JaneWinterMD\u2019s parade to the reception \u269c\ufe0f \n#ASH22 #ASHTrainee https://t.co/MSE6iBVRpM", "conversation_id": "1601246478537744386", "created_at": "2022-12-09T16:04:44.000Z", "edit_history_tweet_ids": ["1601246478537744386"], "author_id": "84072624", "lang": "en", "id": "1601246478537744386"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1601216746349891596"}], "in_reply_to_user_id": "84072624", "text": "Thrombotic Microangiopathies | #ASH22 #TMA", "conversation_id": "1601216719137153026", "entities": {"hashtags": [{"start": 31, "end": 37, "tag": "ASH22"}, {"start": 38, "end": 42, "tag": "TMA"}]}, "created_at": "2022-12-09T14:06:36.000Z", "edit_history_tweet_ids": ["1601216749533552641"], "author_id": "84072624", "lang": "cy", "id": "1601216749533552641"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1601216743568965633"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 44, "end": 53, "probability": 0.5915, "type": "Other", "normalized_text": "Hematology"}, {"start": 58, "end": 62, "probability": 0.5346, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 43, "end": 54, "tag": "Hematology"}, {"start": 57, "end": 63, "tag": "ASH22"}, {"start": 64, "end": 79, "tag": "clinicaltrials"}, {"start": 80, "end": 97, "tag": "clinicalresearch"}]}, "text": "Advancing Decentralized Clinical Trials in #Hematology | #ASH22 #clinicaltrials #clinicalresearch", "conversation_id": "1601216719137153026", "created_at": "2022-12-09T14:06:36.000Z", "edit_history_tweet_ids": ["1601216746349891596"], "author_id": "84072624", "lang": "en", "id": "1601216746349891596"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1601216740742103041"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 0, "end": 7, "probability": 0.4366, "type": "Other", "normalized_text": "Germline"}, {"start": 81, "end": 85, "probability": 0.405, "type": "Other", "normalized_text": "ASH22"}, {"start": 88, "end": 92, "probability": 0.4965, "type": "Other", "normalized_text": "BMFSM"}, {"start": 95, "end": 99, "probability": 0.5641, "type": "Organization", "normalized_text": "mdssm"}, {"start": 102, "end": 106, "probability": 0.5647, "type": "Organization", "normalized_text": "mpnsm"}], "hashtags": [{"start": 80, "end": 86, "tag": "ASH22"}, {"start": 87, "end": 93, "tag": "BMFSM"}, {"start": 94, "end": 100, "tag": "mdssm"}, {"start": 101, "end": 107, "tag": "mpnsm"}]}, "text": "Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure | #ASH22 #BMFSM #mdssm #mpnsm", "conversation_id": "1601216719137153026", "created_at": "2022-12-09T14:06:35.000Z", "edit_history_tweet_ids": ["1601216743568965633"], "author_id": "84072624", "lang": "en", "id": "1601216743568965633"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1601216737017561088"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 34, "end": 40, "probability": 0.6144, "type": "Other", "normalized_text": "to Stay"}, {"start": 45, "end": 49, "probability": 0.5309, "type": "Other", "normalized_text": "ASH22"}, {"start": 52, "end": 57, "probability": 0.3951, "type": "Other", "normalized_text": "CRISPR"}, {"start": 73, "end": 76, "probability": 0.5335, "type": "Other", "normalized_text": "SCGE"}], "hashtags": [{"start": 16, "end": 27, "tag": "Hematology"}, {"start": 44, "end": 50, "tag": "ASH22"}, {"start": 51, "end": 58, "tag": "CRISPR"}, {"start": 59, "end": 71, "tag": "geneediting"}, {"start": 72, "end": 77, "tag": "SCGE"}]}, "text": "Gene Editing in #Hematology: Here to Stay | #ASH22 #CRISPR #geneediting #SCGE", "conversation_id": "1601216719137153026", "created_at": "2022-12-09T14:06:34.000Z", "edit_history_tweet_ids": ["1601216740742103041"], "author_id": "84072624", "lang": "en", "id": "1601216740742103041"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1601216734127702016"}], "in_reply_to_user_id": "84072624", "text": "Myeloid Development | #ASH22 #AMLsm #CML", "conversation_id": "1601216719137153026", "entities": {"hashtags": [{"start": 22, "end": 28, "tag": "ASH22"}, {"start": 29, "end": 35, "tag": "AMLsm"}, {"start": 36, "end": 40, "tag": "CML"}]}, "created_at": "2022-12-09T14:06:33.000Z", "edit_history_tweet_ids": ["1601216737017561088"], "author_id": "84072624", "lang": "ht", "id": "1601216737017561088"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1601216731317403652"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 71, "end": 76, "probability": 0.7153, "type": "Other", "normalized_text": "Cancer"}, {"start": 81, "end": 85, "probability": 0.5662, "type": "Other", "normalized_text": "ASH22"}, {"start": 101, "end": 104, "probability": 0.7332, "type": "Other", "normalized_text": "MMSM"}, {"start": 107, "end": 114, "probability": 0.5503, "type": "Other", "normalized_text": "leukemia"}], "hashtags": [{"start": 80, "end": 86, "tag": "ASH22"}, {"start": 87, "end": 99, "tag": "bloodcancer"}, {"start": 100, "end": 105, "tag": "MMSM"}, {"start": 106, "end": 115, "tag": "leukemia"}, {"start": 116, "end": 125, "tag": "genomics"}]}, "text": "Translational Molecular Diagnostics: Genomic Reclassification of Blood Cancer | #ASH22 #bloodcancer #MMSM #leukemia #genomics", "conversation_id": "1601216719137153026", "created_at": "2022-12-09T14:06:33.000Z", "edit_history_tweet_ids": ["1601216734127702016"], "author_id": "84072624", "lang": "en", "id": "1601216734127702016"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1601216728465383424"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 94, "end": 98, "probability": 0.5539, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 93, "end": 99, "tag": "ASH22"}, {"start": 100, "end": 113, "tag": "epidemiology"}, {"start": 114, "end": 127, "tag": "publichealth"}]}, "text": "Epidemiology: Leveraging Digital Technology to Modernize and Enhance Observational Studies | #ASH22 #epidemiology #publichealth", "conversation_id": "1601216719137153026", "created_at": "2022-12-09T14:06:32.000Z", "edit_history_tweet_ids": ["1601216731317403652"], "author_id": "84072624", "lang": "en", "id": "1601216731317403652"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1601216725600673792"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 91, "end": 99, "probability": 0.5037, "type": "Other", "normalized_text": "CAR_TCell"}], "hashtags": [{"start": 83, "end": 89, "tag": "ASH22"}, {"start": 90, "end": 100, "tag": "CAR_TCell"}]}, "text": "Bedside to Bench: Dissecting Emergent CAR T-cell Toxicities Beyond CRS and ICANS | #ASH22 #CAR_TCell", "conversation_id": "1601216719137153026", "created_at": "2022-12-09T14:06:31.000Z", "edit_history_tweet_ids": ["1601216728465383424"], "author_id": "84072624", "lang": "en", "id": "1601216728465383424"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1601216722584879106"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 24, "end": 28, "probability": 0.6258, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 23, "end": 29, "tag": "ASH22"}, {"start": 30, "end": 41, "tag": "hematology"}, {"start": 42, "end": 55, "tag": "healthyaging"}, {"start": 56, "end": 70, "tag": "patientsafety"}]}, "text": "Hematology and Aging | #ASH22 #hematology #healthyaging #patientsafety", "conversation_id": "1601216719137153026", "created_at": "2022-12-09T14:06:31.000Z", "edit_history_tweet_ids": ["1601216725600673792"], "author_id": "84072624", "lang": "en", "id": "1601216725600673792"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1601216719137153026"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 48, "end": 52, "probability": 0.5616, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 47, "end": 53, "tag": "ASH22"}, {"start": 54, "end": 72, "tag": "bleedingdisorders"}, {"start": 73, "end": 84, "tag": "hemophilia"}]}, "text": "Interplay between Coagulation and Malignancy | #ASH22 #bleedingdisorders #hemophilia", "conversation_id": "1601216719137153026", "created_at": "2022-12-09T14:06:30.000Z", "edit_history_tweet_ids": ["1601216722584879106"], "author_id": "84072624", "lang": "en", "id": "1601216722584879106"}, {"source": "Loomly", "entities": {"annotations": [{"start": 5, "end": 9, "probability": 0.6771, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 4, "end": 10, "tag": "ASH22"}], "urls": [{"start": 111, "end": 134, "url": "https://t.co/ahlfV8WYCa", "expanded_url": "https://twitter.com/ASH_hematology/status/1601216719137153026/photo/1", "display_url": "pic.twitter.com/ahlfV8WYCa", "media_key": "3_1601216716851257345"}]}, "text": "The #ASH22 Scientific Workshops are happening today from 2:00-5:00 p.m. CT! Check out the discussion topics \ud83e\uddf5\ud83d\udc47 https://t.co/ahlfV8WYCa", "conversation_id": "1601216719137153026", "created_at": "2022-12-09T14:06:29.000Z", "edit_history_tweet_ids": ["1601216719137153026"], "author_id": "84072624", "lang": "en", "id": "1601216719137153026"}, {"entities": {"mentions": [{"start": 3, "end": 17, "username": "DavidSteensma", "id": "2739065578"}, {"start": 117, "end": 132, "username": "ASH_hematology", "id": "84072624"}], "annotations": [{"start": 33, "end": 37, "probability": 0.6389, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 32, "end": 38, "tag": "ASH22"}]}, "source": "TweetDeck", "referenced_tweets": [{"type": "retweeted", "id": "1600956349105713152"}], "text": "RT @DavidSteensma: Attendees at #ASH22 might be interested in seeing the complete 4-page program from the first time @ASH_hematology held a\u2026", "conversation_id": "1600972025535029251", "created_at": "2022-12-08T21:54:10.000Z", "edit_history_tweet_ids": ["1600972025535029251"], "author_id": "84072624", "lang": "en", "id": "1600972025535029251"}, {"entities": {"mentions": [{"start": 0, "end": 9, "username": "maadulon", "id": "1375416370524000260"}], "annotations": [{"start": 22, "end": 26, "probability": 0.5948, "type": "Other", "normalized_text": "ASH22"}, {"start": 52, "end": 65, "probability": 0.84, "type": "Other", "normalized_text": "ASH News Daily"}], "hashtags": [{"start": 21, "end": 27, "tag": "ASH22"}], "urls": [{"start": 143, "end": 166, "url": "https://t.co/DJe8yMWRca", "expanded_url": "https://ashpublications.org/ashnewsdaily/news/6588/Getting-the-Most-Out-of-the-2022-Annual-Meeting-In/", "display_url": "ashpublications.org/ashnewsdaily/n\u2026", "status": 200, "title": "Getting the Most Out of the 2022 Annual Meeting \u2026 In Person AND Virtually! | ASH News Daily | American Society of Hematology", "description": "2022 marks 64 years of presenting the best science in hematology to the world. That\u2019s a lot of time to get things right, change with the times, and innovate for the sake of attendees and the g lobal profession overall. Compared to the three short years that the ASH annual meeting has been held with a virtual component, 64 years is literally a lifetime. It also puts into perspective the strides of the previous few years since going virtual. Like last year, 2022 sees the continued evolution of a customized", "unwound_url": "https://ashpublications.org/ashnewsdaily/news/6588/Getting-the-Most-Out-of-the-2022-Annual-Meeting-In/"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600567122215714833"}], "in_reply_to_user_id": "1375416370524000260", "text": "@maadulon Welcome to #ASH22! Find helpful tips from ASH News Daily: Getting the Most Out of the 2022 Annual Meeting \u2026 In Person AND Virtually! https://t.co/DJe8yMWRca", "conversation_id": "1600567122215714833", "created_at": "2022-12-08T16:32:19.000Z", "edit_history_tweet_ids": ["1600891032656171012"], "author_id": "84072624", "lang": "en", "id": "1600891032656171012"}, {"entities": {"mentions": [{"start": 0, "end": 15, "username": "LaurelMenapace", "id": "1064662683407003648"}], "urls": [{"start": 194, "end": 217, "url": "https://t.co/oPIEQtC9P8", "expanded_url": "https://loom.ly/XZDq84E", "display_url": "loom.ly/XZDq84E", "status": 200, "title": "64th ASH Annual Meeting FAQs - Hematology.org", "description": "64th ASH Annual Meeting FAQs", "unwound_url": "https://www.hematology.org/meetings/annual-meeting/ash-annual-meeting-faqs"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600654522317438977"}], "in_reply_to_user_id": "1064662683407003648", "text": "@LaurelMenapace This year badge pick-up is only in person - please make sure your vaccine verification is ready to go to avoid delays. Check out our meeting FAQs if you have any more questions! https://t.co/oPIEQtC9P8", "conversation_id": "1600654522317438977", "created_at": "2022-12-08T16:09:56.000Z", "edit_history_tweet_ids": ["1600885396698701824"], "author_id": "84072624", "lang": "en", "id": "1600885396698701824"}, {"entities": {"mentions": [{"start": 0, "end": 13, "username": "PedalheadPHX", "id": "32760936"}, {"start": 14, "end": 25, "username": "jmikhaelmd", "id": "2377190652"}], "urls": [{"start": 134, "end": 157, "url": "https://t.co/oPIEQtCHEG", "expanded_url": "https://loom.ly/XZDq84E", "display_url": "loom.ly/XZDq84E", "status": 200, "title": "64th ASH Annual Meeting FAQs - Hematology.org", "description": "64th ASH Annual Meeting FAQs", "unwound_url": "https://www.hematology.org/meetings/annual-meeting/ash-annual-meeting-faqs"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600632832522702848"}], "in_reply_to_user_id": "32760936", "text": "@PedalheadPHX @jmikhaelmd This year badge pick-up is only in person. Check out our meeting FAQs if you have any additional questions! https://t.co/oPIEQtCHEG", "conversation_id": "1600632832522702848", "created_at": "2022-12-08T16:07:42.000Z", "edit_history_tweet_ids": ["1600884834683203589"], "author_id": "84072624", "lang": "en", "id": "1600884834683203589"}, {"source": "Loomly", "entities": {"annotations": [{"start": 0, "end": 10, "probability": 0.9784, "type": "Place", "normalized_text": "New Orleans"}, {"start": 64, "end": 68, "probability": 0.3733, "type": "Other", "normalized_text": "ASH22"}, {"start": 183, "end": 188, "probability": 0.9827, "type": "Place", "normalized_text": "Denver"}, {"start": 202, "end": 205, "probability": 0.9775, "type": "Place", "normalized_text": "NOLA"}, {"start": 223, "end": 228, "probability": 0.6175, "type": "Place", "normalized_text": "Foshan"}], "hashtags": [{"start": 63, "end": 69, "tag": "ASH22"}], "urls": [{"start": 277, "end": 300, "url": "https://t.co/onkjS3hLVE", "expanded_url": "https://twitter.com/ASH_hematology/status/1600856480026075136/photo/1", "display_url": "pic.twitter.com/onkjS3hLVE", "media_key": "3_1600856477333422081"}]}, "text": "New Orleans, here we come\u2026 \ud83d\udeeb \ud83e\uddf3 Show us how you\u2019re traveling to #ASH22 &amp; reply with a photo of your journey \ud83d\udcf8 Whether you\u2019re commuting from your kitchen to the couch, driving from Denver to downtown NOLA, or flying from Foshan to the French Quarter \u2013 we want to see it all! https://t.co/onkjS3hLVE", "conversation_id": "1600856480026075136", "created_at": "2022-12-08T14:15:01.000Z", "edit_history_tweet_ids": ["1600856480026075136"], "author_id": "84072624", "lang": "en", "id": "1600856480026075136"}, {"entities": {"mentions": [{"start": 3, "end": 12, "username": "beckyzon", "id": "3242517017"}], "annotations": [{"start": 15, "end": 24, "probability": 0.376, "type": "Other", "normalized_text": "ASHtrainee"}, {"start": 47, "end": 49, "probability": 0.4164, "type": "Place", "normalized_text": "ASH"}, {"start": 53, "end": 59, "probability": 0.4215, "type": "Other", "normalized_text": "Palooza"}], "hashtags": [{"start": 14, "end": 25, "tag": "ASHtrainee"}, {"start": 89, "end": 95, "tag": "ASH22"}], "urls": [{"start": 112, "end": 135, "url": "https://t.co/DsQNtNgQ6K", "expanded_url": "https://tinyurl.com/mwr89tp9", "display_url": "tinyurl.com/mwr89tp9", "images": [{"url": "https://pbs.twimg.com/news_img/1599114806459449344/2wS7IprP?format=jpg&name=orig", "width": 660, "height": 495}, {"url": "https://pbs.twimg.com/news_img/1599114806459449344/2wS7IprP?format=jpg&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "I\u2019ve Registered for ASH. Now What? - Hematology.org", "description": "I\u2019ve Registered for ASH. Now What?", "unwound_url": "https://www.hematology.org/education/trainees/fellows/trainee-news/2022/registered-for-ash"}]}, "source": "TweetDeck", "referenced_tweets": [{"type": "retweeted", "id": "1599127783099494400"}], "text": "RT @beckyzon: #ASHtrainee make sure to come to ASH-a-Palooza. It is going to be AMAZING. #ASH22\n\nFor more info: https://t.co/DsQNtNgQ6K \n\n@\u2026", "conversation_id": "1600664082079703042", "created_at": "2022-12-08T01:30:30.000Z", "edit_history_tweet_ids": ["1600664082079703042"], "author_id": "84072624", "lang": "en", "id": "1600664082079703042"}, {"entities": {"mentions": [{"start": 3, "end": 15, "username": "FStPierreMD", "id": "1026289734904164353"}, {"start": 60, "end": 73, "username": "JaneWinterMD", "id": "1433149659808247813"}, {"start": 74, "end": 86, "username": "heMEGirl_MD", "id": "3608131998"}], "hashtags": [{"start": 53, "end": 59, "tag": "ASH22"}], "urls": [{"start": 87, "end": 110, "url": "https://t.co/GJThGGwzM4", "expanded_url": "https://twitter.com/FStPierreMD/status/1600652194541441025/photo/1", "display_url": "pic.twitter.com/GJThGGwzM4", "media_key": "3_1600652188220637184"}]}, "source": "TweetDeck", "referenced_tweets": [{"type": "retweeted", "id": "1600652194541441025"}], "text": "RT @FStPierreMD: Wine and cheese with the President.\n#ASH22\n@JaneWinterMD @heMEGirl_MD https://t.co/GJThGGwzM4", "conversation_id": "1600660920329461760", "created_at": "2022-12-08T01:17:56.000Z", "edit_history_tweet_ids": ["1600660920329461760"], "author_id": "84072624", "lang": "en", "id": "1600660920329461760"}, {"entities": {"mentions": [{"start": 3, "end": 15, "username": "DocsDock200", "id": "1586415236935991296"}], "annotations": [{"start": 34, "end": 37, "probability": 0.752, "type": "Place", "normalized_text": "NOLA"}, {"start": 71, "end": 77, "probability": 0.4165, "type": "Other", "normalized_text": "ASH2022"}], "hashtags": [{"start": 70, "end": 78, "tag": "ASH2022"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "retweeted", "id": "1600612587825143820"}], "text": "RT @DocsDock200: Just walked thru NOLA convention center. All set for #ASH2022. Place looks great. 80 degrees and sunny. https://t.co/DAiSG\u2026", "conversation_id": "1600659323272957953", "created_at": "2022-12-08T01:11:36.000Z", "edit_history_tweet_ids": ["1600659323272957953"], "author_id": "84072624", "lang": "en", "id": "1600659323272957953"}, {"source": "Twitter Web App", "entities": {"annotations": [{"start": 9, "end": 16, "probability": 0.5327, "type": "Organization", "normalized_text": "ASHKudos"}], "hashtags": [{"start": 8, "end": 17, "tag": "ASHKudos"}, {"start": 175, "end": 186, "tag": "hematology"}], "urls": [{"start": 237, "end": 260, "url": "https://t.co/Tft4trsWqB", "expanded_url": "https://loom.ly/yblGxIM", "display_url": "loom.ly/yblGxIM", "status": 200, "title": "ASH Announces Recipients of 2022 Advocacy Awards - Hematology.org", "description": "ASH Announces Recipients of 2022 Advocacy Awards", "unwound_url": "https://www.hematology.org/newsroom/press-releases/2022/ash-announces-recipients-of-2022-advocacy-awards?utm_source=organic_social&utm_medium=twitter&utm_campaign=advocacyaward_22"}, {"start": 261, "end": 284, "url": "https://t.co/8l4FrrYu1Q", "expanded_url": "https://twitter.com/ASH_hematology/status/1600605588022562817/photo/1", "display_url": "pic.twitter.com/8l4FrrYu1Q", "media_key": "3_1600605391259373568"}]}, "text": "Another #ASHKudos is in order -  this year's ASH Outstanding Service &amp; Public Service Awards  recipients have demonstrated incredible leadership in advancing the field of #hematology through advocacy! Learn more about their efforts: https://t.co/Tft4trsWqB https://t.co/8l4FrrYu1Q", "conversation_id": "1600605588022562817", "created_at": "2022-12-07T21:38:04.000Z", "edit_history_tweet_ids": ["1600605588022562817"], "author_id": "84072624", "lang": "en", "id": "1600605588022562817"}, {"entities": {"mentions": [{"start": 3, "end": 19, "username": "ASHClinicalNews", "id": "2842612449"}], "annotations": [{"start": 58, "end": 60, "probability": 0.8803, "type": "Organization", "normalized_text": "WHO"}, {"start": 63, "end": 66, "probability": 0.7781, "type": "Organization", "normalized_text": "IARC"}, {"start": 77, "end": 79, "probability": 0.7741, "type": "Organization", "normalized_text": "ICC"}], "hashtags": [{"start": 57, "end": 61, "tag": "WHO"}, {"start": 62, "end": 67, "tag": "IARC"}, {"start": 76, "end": 80, "tag": "ICC"}, {"start": 100, "end": 112, "tag": "hematologic"}, {"start": 113, "end": 123, "tag": "neoplasms"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "retweeted", "id": "1600589369152339969"}], "text": "RT @ASHClinicalNews: Though there is overlap between the #WHO #IARC and new #ICC classifications of #hematologic #neoplasms, having two cla\u2026", "conversation_id": "1600590701699469330", "created_at": "2022-12-07T20:38:55.000Z", "edit_history_tweet_ids": ["1600590701699469330"], "author_id": "84072624", "lang": "en", "id": "1600590701699469330"}, {"entities": {"mentions": [{"start": 0, "end": 10, "username": "eskazanae", "id": "89017265"}], "annotations": [{"start": 66, "end": 70, "probability": 0.7211, "type": "Other", "normalized_text": "ASH22"}, {"start": 108, "end": 111, "probability": 0.9351, "type": "Place", "normalized_text": "NOLA"}], "hashtags": [{"start": 65, "end": 71, "tag": "ASH22"}]}, "source": "TweetDeck", "referenced_tweets": [{"type": "replied_to", "id": "1600560087809941504"}], "in_reply_to_user_id": "89017265", "text": "@eskazanae So lovely to see where everyone is traveling from for #ASH22! We look forward to greeting you in NOLA!", "conversation_id": "1600560087809941504", "created_at": "2022-12-07T19:48:32.000Z", "edit_history_tweet_ids": ["1600578023715135488"], "author_id": "84072624", "lang": "en", "id": "1600578023715135488"}, {"entities": {"mentions": [{"start": 0, "end": 16, "username": "ShuchiChromaBio", "id": "1291680846156529664"}, {"start": 17, "end": 29, "username": "BritSocHaem", "id": "201645895"}], "annotations": [{"start": 55, "end": 65, "probability": 0.9941, "type": "Place", "normalized_text": "New Orleans"}]}, "source": "TweetDeck", "referenced_tweets": [{"type": "replied_to", "id": "1600557710218387456"}], "in_reply_to_user_id": "1291680846156529664", "text": "@ShuchiChromaBio @BritSocHaem Can't wait to see you in New Orleans!!", "conversation_id": "1600555830939631618", "created_at": "2022-12-07T18:32:19.000Z", "edit_history_tweet_ids": ["1600558843162812416"], "author_id": "84072624", "lang": "en", "id": "1600558843162812416"}, {"source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600555865295175698"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 27, "end": 34, "probability": 0.5652, "type": "Organization", "normalized_text": "ASHKudos"}, {"start": 106, "end": 110, "probability": 0.7096, "type": "Other", "normalized_text": "ASH22"}, {"start": 124, "end": 130, "probability": 0.988, "type": "Other", "normalized_text": "Twitter"}, {"start": 244, "end": 247, "probability": 0.7854, "type": "Place", "normalized_text": "NOLA"}], "hashtags": [{"start": 26, "end": 35, "tag": "ASHKudos"}, {"start": 105, "end": 111, "tag": "ASH22"}, {"start": 243, "end": 248, "tag": "NOLA"}], "urls": [{"start": 250, "end": 273, "url": "https://t.co/xXQjMqmXTE", "expanded_url": "https://loom.ly/Gv0idBE", "display_url": "loom.ly/Gv0idBE", "status": 404, "unwound_url": "https://twitter.com/i/lists/1592281764646592514?s=20&utm_source=twitter&utm_medium=organic_social&utm_campaign=voices_of_ash22"}]}, "text": "Let's give them all a big #ASHKudos \ud83d\udc4f\ud83c\udffb\ud83d\udc4f\ud83c\udffd\ud83d\udc4f\ud83c\udffe\ud83d\udc4f\ud83c\udfff on their achievements! Want to hear more from our Voices of #ASH22? Follow our Twitter list to get their full take on the meeting, learn more about their work, &amp; find out where to catch them in #NOLA: https://t.co/xXQjMqmXTE \n9/9", "conversation_id": "1600555830939631618", "created_at": "2022-12-07T18:20:30.000Z", "edit_history_tweet_ids": ["1600555867132362754"], "author_id": "84072624", "lang": "en", "id": "1600555867132362754"}, {"entities": {"mentions": [{"start": 19, "end": 31, "username": "nsarellano9", "id": "1384691585011572739"}], "annotations": [{"start": 132, "end": 136, "probability": 0.4563, "type": "Other", "normalized_text": "mpnsm"}], "hashtags": [{"start": 131, "end": 137, "tag": "mpnsm"}, {"start": 169, "end": 175, "tag": "ASH22"}], "urls": [{"start": 187, "end": 210, "url": "https://t.co/HlzNLzO1yE", "expanded_url": "https://twitter.com/ASH_hematology/status/1600555865295175698/photo/1", "display_url": "pic.twitter.com/HlzNLzO1yE", "media_key": "3_1600555726027489280"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600555859691585555"}], "in_reply_to_user_id": "84072624", "text": "Finally, we've got @nsarellano9! This graduate student from @ElflLabUChicago is attending this year's meeting to share her work on #mpnsm \ud83d\udc69\ud83c\udffb\u200d\u2695\ufe0f\ud83d\udd2c Check out her plans for #ASH22 below!\n8/9 https://t.co/HlzNLzO1yE", "conversation_id": "1600555830939631618", "created_at": "2022-12-07T18:20:29.000Z", "edit_history_tweet_ids": ["1600555865295175698"], "author_id": "84072624", "lang": "en", "id": "1600555865295175698"}, {"entities": {"mentions": [{"start": 27, "end": 43, "username": "ShuchiChromaBio", "id": "1291680846156529664"}, {"start": 69, "end": 81, "username": "BritSocHaem", "id": "201645895"}], "annotations": [{"start": 65, "end": 67, "probability": 0.3153, "type": "Other", "normalized_text": "ASH"}, {"start": 103, "end": 107, "probability": 0.566, "type": "Other", "normalized_text": "Award"}, {"start": 114, "end": 118, "probability": 0.4571, "type": "Other", "normalized_text": "Singh"}, {"start": 149, "end": 153, "probability": 0.6199, "type": "Other", "normalized_text": "HOXA9"}, {"start": 199, "end": 201, "probability": 0.363, "type": "Organization", "normalized_text": "AML"}, {"start": 234, "end": 237, "probability": 0.7096, "type": "Place", "normalized_text": "NOLA"}], "hashtags": [{"start": 148, "end": 154, "tag": "HOXA9"}, {"start": 198, "end": 202, "tag": "AML"}, {"start": 265, "end": 271, "tag": "ASH22"}], "urls": [{"start": 278, "end": 301, "url": "https://t.co/zbVdCBildz", "expanded_url": "https://twitter.com/ASH_hematology/status/1600555859691585555/photo/1", "display_url": "pic.twitter.com/zbVdCBildz", "media_key": "3_1600555613939023881"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600555855308414976"}], "in_reply_to_user_id": "84072624", "text": "From across the pond, it's @ShuchiChromaBio! As recipient of the ASH-@BritSocHaem Abstract Achievement Award, Dr. Singh will be sharing her work on #HOXA9 &amp; the importance of differentiation in #AML \ud83e\uddec Find out why she\u2019s coming to NOLA for all the excitement of #ASH22\u2935\ufe0f\n7/9 https://t.co/zbVdCBildz", "conversation_id": "1600555830939631618", "created_at": "2022-12-07T18:20:28.000Z", "edit_history_tweet_ids": ["1600555859691585555"], "author_id": "84072624", "lang": "en", "id": "1600555859691585555"}, {"entities": {"mentions": [{"start": 14, "end": 26, "username": "Djeffreedom", "id": "343131539"}], "annotations": [{"start": 32, "end": 38, "probability": 0.6464, "type": "Other", "normalized_text": "Edwards"}, {"start": 82, "end": 84, "probability": 0.4019, "type": "Other", "normalized_text": "TCD"}, {"start": 172, "end": 174, "probability": 0.3465, "type": "Organization", "normalized_text": "SCD"}], "hashtags": [{"start": 81, "end": 85, "tag": "TCD"}, {"start": 113, "end": 124, "tag": "sicklecell"}, {"start": 142, "end": 159, "tag": "healthinequities"}, {"start": 171, "end": 175, "tag": "SCD"}, {"start": 270, "end": 276, "tag": "ASH22"}], "urls": [{"start": 283, "end": 306, "url": "https://t.co/Lp2Ne5L3M4", "expanded_url": "https://twitter.com/ASH_hematology/status/1600555855308414976/photo/1", "display_url": "pic.twitter.com/Lp2Ne5L3M4", "media_key": "3_1600555501091274817"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600555849855950848"}], "in_reply_to_user_id": "84072624", "text": "Next, we have @Djeffreedom! Dr. Edwards will be presenting on his work improving #TCD screening in children with #sicklecell &amp; addressing #healthinequities within the #SCD community at the Promoting Minorities in Hematology event \u2764\ufe0f\ud83e\udd1d\ud83c\udffd See why he can\u2019t wait to be at #ASH22\u2935\ufe0f\n6/9 https://t.co/Lp2Ne5L3M4", "conversation_id": "1600555830939631618", "created_at": "2022-12-07T18:20:27.000Z", "edit_history_tweet_ids": ["1600555855308414976"], "author_id": "84072624", "lang": "en", "id": "1600555855308414976"}, {"entities": {"mentions": [{"start": 44, "end": 56, "username": "chancolonne", "id": "16681509"}, {"start": 85, "end": 98, "username": "hsanz_org_au", "id": "1055695780676169729"}], "annotations": [{"start": 17, "end": 22, "probability": 0.7252, "type": "Place", "normalized_text": "Sydney"}, {"start": 25, "end": 33, "probability": 0.9706, "type": "Place", "normalized_text": "Australia"}, {"start": 108, "end": 124, "probability": 0.7076, "type": "Other", "normalized_text": "Achievement Award"}], "hashtags": [{"start": 201, "end": 212, "tag": "hematology"}, {"start": 264, "end": 270, "tag": "ASH22"}], "urls": [{"start": 276, "end": 299, "url": "https://t.co/Y2Qe6jA8yw", "expanded_url": "https://twitter.com/ASH_hematology/status/1600555849855950848/photo/1", "display_url": "pic.twitter.com/Y2Qe6jA8yw", "media_key": "3_1600555348926119967"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600555844814315520"}], "in_reply_to_user_id": "84072624", "text": "All the way from Sydney, Australia, we have @chancolonne! She's been awarded the ASH-@hsanz_org_au Abstract Achievement Award for her research on a new subtype of erythroblasts \ud83d\udd2c \ud83e\ude78 Read about why this #hematology expert is traveling across the world to experience #ASH22!\n5/9 https://t.co/Y2Qe6jA8yw", "conversation_id": "1600555830939631618", "created_at": "2022-12-07T18:20:26.000Z", "edit_history_tweet_ids": ["1600555849855950848"], "author_id": "84072624", "lang": "en", "id": "1600555849855950848"}, {"entities": {"mentions": [{"start": 11, "end": 27, "username": "MayaAbdallah_MD", "id": "1117914517567098880"}], "annotations": [{"start": 58, "end": 67, "probability": 0.5108, "type": "Other", "normalized_text": "ASHTrainee"}, {"start": 186, "end": 190, "probability": 0.4992, "type": "Other", "normalized_text": "ASH22"}, {"start": 235, "end": 247, "probability": 0.5557, "type": "Other", "normalized_text": "SHEmatologist"}], "hashtags": [{"start": 57, "end": 68, "tag": "ASHTrainee"}, {"start": 185, "end": 191, "tag": "ASH22"}, {"start": 234, "end": 248, "tag": "SHEmatologist"}], "urls": [{"start": 275, "end": 298, "url": "https://t.co/GaAVkXEErl", "expanded_url": "https://twitter.com/ASH_hematology/status/1600555844814315520/photo/1", "display_url": "pic.twitter.com/GaAVkXEErl", "media_key": "3_1600555235755409440"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600555840385204230"}], "in_reply_to_user_id": "84072624", "text": "Next up is @MayaAbdallah_MD! This standing member of the #ASHTrainee Council has just joined our Communications Committee &amp; is a \u2728certified social media superstar\u2728 Read her special #ASH22 message to learn about what sessions this #SHEmatologist is excited to attend!\n4/9 https://t.co/GaAVkXEErl", "conversation_id": "1600555830939631618", "created_at": "2022-12-07T18:20:24.000Z", "edit_history_tweet_ids": ["1600555844814315520"], "author_id": "84072624", "lang": "en", "id": "1600555844814315520"}, {"entities": {"mentions": [{"start": 34, "end": 48, "username": "Andresnoyolaa", "id": "1936057358"}], "annotations": [{"start": 13, "end": 21, "probability": 0.7613, "type": "Place", "normalized_text": "Monterrey"}, {"start": 24, "end": 25, "probability": 0.4108, "type": "Place", "normalized_text": "MX"}, {"start": 108, "end": 123, "probability": 0.6031, "type": "Other", "normalized_text": "ASH HONORS Award"}], "hashtags": [{"start": 159, "end": 171, "tag": "celltherapy"}, {"start": 178, "end": 195, "tag": "healthinequities"}, {"start": 263, "end": 269, "tag": "ASH22"}], "urls": [{"start": 283, "end": 306, "url": "https://t.co/9oOzkLu4ML", "expanded_url": "https://twitter.com/ASH_hematology/status/1600555840385204230/photo/1", "display_url": "pic.twitter.com/9oOzkLu4ML", "media_key": "3_1600555120407855133"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600555835331342336"}], "in_reply_to_user_id": "84072624", "text": "Hailing from Monterrey, MX , it's @andresnoyolaa! As a medical student, his outstanding work earned him the ASH HONORS Award to help carry out his research in #celltherapy &amp; #healthinequities \ud83d\udc89\ud83c\udfe5 See why he's eager to help build international community in his #ASH22 message!\n3/9 https://t.co/9oOzkLu4ML", "conversation_id": "1600555830939631618", "created_at": "2022-12-07T18:20:23.000Z", "edit_history_tweet_ids": ["1600555840385204230"], "author_id": "84072624", "lang": "en", "id": "1600555840385204230"}, {"entities": {"mentions": [{"start": 10, "end": 19, "username": "beckyzon", "id": "3242517017"}], "annotations": [{"start": 26, "end": 35, "probability": 0.6756, "type": "Other", "normalized_text": "ASHTrainee"}, {"start": 150, "end": 156, "probability": 0.692, "type": "Other", "normalized_text": "heparin"}, {"start": 166, "end": 181, "probability": 0.6591, "type": "Other", "normalized_text": "thrombocytopenia"}, {"start": 223, "end": 227, "probability": 0.4945, "type": "Other", "normalized_text": ". Zon"}], "hashtags": [{"start": 25, "end": 36, "tag": "ASHTrainee"}, {"start": 259, "end": 265, "tag": "ASH22"}], "urls": [{"start": 273, "end": 296, "url": "https://t.co/b42rmtSCpL", "expanded_url": "https://twitter.com/ASH_hematology/status/1600555835331342336/photo/1", "display_url": "pic.twitter.com/b42rmtSCpL", "media_key": "3_1600554965310783488"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600555830939631618"}], "in_reply_to_user_id": "84072624", "text": "First up, @beckyzon! Our #ASHTrainee Council Chair will be presenting on implementation of electronic health alerts to improve care for patients with heparin-induced thrombocytopenia \u2695\ufe0f\ud83d\udda5\ufe0f Check out a special message from Dr. Zon below on why she's pumped for #ASH22!  \n2/9 https://t.co/b42rmtSCpL", "conversation_id": "1600555830939631618", "created_at": "2022-12-07T18:20:22.000Z", "edit_history_tweet_ids": ["1600555835331342336"], "author_id": "84072624", "lang": "en", "id": "1600555835331342336"}, {"source": "Twitter Web App", "entities": {"annotations": [{"start": 68, "end": 72, "probability": 0.64, "type": "Other", "normalized_text": "ASH22"}, {"start": 178, "end": 188, "probability": 0.9894, "type": "Place", "normalized_text": "New Orleans"}], "hashtags": [{"start": 67, "end": 73, "tag": "ASH22"}, {"start": 97, "end": 108, "tag": "hematology"}], "urls": [{"start": 275, "end": 298, "url": "https://t.co/WGIwYK34th", "expanded_url": "https://twitter.com/ASH_hematology/status/1600555830939631618/photo/1", "display_url": "pic.twitter.com/WGIwYK34th", "media_key": "3_1600554823052673054"}]}, "text": "Drumroll, please...\ud83e\udd41\ud83e\udd41\ud83e\udd41 We'd like to introduce you to our Voices of #ASH22! These rising stars in #hematology are traveling from around the globe to attend this year's meeting in New Orleans \u269c\ufe0f Check out the \ud83e\uddf5\ud83d\udc47 to find out why they're all excited to get in on the action!\n1/9 https://t.co/WGIwYK34th", "conversation_id": "1600555830939631618", "created_at": "2022-12-07T18:20:21.000Z", "edit_history_tweet_ids": ["1600555830939631618"], "author_id": "84072624", "lang": "en", "id": "1600555830939631618"}, {"entities": {"mentions": [{"start": 0, "end": 14, "username": "Dr_AmerZeidan", "id": "1144997352148787201"}], "annotations": [{"start": 113, "end": 117, "probability": 0.7896, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 112, "end": 118, "tag": "ASH22"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600528627086622726"}], "in_reply_to_user_id": "1144997352148787201", "text": "@Dr_AmerZeidan We love that our annual meetings can create experiences like this one - a core memory! Hopefully #ASH22 has something just as special in store \ud83d\ude0a", "conversation_id": "1600528627086622726", "created_at": "2022-12-07T18:14:47.000Z", "edit_history_tweet_ids": ["1600554431010918400"], "author_id": "84072624", "lang": "en", "id": "1600554431010918400"}, {"entities": {"mentions": [{"start": 0, "end": 12, "username": "DrAlbertoLG", "id": "1145441671129292801"}], "annotations": [{"start": 83, "end": 93, "probability": 0.9903, "type": "Place", "normalized_text": "New Orleans"}, {"start": 99, "end": 103, "probability": 0.4687, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 98, "end": 104, "tag": "ASH22"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600412235116912640"}], "in_reply_to_user_id": "1145441671129292801", "text": "@DrAlbertoLG Final prep in the airport - we love it! Safe travels &amp; see you in New Orleans at #ASH22 \ud83e\udd17", "conversation_id": "1600412235116912640", "created_at": "2022-12-07T17:18:43.000Z", "edit_history_tweet_ids": ["1600540319367327744"], "author_id": "84072624", "lang": "en", "id": "1600540319367327744"}, {"entities": {"mentions": [{"start": 0, "end": 15, "username": "AkshaySharmaMD", "id": "754664467015892992"}, {"start": 16, "end": 29, "username": "rosslevinemd", "id": "2700794490"}], "annotations": [{"start": 114, "end": 118, "probability": 0.5805, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 113, "end": 119, "tag": "ASH22"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600474108130603008"}], "in_reply_to_user_id": "754664467015892992", "text": "@AkshaySharmaMD @rosslevinemd And be sure to verify your vaccination status before going to pick up your badge!! #ASH22", "conversation_id": "1600469018825019393", "created_at": "2022-12-07T16:36:11.000Z", "edit_history_tweet_ids": ["1600529614396350464"], "author_id": "84072624", "lang": "en", "id": "1600529614396350464"}, {"entities": {"mentions": [{"start": 0, "end": 12, "username": "FStPierreMD", "id": "1026289734904164353"}, {"start": 13, "end": 28, "username": "NUHemOncFellow", "id": "1527734252112162819"}, {"start": 29, "end": 45, "username": "NorthwesternMed", "id": "21438665"}, {"start": 46, "end": 58, "username": "LurieCancer", "id": "1006862749"}, {"start": 59, "end": 72, "username": "JaneWinterMD", "id": "1433149659808247813"}, {"start": 73, "end": 85, "username": "heMEGirl_MD", "id": "3608131998"}], "annotations": [{"start": 130, "end": 134, "probability": 0.5527, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 129, "end": 135, "tag": "ASH22"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600512703038119936"}], "in_reply_to_user_id": "1026289734904164353", "text": "@FStPierreMD @NUHemOncFellow @NorthwesternMed @LurieCancer @JaneWinterMD @heMEGirl_MD Safe travels!! We can't wait to see you at #ASH22 \ud83e\udd29", "conversation_id": "1600512703038119936", "created_at": "2022-12-07T16:29:13.000Z", "edit_history_tweet_ids": ["1600527863563919360"], "author_id": "84072624", "lang": "en", "id": "1600527863563919360"}, {"source": "Loomly", "entities": {"annotations": [{"start": 5, "end": 9, "probability": 0.7999, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 4, "end": 10, "tag": "ASH22"}], "urls": [{"start": 73, "end": 96, "url": "https://t.co/UKP5C16Fcr", "expanded_url": "https://loom.ly/1FMjjis", "display_url": "loom.ly/1FMjjis", "status": 200, "title": "64th ASH Annual Meeting and Exposition", "description": "64th ASH Annual Meeting and Exposition", "unwound_url": "https://annualmeeting.hematology.org/?utm_source=organic_social&utm_medium=twitter&utm_campaign=virtualplatform_22"}, {"start": 97, "end": 120, "url": "https://t.co/59GoiHbs78", "expanded_url": "https://twitter.com/ASH_hematology/status/1600507688705818627/photo/1", "display_url": "pic.twitter.com/59GoiHbs78", "media_key": "3_1600507685518065667"}]}, "text": "The #ASH22 virtual platform is officially OPEN! Start exploring now \ud83e\uddd1\u200d\ud83d\udcbb: https://t.co/UKP5C16Fcr https://t.co/59GoiHbs78", "conversation_id": "1600507688705818627", "created_at": "2022-12-07T15:09:03.000Z", "edit_history_tweet_ids": ["1600507688705818627"], "author_id": "84072624", "lang": "en", "id": "1600507688705818627"}, {"source": "Loomly", "entities": {"annotations": [{"start": 36, "end": 40, "probability": 0.6569, "type": "Other", "normalized_text": "ASH22"}, {"start": 160, "end": 162, "probability": 0.3535, "type": "Place", "normalized_text": "ASH"}, {"start": 234, "end": 235, "probability": 0.9532, "type": "Place", "normalized_text": "US"}], "hashtags": [{"start": 35, "end": 41, "tag": "ASH22"}], "urls": [{"start": 256, "end": 279, "url": "https://t.co/qKvvYZZcOi", "expanded_url": "https://loom.ly/smoqjms", "display_url": "loom.ly/smoqjms", "status": 200, "title": "2023 Highlights of ASH\u00ae", "description": "Get a synopsis of the top hematology research presented at the latest ASH annual meeting and learn how it can help improve your patient management and care strategies at Highlights of ASH.", "unwound_url": "https://www.hematology.org/meetings/highlights?utm_source=twitter&utm_medium=organic_social&utm_campaign=HOA_2023"}, {"start": 280, "end": 303, "url": "https://t.co/gDH4Jd9g9a", "expanded_url": "https://twitter.com/ASH_hematology/status/1600120439040360450/photo/1", "display_url": "pic.twitter.com/gDH4Jd9g9a", "media_key": "3_1600120437178073091"}]}, "text": "Interested in how new science from #ASH22 could impact hematology research &amp; clinical practice your region? Don't miss the only official 2023 Highlights of ASH! Register to attend one (or more \ud83e\udd13) of eight regional recaps \u2013 in the US or abroad \u2013 today: https://t.co/qKvvYZZcOi https://t.co/gDH4Jd9g9a", "conversation_id": "1600120439040360450", "created_at": "2022-12-06T13:30:16.000Z", "edit_history_tweet_ids": ["1600120439040360450"], "author_id": "84072624", "lang": "en", "id": "1600120439040360450"}, {"entities": {"mentions": [{"start": 3, "end": 19, "username": "ASHClinicalNews", "id": "2842612449"}], "annotations": [{"start": 54, "end": 58, "probability": 0.7493, "type": "Other", "normalized_text": "ASH22"}, {"start": 128, "end": 138, "probability": 0.7328, "type": "Other", "normalized_text": "Olatoyosi O"}], "hashtags": [{"start": 53, "end": 59, "tag": "ASH22"}]}, "source": "TweetDeck", "referenced_tweets": [{"type": "retweeted", "id": "1599811273528590336"}], "text": "RT @ASHClinicalNews: Check out what's to come in the #ASH22 Education Program in our exclusive interview with program co-chairs Olatoyosi O\u2026", "conversation_id": "1599909991812681728", "created_at": "2022-12-05T23:34:01.000Z", "edit_history_tweet_ids": ["1599909991812681728"], "author_id": "84072624", "lang": "en", "id": "1599909991812681728"}, {"source": "Loomly", "entities": {"annotations": [{"start": 7, "end": 14, "probability": 0.5231, "type": "Organization", "normalized_text": "ASHKudos"}, {"start": 28, "end": 54, "probability": 0.5877, "type": "Other", "normalized_text": "ASH Exemplary Service Award"}, {"start": 117, "end": 119, "probability": 0.7245, "type": "Organization", "normalized_text": "ASH"}, {"start": 123, "end": 130, "probability": 0.9874, "type": "Other", "normalized_text": "COVID-19"}, {"start": 241, "end": 249, "probability": 0.4463, "type": "Other", "normalized_text": "ASHAwards"}], "hashtags": [{"start": 6, "end": 15, "tag": "ASHKudos"}, {"start": 240, "end": 250, "tag": "ASHAwards"}], "urls": [{"start": 216, "end": 239, "url": "https://t.co/us6BGbqAML", "expanded_url": "https://loom.ly/2OHz9Pc", "display_url": "loom.ly/2OHz9Pc", "status": 200, "title": "The American Society of Hematology Honors Drs. Chancellor Donald, Cynthia Dunbar, Stephanie Lee, and Laura Michaelis with the 2022 Exemplary Service Award - Hematology.org", "description": "The American Society of Hematology Honors Drs. Chancellor Donald, Cynthia Dunbar, Stephanie Lee, and Laura Michaelis with the 2022 Exemplary Service Award", "unwound_url": "https://www.hematology.org/newsroom/press-releases/2022/exemplary-service-2022?utm_source=organic_social&utm_medium=twitter&utm_campaign=exemplaryservicepr_22"}, {"start": 251, "end": 274, "url": "https://t.co/G5kz2rRiEz", "expanded_url": "https://twitter.com/ASH_hematology/status/1599782254582145024/photo/1", "display_url": "pic.twitter.com/G5kz2rRiEz", "media_key": "3_1599782252560453633"}]}, "text": "A big #ASHKudos to our 2022 ASH Exemplary Service Award recipients! We are so appreciative of all their hard work on ASH's COVID-19 response efforts &amp; admire their commitment to the community \ud83d\udc4f\ud83c\udffb\ud83d\udc4f\ud83c\udffd\ud83d\udc4f\ud83c\udffe\ud83d\udc4f\ud83c\udfff Read more: https://t.co/us6BGbqAML\n#ASHAwards https://t.co/G5kz2rRiEz", "conversation_id": "1599782254582145024", "created_at": "2022-12-05T15:06:26.000Z", "edit_history_tweet_ids": ["1599782254582145024"], "author_id": "84072624", "lang": "en", "id": "1599782254582145024"}, {"source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1598791621587439634"}], "in_reply_to_user_id": "84072624", "text": "The annual meeting virtual platform will open on 12/7, at 9:00 a.m. CT &amp; is available to ALL attendees! Log in during Preview Days to get re-acquainted with the platform and build your schedule \ud83e\uddd1\u200d\ud83d\udcbb Be sure to bookmark https://t.co/gCdNj8lLH4 to access the platform!", "conversation_id": "1598791474325630976", "created_at": "2022-12-02T21:30:02.000Z", "edit_history_tweet_ids": ["1598791625760641024"], "entities": {"urls": [{"start": 222, "end": 245, "url": "https://t.co/gCdNj8lLH4", "expanded_url": "http://annualmeeting.hematology.org", "display_url": "annualmeeting.hematology.org", "status": 403, "unwound_url": "http://annualmeeting.hematology.org"}]}, "author_id": "84072624", "lang": "en", "id": "1598791625760641024"}, {"source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1598791543573385243"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 190, "end": 192, "probability": 0.5113, "type": "Organization", "normalized_text": "GPS"}], "urls": [{"start": 251, "end": 274, "url": "https://t.co/4drhbuESor", "expanded_url": "https://loom.ly/GpFJdp0", "display_url": "loom.ly/GpFJdp0", "status": 200, "title": "ASH Annual Meeting App", "description": "The ASH annual meeting app includes the complete ASH annual meeting program, the full text of all annual meeting abstracts, and more. Download the app for iOS or Android devices.", "unwound_url": "https://www.hematology.org/meetings/annual-meeting/attendee-resources/mobile-app?utm_source=organic_social&utm_medium=twitter&utm_campaign=mobileapp_22"}, {"start": 275, "end": 298, "url": "https://t.co/u1uXwfq03A", "expanded_url": "https://twitter.com/ASH_hematology/status/1598791621587439634/video/1", "display_url": "pic.twitter.com/u1uXwfq03A", "media_key": "7_1598791394608484379"}]}, "text": "Get access to everything you need, including the complete annual meeting program, the full text of all annual meeting abstracts, &amp; other general information with our mobile app \ud83d\udcf2 with a GPS-enabled tool to help you navigate the convention center!\nhttps://t.co/4drhbuESor https://t.co/u1uXwfq03A", "conversation_id": "1598791474325630976", "created_at": "2022-12-02T21:30:01.000Z", "edit_history_tweet_ids": ["1598791621587439634"], "author_id": "84072624", "lang": "en", "id": "1598791621587439634"}, {"source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1598791474325630976"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 54, "end": 58, "probability": 0.6847, "type": "Other", "normalized_text": "ASH22"}, {"start": 156, "end": 166, "probability": 0.9941, "type": "Place", "normalized_text": "New Orleans"}], "hashtags": [{"start": 53, "end": 59, "tag": "ASH22"}], "urls": [{"start": 63, "end": 86, "url": "https://t.co/XiyabRBax2", "expanded_url": "https://loom.ly/Lmicp4c", "display_url": "loom.ly/Lmicp4c", "status": 200, "title": "ASH Annual Meeting Health and Safety Protocols - Hematology.org", "description": "The safety of meeting attendees is ASH\u2019s top priority, and we believe the most effective way to ensure the safety of all attendees is for them to be vaccinated against COVID-19. Please note that proof of vaccination will be required for all in-person meeting attendees prior to traveling to Atlanta.", "unwound_url": "https://www.hematology.org/meetings/annual-meeting/attendee-resources/health-and-safety-protocols?utm_source=organic_social&utm_medium=twitter&utm_campaign=healthandsafety_22"}, {"start": 282, "end": 305, "url": "https://t.co/70DOcnGmTs", "expanded_url": "https://twitter.com/ASH_hematology/status/1598791543573385243/video/1", "display_url": "pic.twitter.com/70DOcnGmTs", "media_key": "7_1598791336777420815"}]}, "text": "Below are some key health &amp; safety protocols for #ASH22 \u23ef\ufe0f https://t.co/XiyabRBax2\n\nDon't forget to upload your proof of vaccination before arriving in New Orleans and enroll in medical evacuation and quarantine support coverage (free for non-industry attendees) by December 4! https://t.co/70DOcnGmTs", "conversation_id": "1598791474325630976", "created_at": "2022-12-02T21:29:42.000Z", "edit_history_tweet_ids": ["1598791543573385243"], "author_id": "84072624", "lang": "en", "id": "1598791543573385243"}, {"source": "Twitter Web App", "entities": {"annotations": [{"start": 14, "end": 23, "probability": 0.3941, "type": "Other", "normalized_text": "Bourbon St"}, {"start": 127, "end": 131, "probability": 0.5796, "type": "Other", "normalized_text": "ASH22"}, {"start": 202, "end": 219, "probability": 0.7517, "type": "Other", "normalized_text": "Know Before You Go"}], "hashtags": [{"start": 126, "end": 132, "tag": "ASH22"}], "urls": [{"start": 248, "end": 271, "url": "https://t.co/eJ8zJHb7HQ", "expanded_url": "https://loom.ly/DwBfDis", "display_url": "loom.ly/DwBfDis", "status": 200, "title": "Know Before You Go - Hematology.org", "description": "Know Before You Go", "unwound_url": "https://www.hematology.org/meetings/annual-meeting/know-before-you-go?utm_source=organic_social&utm_medium=twitter&utm_campaign=kbyg_22"}, {"start": 272, "end": 295, "url": "https://t.co/G4oDWobwHm", "expanded_url": "https://twitter.com/ASH_hematology/status/1598791474325630976/video/1", "display_url": "pic.twitter.com/G4oDWobwHm", "media_key": "7_1598790770240196608"}]}, "text": "Get ready for Bourbon St., beignets, &amp; a bloody good time! We\u2019ve got everything you need to know to make the most of your #ASH22 experience \ud83d\ude4c Check out the thread below for a breakdown\ud83e\uddf5\u2935\ufe0f\n\nHit our \"Know Before You Go\" page for a one-stop-shop: https://t.co/eJ8zJHb7HQ https://t.co/G4oDWobwHm", "conversation_id": "1598791474325630976", "created_at": "2022-12-02T21:29:26.000Z", "edit_history_tweet_ids": ["1598791474325630976"], "author_id": "84072624", "lang": "en", "id": "1598791474325630976"}, {"entities": {"mentions": [{"start": 3, "end": 14, "username": "ConquerSCD", "id": "900068688140873729"}, {"start": 20, "end": 35, "username": "ASH_hematology", "id": "84072624"}], "hashtags": [{"start": 112, "end": 123, "tag": "sicklecell"}]}, "source": "TweetDeck", "referenced_tweets": [{"type": "retweeted", "id": "1598378909569060896"}], "text": "RT @ConquerSCD: The @ASH_hematology Annual Meeting is just around the corner, and we are excited to learn about #sicklecell education and r\u2026", "conversation_id": "1598762990186135572", "created_at": "2022-12-02T19:36:15.000Z", "edit_history_tweet_ids": ["1598762990186135572"], "author_id": "84072624", "lang": "en", "id": "1598762990186135572"}, {"source": "Loomly", "entities": {"annotations": [{"start": 46, "end": 50, "probability": 0.5775, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 45, "end": 51, "tag": "ASH22"}], "urls": [{"start": 186, "end": 209, "url": "https://t.co/C8CLv46NlS", "expanded_url": "https://loom.ly/4N-GJhs", "display_url": "loom.ly/4N-GJhs", "status": 200, "title": "Annual Meeting Schedule-at-a-Glance", "description": "All times listed reflect the Central time zone. Unless otherwise noted, all events will take place in person and on the virtual platform. Beginning at 9:00 a.m. Preview Day (virtual platform only) Preview Day is an opportunity to explore the annual meeting virtual platform and become familiar with its features and navigation. Participants will not have access to pre-recorded presentations that are subject to an embargo (i.e., oral abstract presentations and poster presentations). All Day Preview Day", "unwound_url": "https://www.hematology.org/meetings/annual-meeting/schedule-and-program/schedule-at-a-glance?utm_source=organic_social&utm_medium=twitter&utm_campaign=am_22_schedule"}, {"start": 210, "end": 233, "url": "https://t.co/fbeiMGWcyD", "expanded_url": "https://twitter.com/ASH_hematology/status/1598377743565131804/photo/1", "display_url": "pic.twitter.com/fbeiMGWcyD", "media_key": "3_1598377740335517710"}]}, "text": "The countdown is on! Only 12 more days until #ASH22 \ud83e\udd13 Which colleagues are you most excited to see? Tag them in your reply \ud83d\udc47 &amp; plan what sessions you'll be attending together \ud83e\uddd1\u200d\ud83e\udd1d\u200d\ud83e\uddd1: https://t.co/C8CLv46NlS https://t.co/fbeiMGWcyD", "conversation_id": "1598377743565131804", "created_at": "2022-12-01T18:05:25.000Z", "edit_history_tweet_ids": ["1598377743565131804"], "author_id": "84072624", "lang": "en", "id": "1598377743565131804"}, {"source": "Loomly", "entities": {"annotations": [{"start": 12, "end": 21, "probability": 0.6634, "type": "Other", "normalized_text": "Hematology"}, {"start": 74, "end": 95, "probability": 0.4653, "type": "Other", "normalized_text": "National Medical Board"}, {"start": 208, "end": 218, "probability": 0.7766, "type": "Other", "normalized_text": "ASH Academy"}, {"start": 223, "end": 228, "probability": 0.3511, "type": "Other", "normalized_text": "Demand"}, {"start": 258, "end": 267, "probability": 0.6909, "type": "Other", "normalized_text": "MedTwitter"}], "hashtags": [{"start": 257, "end": 268, "tag": "MedTwitter"}], "urls": [{"start": 233, "end": 256, "url": "https://t.co/kmISqAozNf", "expanded_url": "https://loom.ly/x0hJdbc", "display_url": "loom.ly/x0hJdbc", "images": [{"url": "https://pbs.twimg.com/news_img/1597939368655818753/4ogIn0eU?format=png&name=orig", "width": 265, "height": 265}, {"url": "https://pbs.twimg.com/news_img/1597939368655818753/4ogIn0eU?format=png&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "2022 Hematology Review Series", "description": "The ASH Hematology Review Series is designed for fellows preparing to take the internal medicine hematology certification exam or those desiring a comprehensive update of hematology standards of care. This series p rovides a review of hematology patterned after the American Board of Internal Medicine (ABIM) Certification Examination Blueprint. The 2022 ASH Hematology Review Series will air two to three episodes every week from July through October 2022 leading up to the fall Board Exams. At the beginning", "unwound_url": "https://academy.hematology.org/local/catalog/view/product.php?productid=1490&utm_source=HRS_Twitter&utm_medium=HRS_Organic"}, {"start": 269, "end": 292, "url": "https://t.co/lzgkKUWA64", "expanded_url": "https://twitter.com/ASH_hematology/status/1597939324082872322/video/1", "display_url": "pic.twitter.com/lzgkKUWA64", "media_key": "7_1597938939037351936"}]}, "text": "We hope our Hematology Review Series was helpful in preparing for today's National Medical Board exams \ud83e\udd13\ud83d\udcda Good luck to all those taking the assessment &amp; don't forget - the course can still be accessed on ASH Academy on Demand \ud83d\udcbb: https://t.co/kmISqAozNf\n#MedTwitter https://t.co/lzgkKUWA64", "conversation_id": "1597939324082872322", "created_at": "2022-11-30T13:03:17.000Z", "edit_history_tweet_ids": ["1597939324082872322"], "author_id": "84072624", "lang": "en", "id": "1597939324082872322"}, {"source": "Loomly", "entities": {"annotations": [{"start": 57, "end": 60, "probability": 0.9395, "type": "Place", "normalized_text": "NOLA"}, {"start": 65, "end": 71, "probability": 0.7221, "type": "Other", "normalized_text": "ASHaiku"}], "hashtags": [{"start": 64, "end": 72, "tag": "ASHaiku"}, {"start": 73, "end": 79, "tag": "ASH22"}], "urls": [{"start": 81, "end": 104, "url": "https://t.co/Lz3DY4eVDp", "expanded_url": "https://loom.ly/FrveU7U", "display_url": "loom.ly/FrveU7U", "status": 200, "title": "Registration Information", "description": "ASH annual meeting registration information, including fees, key dates and deadlines, special registration instructions, and more.", "unwound_url": "https://www.hematology.org/meetings/annual-meeting/registration-information?utm_source=AMRegistration_Twitter&utm_medium=AMRegistration_Organic"}, {"start": 105, "end": 128, "url": "https://t.co/eQIdY28eLn", "expanded_url": "https://twitter.com/ASH_hematology/status/1597682667599691776/photo/1", "display_url": "pic.twitter.com/eQIdY28eLn", "media_key": "3_1597682664248643585"}]}, "text": "Ready your haikus\nThe meeting is approaching \nSee you in NOLA! \n#ASHaiku #ASH22 \nhttps://t.co/Lz3DY4eVDp https://t.co/eQIdY28eLn", "conversation_id": "1597682667599691776", "created_at": "2022-11-29T20:03:26.000Z", "edit_history_tweet_ids": ["1597682667599691776"], "author_id": "84072624", "lang": "en", "id": "1597682667599691776"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1597652162804424705"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 18, "end": 22, "probability": 0.781, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 17, "end": 23, "tag": "ASH22"}], "urls": [{"start": 56, "end": 79, "url": "https://t.co/4F9nWptdBC", "expanded_url": "https://loom.ly/RL61e-s", "display_url": "loom.ly/RL61e-s", "status": 200, "title": "Special Interest Sessions - Hematology.org", "description": "Special Interest Sessions", "unwound_url": "https://www.hematology.org/meetings/annual-meeting/programs/special-interest-sessions#21925?utm_source=organic_social&utm_medium=twitter&utm_campaign=quality_am_sessions_22"}]}, "text": "Find more on all #ASH22 special-interest sessions here: https://t.co/4F9nWptdBC", "conversation_id": "1597652156479332352", "created_at": "2022-11-29T18:02:13.000Z", "edit_history_tweet_ids": ["1597652166046539776"], "author_id": "84072624", "lang": "en", "id": "1597652166046539776"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1597652159822168067"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 0, "end": 2, "probability": 0.5728, "type": "Organization", "normalized_text": "ASH"}, {"start": 113, "end": 146, "probability": 0.4902, "type": "Person", "normalized_text": "Ernest N. Morial Convention Center"}], "hashtags": [{"start": 157, "end": 163, "tag": "ASH22"}]}, "text": "ASH Choosing Wisely Campaign: 2022 ASH Choosing Wisely Champions \n\ud83d\udcc5 Monday, December 12\n\ud83d\udd51 12:15 \u2013 1:15 p.m. CT\n\ud83d\udccd Ernest N. Morial Convention Center, 243-245\n#ASH22", "conversation_id": "1597652156479332352", "created_at": "2022-11-29T18:02:13.000Z", "edit_history_tweet_ids": ["1597652162804424705"], "author_id": "84072624", "lang": "en", "id": "1597652162804424705"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1597652156479332352"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 0, "end": 2, "probability": 0.587, "type": "Other", "normalized_text": "ASH"}, {"start": 87, "end": 120, "probability": 0.4444, "type": "Other", "normalized_text": "Ernest N. Morial Convention Center"}], "hashtags": [{"start": 131, "end": 137, "tag": "ASH22"}]}, "text": "ASH Guideline Implementation Champions \n\ud83d\udcc5 Sunday, December 11\n\ud83d\udd51 9:30 \u2013 11:00 a.m. CT\n\ud83d\udccd Ernest N. Morial Convention Center, 353-355\n#ASH22", "conversation_id": "1597652156479332352", "created_at": "2022-11-29T18:02:12.000Z", "edit_history_tweet_ids": ["1597652159822168067"], "author_id": "84072624", "lang": "en", "id": "1597652159822168067"}, {"source": "Loomly", "entities": {"annotations": [{"start": 24, "end": 36, "probability": 0.5219, "type": "Other", "normalized_text": "ASHGuidelines"}, {"start": 158, "end": 162, "probability": 0.4558, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 23, "end": 37, "tag": "ASHGuidelines"}, {"start": 44, "end": 63, "tag": "QualityImprovement"}, {"start": 157, "end": 163, "tag": "ASH22"}], "urls": [{"start": 164, "end": 187, "url": "https://t.co/bg1SpMASPC", "expanded_url": "https://twitter.com/ASH_hematology/status/1597652156479332352/photo/1", "display_url": "pic.twitter.com/bg1SpMASPC", "media_key": "3_1597652154281590784"}]}, "text": "Don't miss this year's #ASHGuidelines &amp; #QualityImprovement sessions at the annual meeting \ud83e\ude7a\ud83c\udfe5 Check out this \ud83e\uddf5\u2b07\ufe0f to find more info on each presentation!\n#ASH22 https://t.co/bg1SpMASPC", "conversation_id": "1597652156479332352", "created_at": "2022-11-29T18:02:11.000Z", "edit_history_tweet_ids": ["1597652156479332352"], "author_id": "84072624", "lang": "en", "id": "1597652156479332352"}, {"source": "Loomly", "entities": {"annotations": [{"start": 8, "end": 15, "probability": 0.6269, "type": "Organization", "normalized_text": "ASHKudos"}, {"start": 45, "end": 74, "probability": 0.648, "type": "Other", "normalized_text": "ASH Abstract Achievement Award"}, {"start": 206, "end": 210, "probability": 0.5685, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 7, "end": 16, "tag": "ASHKudos"}, {"start": 205, "end": 211, "tag": "ASH22"}], "urls": [{"start": 252, "end": 275, "url": "https://t.co/RHRc2l6HSh", "expanded_url": "https://loom.ly/t-7rX5w", "display_url": "loom.ly/t-7rX5w", "status": 200, "title": "Outstanding Abstract Achievement Awards", "description": "Outstanding Abstract Achievement Awards are provided to abstract presenters with the highest scoring ASH annual meeting abstracts of which they are the first author. Awards are given to individuals at various career levels.", "unwound_url": "https://www.hematology.org/awards/award-recipients/outstanding-abstract-achievement?utm_source=organic_social&utm_medium=twitter&utm_campaign=oaaa_22"}, {"start": 276, "end": 299, "url": "https://t.co/xKrJpzfala", "expanded_url": "https://twitter.com/ASH_hematology/status/1597622177305710592/photo/1", "display_url": "pic.twitter.com/xKrJpzfala", "media_key": "3_1597622174877089799"}]}, "text": "A huge #ASHKudos is in order for this year's ASH Abstract Achievement Award winners \ud83d\udc4f\ud83c\udffb\ud83d\udc4f\ud83c\udffd\ud83d\udc4f\ud83c\udffe\ud83d\udc4f\ud83c\udfff We're delighted to congratulate all our awardees on their awesome work &amp; can't wait to hear all about it at #ASH22! Check out the full list of recipients: https://t.co/RHRc2l6HSh https://t.co/xKrJpzfala", "conversation_id": "1597622177305710592", "created_at": "2022-11-29T16:03:04.000Z", "edit_history_tweet_ids": ["1597622177305710592"], "author_id": "84072624", "lang": "en", "id": "1597622177305710592"}, {"source": "Loomly", "entities": {"annotations": [{"start": 60, "end": 71, "probability": 0.523, "type": "Organization", "normalized_text": "ASHimagebank"}], "hashtags": [{"start": 59, "end": 72, "tag": "ASHimagebank"}], "urls": [{"start": 125, "end": 148, "url": "https://t.co/NTwOrER948", "expanded_url": "https://loom.ly/VFXU1LQ", "display_url": "loom.ly/VFXU1LQ", "status": 200, "title": "ImageBank | Home | Regular Bank", "description": "Shoot for 150-160 chars", "unwound_url": "http://imagebank.hematology.org/?utm_source=ImageBank_Twitter&utm_medium=ImageBank_Organic"}, {"start": 149, "end": 172, "url": "https://t.co/CtqotXSaPa", "expanded_url": "https://twitter.com/ASH_hematology/status/1597320453344747520/photo/1", "display_url": "pic.twitter.com/CtqotXSaPa", "media_key": "3_1597320450358607873"}]}, "text": "What do you see? \ud83d\udc40\ud83d\udd2c Reply with your guess \ud83d\udc47\n\nCheck out the #ASHimagebank for a library of new atlas &amp; case study images: https://t.co/NTwOrER948 https://t.co/CtqotXSaPa", "conversation_id": "1597320453344747520", "created_at": "2022-11-28T20:04:07.000Z", "edit_history_tweet_ids": ["1597320453344747520"], "author_id": "84072624", "lang": "en", "id": "1597320453344747520"}, {"source": "Loomly", "entities": {"annotations": [{"start": 32, "end": 34, "probability": 0.4145, "type": "Other", "normalized_text": "VTE"}, {"start": 40, "end": 50, "probability": 0.696, "type": "Other", "normalized_text": "amyloidosis"}, {"start": 144, "end": 146, "probability": 0.4302, "type": "Other", "normalized_text": "VTE"}, {"start": 236, "end": 246, "probability": 0.5867, "type": "Other", "normalized_text": "Amyloidosis"}], "hashtags": [{"start": 31, "end": 35, "tag": "VTE"}, {"start": 39, "end": 51, "tag": "amyloidosis"}], "urls": [{"start": 173, "end": 196, "url": "https://t.co/2joGdj2WkQ", "expanded_url": "https://loom.ly/UoL4QLA", "display_url": "loom.ly/UoL4QLA", "status": 200, "title": "ASH VTE Guidelines: Pediatrics", "description": "Pediatric VTE is considered a severe problem because of the potential for associated mortality and significant complications including PE, and cerebrovascular events, as well as post-thrombotic syndrome. Over recent years there has been a dramatic increase in available information, knowledge, and expertise in relation to appropriate diagnosis, prevention, and clinical management of VTE in neonates and children. The purpose of these guidelines is to provide evidence-based recommendations about the management of VTE in this population.", "unwound_url": "https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/pediatrics?utm_source=twitter&utm_medium=organic_social&utm_campaign=guidelines_nom_pediatrics"}, {"start": 250, "end": 273, "url": "https://t.co/DaEcpsFjmL", "expanded_url": "https://loom.ly/ncSSogI", "display_url": "loom.ly/ncSSogI", "status": 200, "title": "ASH Clinical Practice Guidelines on Amyloidosis - Hematology.org", "description": "ASH Clinical Practice Guidelines on Amyloidosis", "unwound_url": "https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/amyloidosis-guidelines?utm_source=twitter&utm_medium=organic_social&utm_campaign=guidelines_nom_amyloidosis"}, {"start": 274, "end": 297, "url": "https://t.co/a0kJtqX9Kp", "expanded_url": "https://twitter.com/ASH_hematology/status/1597217500231393280/photo/1", "display_url": "pic.twitter.com/a0kJtqX9Kp", "media_key": "3_1597217497694015490"}]}, "text": "Are you an expert in pediatric #VTE or #amyloidosis? Nominate yourself or a colleague to become an ASH Clinical Guidelines panel member!\n\n\ud83e\ude7a ASH VTE Guidelines: Pediatrics - https://t.co/2joGdj2WkQ\n\n\ud83e\ude7a ASH Clinical Practice Guidelines on Amyloidosis - https://t.co/DaEcpsFjmL https://t.co/a0kJtqX9Kp", "conversation_id": "1597217500231393280", "created_at": "2022-11-28T13:15:01.000Z", "edit_history_tweet_ids": ["1597217500231393280"], "author_id": "84072624", "lang": "en", "id": "1597217500231393280"}, {"source": "Loomly", "entities": {"annotations": [{"start": 20, "end": 43, "probability": 0.5899, "type": "Other", "normalized_text": "ASH Minority Recruitment"}], "urls": [{"start": 190, "end": 213, "url": "https://t.co/4LIEo9xiFU", "expanded_url": "https://loom.ly/Dw3KiY0", "display_url": "loom.ly/Dw3KiY0", "status": 200, "title": "ASH Minority Recruitment Initiative", "description": "The ASH Minority Recruitment Initiative (MRI) was created in 2003 to increase the participation of underrepresented minorities training in hematology-related fields and to increase the number of minority hematologists with academic and research appointments. The Minority Hematology Fellow Award (MHFA) encourages junior researchers to pursue careers in academic hematology by providing research funding and mentorship over a two-to-three year period. Listen, as MRI Career Development Mentor and The Hematologi", "unwound_url": "https://www.hematology.org/awards/minority-recruitment?utm_source=MRI_Twitter&utm_medium=MRI_Organic"}, {"start": 214, "end": 237, "url": "https://t.co/Jjrljzxwh6", "expanded_url": "https://twitter.com/ASH_hematology/status/1596127143117086721/photo/1", "display_url": "pic.twitter.com/Jjrljzxwh6", "media_key": "3_1596127141296541697"}]}, "text": "Apply to one of our ASH Minority Recruitment Initiative awards today to receive financial support, benefit from career guidance, &amp; gain exposure to the field of hematology \ud83e\ude78 Learn more: https://t.co/4LIEo9xiFU https://t.co/Jjrljzxwh6", "conversation_id": "1596127143117086721", "created_at": "2022-11-25T13:02:20.000Z", "edit_history_tweet_ids": ["1596127143117086721"], "author_id": "84072624", "lang": "en", "id": "1596127143117086721"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1595508550222155787"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 25, "end": 30, "probability": 0.7682, "type": "Other", "normalized_text": "ASHDEI"}, {"start": 68, "end": 72, "probability": 0.6305, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 24, "end": 31, "tag": "ASHDEI"}, {"start": 67, "end": 73, "tag": "ASH22"}], "urls": [{"start": 88, "end": 111, "url": "https://t.co/Jn1DB91zFo", "expanded_url": "https://loom.ly/fO9FG3Y", "display_url": "loom.ly/fO9FG3Y", "status": 200, "title": "DEI Sessions - Hematology.org", "description": "DEI Sessions", "unwound_url": "https://www.hematology.org/meetings/annual-meeting/programs/dei-sessions?utm_source=twitter&utm_medium=organic_social&utm_campaign=am_dei_22"}]}, "text": "Find all of this year's #ASHDEI sessions &amp; start planning your #ASH22 schedule now: https://t.co/Jn1DB91zFo", "conversation_id": "1595508537584939008", "created_at": "2022-11-23T20:04:16.000Z", "edit_history_tweet_ids": ["1595508553376464896"], "author_id": "84072624", "lang": "en", "id": "1595508553376464896"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1595508546979958793"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 98, "end": 104, "probability": 0.7515, "type": "Place", "normalized_text": "Orleans"}, {"start": 106, "end": 114, "probability": 0.9392, "type": "Place", "normalized_text": "Riverside"}], "hashtags": [{"start": 117, "end": 123, "tag": "ASH22"}]}, "text": "Women in Hematology Networking Dinner \n\ud83d\udcc5 Monday, December 12 \n\ud83d\udd51 7:30 \u2013 9:30 p.m. CT \n\ud83d\udccd Hilton New Orleans Riverside \n#ASH22", "conversation_id": "1595508537584939008", "created_at": "2022-11-23T20:04:16.000Z", "edit_history_tweet_ids": ["1595508550222155787"], "author_id": "84072624", "lang": "en", "id": "1595508550222155787"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1595508543972868096"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 126, "end": 159, "probability": 0.5278, "type": "Other", "normalized_text": "Ernest N. Morial Convention Center"}], "hashtags": [{"start": 162, "end": 168, "tag": "ASH22"}]}, "text": "Maternal Health in Hematology \u2013 Current Resources and Future Advocacy \n\ud83d\udcc5 Monday, December 12 \n\ud83d\udd51 10:30 a.m. \u2013 12:00 p.m. CT \n\ud83d\udccd Ernest N. Morial Convention Center \n#ASH22", "conversation_id": "1595508537584939008", "created_at": "2022-11-23T20:04:15.000Z", "edit_history_tweet_ids": ["1595508546979958793"], "author_id": "84072624", "lang": "en", "id": "1595508546979958793"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1595508540856467456"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 89, "end": 123, "probability": 0.5944, "type": "Place", "normalized_text": "New Orleans Warehouse Arts District"}], "hashtags": [{"start": 126, "end": 132, "tag": "ASH22"}]}, "text": "Health Equity Rounds Lunch\n\ud83d\udcc5 Sunday, December 11\n\ud83d\udd51 11:30 a.m. \u2013 12:30 p.m. CT \n\ud83d\udccd Marriot New Orleans Warehouse Arts District \n#ASH22", "conversation_id": "1595508537584939008", "created_at": "2022-11-23T20:04:14.000Z", "edit_history_tweet_ids": ["1595508543972868096"], "author_id": "84072624", "lang": "en", "id": "1595508543972868096"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1595508537584939008"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 128, "end": 134, "probability": 0.5326, "type": "Place", "normalized_text": "Orleans"}, {"start": 136, "end": 144, "probability": 0.5342, "type": "Place", "normalized_text": "Riverside"}], "hashtags": [{"start": 146, "end": 152, "tag": "ASH22"}]}, "text": "Promoting Minorities in Hematology Presentations &amp; Reception \n\ud83d\udcc5 Saturday, December 10 \n\ud83d\udd51 6:30 \u2013 9:00 p.m. CT  \n\ud83d\udccd Hilton New Orleans Riverside\n#ASH22", "conversation_id": "1595508537584939008", "created_at": "2022-11-23T20:04:13.000Z", "edit_history_tweet_ids": ["1595508540856467456"], "author_id": "84072624", "lang": "en", "id": "1595508540856467456"}, {"source": "Loomly", "entities": {"annotations": [{"start": 16, "end": 20, "probability": 0.695, "type": "Other", "normalized_text": "ASH22"}, {"start": 201, "end": 206, "probability": 0.6355, "type": "Other", "normalized_text": "ASHDEI"}], "hashtags": [{"start": 15, "end": 21, "tag": "ASH22"}, {"start": 200, "end": 207, "tag": "ASHDEI"}]}, "text": "Joining us for #ASH22? Learn about how differences in identity impact outcomes &amp; how to mitigate those differences to achieve equitable outcomes for all individuals with hematologic conditions at #ASHDEI sessions &amp; events. Check out the \ud83e\uddf5\u2b07\ufe0f", "conversation_id": "1595508537584939008", "created_at": "2022-11-23T20:04:13.000Z", "edit_history_tweet_ids": ["1595508537584939008"], "author_id": "84072624", "lang": "en", "id": "1595508537584939008"}, {"entities": {"mentions": [{"start": 3, "end": 10, "username": "US_FDA", "id": "208120290"}], "annotations": [{"start": 79, "end": 90, "probability": 0.8897, "type": "Other", "normalized_text": "Hemophilia B"}, {"start": 110, "end": 138, "probability": 0.7404, "type": "Other", "normalized_text": "Factor IX prophylaxis therapy"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "retweeted", "id": "1595155113987174401"}], "text": "RT @US_FDA: Today, we approved a gene therapy for the treatment of adults with Hemophilia B who currently use Factor IX prophylaxis therapy\u2026", "conversation_id": "1595495988264927232", "created_at": "2022-11-23T19:14:21.000Z", "edit_history_tweet_ids": ["1595495988264927232"], "author_id": "84072624", "lang": "en", "id": "1595495988264927232"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1595447711448567808"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 38, "end": 41, "probability": 0.8501, "type": "Place", "normalized_text": "NOLA"}, {"start": 216, "end": 220, "probability": 0.5042, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 215, "end": 221, "tag": "ASH22"}]}, "text": "Step 3: Grab your masks &amp; head to NOLA for the hematology event of the year! Protective masks are required at any location where an in-person ASH event is being held, so be sure to keep one handy at all times \ud83d\udc4d\n#ASH22", "conversation_id": "1595447703898447872", "created_at": "2022-11-23T16:02:31.000Z", "edit_history_tweet_ids": ["1595447714518634503"], "author_id": "84072624", "lang": "en", "id": "1595447714518634503"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1595447708059246592"}], "in_reply_to_user_id": "84072624", "text": "Step 2: Verify your vaccination status \u2705\n\nSafe Expo: https://t.co/6czslTGDAw\n\nCLEAR: https://t.co/iSzDuRN3yc (code: ASHMEETING22)\n#ASH22", "conversation_id": "1595447703898447872", "entities": {"hashtags": [{"start": 130, "end": 136, "tag": "ASH22"}], "urls": [{"start": 53, "end": 76, "url": "https://t.co/6czslTGDAw", "expanded_url": "https://loom.ly/N-T1j4A", "display_url": "loom.ly/N-T1j4A", "status": 200, "unwound_url": "https://mgl.ud.net/fmi/webd/ash22_vax"}, {"start": 85, "end": 108, "url": "https://t.co/iSzDuRN3yc", "expanded_url": "https://loom.ly/rvRgQJM", "display_url": "loom.ly/rvRgQJM", "images": [{"url": "https://pbs.twimg.com/news_img/1600116236288868352/vnVHoUsM?format=jpg&name=orig", "width": 3120, "height": 1638}, {"url": "https://pbs.twimg.com/news_img/1600116236288868352/vnVHoUsM?format=jpg&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Unlock the power of our mobile app | CLEAR", "description": "The CLEAR app helps you find your nearest CLEAR locations, manage your membership, link your accounts to experience our latest technology, and more \u2013 all in one easy place.", "unwound_url": "https://www.clearme.com/mobileapp"}]}, "created_at": "2022-11-23T16:02:31.000Z", "edit_history_tweet_ids": ["1595447711448567808"], "author_id": "84072624", "lang": "en", "id": "1595447711448567808"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1595447703898447872"}], "in_reply_to_user_id": "84072624", "text": "Step 1: Enroll in free (for non-industry attendees) medical evacuation by December 4 to be covered in case of emergent medical issues of any kind that require transportation to a hospital in another location for care: https://t.co/RqT2WS9j3Z\n#ASH22", "conversation_id": "1595447703898447872", "entities": {"hashtags": [{"start": 242, "end": 248, "tag": "ASH22"}], "urls": [{"start": 218, "end": 241, "url": "https://t.co/RqT2WS9j3Z", "expanded_url": "https://loom.ly/I77eQs4", "display_url": "loom.ly/I77eQs4", "status": 200, "title": "American Society of Hematology - Covac Global", "description": "Covac Global revolutionized medical evacuation without the burden of hospitalization requirements. Our in-house medical staff and worldwide medical transport teams stand ready to bring our members back to their home or hospital of choice without first being hospitalized at the location of injury or illness. Our indemnified membership covers medical transportation for medical emergencies (including obstetric issues, accidents, illness, etc.). Our teams stand ready 24/7 to provide our members support.", "unwound_url": "https://covacglobal.com/american-society-of-hematology-2/"}]}, "created_at": "2022-11-23T16:02:30.000Z", "edit_history_tweet_ids": ["1595447708059246592"], "author_id": "84072624", "lang": "en", "id": "1595447708059246592"}, {"source": "Loomly", "entities": {"annotations": [{"start": 0, "end": 2, "probability": 0.7056, "type": "Organization", "normalized_text": "ASH"}, {"start": 52, "end": 56, "probability": 0.589, "type": "Other", "normalized_text": "ASH22"}, {"start": 71, "end": 81, "probability": 0.9936, "type": "Place", "normalized_text": "New Orleans"}, {"start": 173, "end": 180, "probability": 0.9776, "type": "Other", "normalized_text": "COVID-19"}], "hashtags": [{"start": 51, "end": 57, "tag": "ASH22"}], "urls": [{"start": 203, "end": 226, "url": "https://t.co/Jv9RGUtLPY", "expanded_url": "https://loom.ly/_mT5VbQ", "display_url": "loom.ly/_mT5VbQ", "status": 200, "title": "ASH Annual Meeting Health and Safety Protocols - Hematology.org", "description": "The safety of meeting attendees is ASH\u2019s top priority, and we believe the most effective way to ensure the safety of all attendees is for them to be vaccinated against COVID-19. Please note that proof of vaccination will be required for all in-person meeting attendees prior to traveling to Atlanta.", "unwound_url": "https://www.hematology.org/meetings/annual-meeting/attendee-resources/health-and-safety-protocols?utm_source=organic_social&utm_medium=twitter&utm_campaign=am_22_healthandsafety"}, {"start": 279, "end": 302, "url": "https://t.co/uwpwB8LjyA", "expanded_url": "https://twitter.com/ASH_hematology/status/1595447703898447872/photo/1", "display_url": "pic.twitter.com/uwpwB8LjyA", "media_key": "3_1595447700870266881"}]}, "text": "ASH wants to ensure the health &amp; safety of all #ASH22 attendees in New Orleans \u269c\ufe0f Do your part by reviewing this year's protocols on vaccinations, masking requirements, COVID-19 testing, &amp; more: https://t.co/Jv9RGUtLPY \n\nCheck out the \ud83e\uddf5\u2b07\ufe0f for a protocol prep tweetorial! https://t.co/uwpwB8LjyA", "conversation_id": "1595447703898447872", "created_at": "2022-11-23T16:02:29.000Z", "edit_history_tweet_ids": ["1595447703898447872"], "author_id": "84072624", "lang": "en", "id": "1595447703898447872"}, {"source": "Loomly", "entities": {"annotations": [{"start": 130, "end": 134, "probability": 0.6588, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 129, "end": 135, "tag": "ASH22"}], "urls": [{"start": 47, "end": 70, "url": "https://t.co/SdJJX9Uytj", "expanded_url": "https://loom.ly/SGo_ik4", "display_url": "loom.ly/SGo_ik4", "status": 200, "title": "ASH Annual Meeting Abstracts", "description": "Abstracts submitted for oral and poster presentations at the ASH annual meeting represent important, novel research in the field and are considered the best of the thousands of abstracts submitted. Typically, more than 5,000 scientific abstracts are submitted each year and more than 3,000 abstracts are accepted for oral and poster presentations through an extensive peer review process. The Plenary Scientific Sess ion, which includes the top six abstracts as selected by the Program Committee, is traditional", "unwound_url": "https://www.hematology.org/meetings/annual-meeting/abstracts?utm_source=organic_social&utm_medium=twitter&utm_campaign=am_lba_22"}, {"start": 166, "end": 189, "url": "https://t.co/1sHpoODqzS", "expanded_url": "https://twitter.com/ASH_hematology/status/1595063940949708802/photo/1", "display_url": "pic.twitter.com/1sHpoODqzS", "media_key": "3_1595063939515170817"}]}, "text": "Late-breaking abstracts are LIVE! Take a look: https://t.co/SdJJX9Uytj\n\nLet us know which abstract you\u2019re most excited to see at #ASH22 with a reply or quote tweet \ud83e\udd29 https://t.co/1sHpoODqzS", "conversation_id": "1595063940949708802", "created_at": "2022-11-22T14:37:33.000Z", "edit_history_tweet_ids": ["1595063940949708802"], "author_id": "84072624", "lang": "en", "id": "1595063940949708802"}, {"entities": {"mentions": [{"start": 3, "end": 17, "username": "JoselleCookMD", "id": "904726197224996868"}, {"start": 58, "end": 67, "username": "n_gangat", "id": "2833103654"}], "annotations": [{"start": 44, "end": 55, "probability": 0.5109, "type": "Organization", "normalized_text": "ASHNewsDaily"}, {"start": 112, "end": 116, "probability": 0.5006, "type": "Other", "normalized_text": "ASH22"}, {"start": 122, "end": 131, "probability": 0.537, "type": "Other", "normalized_text": "NewOrleans"}], "hashtags": [{"start": 43, "end": 56, "tag": "ASHNewsDaily"}, {"start": 111, "end": 117, "tag": "ASH22"}, {"start": 121, "end": 132, "tag": "NewOrleans"}]}, "source": "TweetDeck", "referenced_tweets": [{"type": "retweeted", "id": "1593774060764266496"}], "text": "RT @JoselleCookMD: The Classiest editor of #ASHNewsDaily, @n_gangat highlights the awesome events coming up at #ASH22 in #NewOrleans. @ASH_\u2026", "conversation_id": "1594781988200009728", "created_at": "2022-11-21T19:57:10.000Z", "edit_history_tweet_ids": ["1594781988200009728"], "author_id": "84072624", "lang": "en", "id": "1594781988200009728"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1594727341086965763"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 27, "end": 33, "probability": 0.9842, "type": "Other", "normalized_text": "Twitter"}, {"start": 62, "end": 66, "probability": 0.605, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 61, "end": 67, "tag": "ASH22"}], "urls": [{"start": 95, "end": 118, "url": "https://t.co/HVtex9Aoes", "expanded_url": "https://loom.ly/A5cDs8Y", "display_url": "loom.ly/A5cDs8Y", "images": [{"url": "https://pbs.twimg.com/news_img/1600116298691727360/z9YM_Bzw?format=jpg&name=orig", "width": 1500, "height": 500}, {"url": "https://pbs.twimg.com/news_img/1600116298691727360/z9YM_Bzw?format=jpg&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "@ASH_hematology/Top ASH Hashtag Users '22 / Twitter", "description": "Catch the #ASH22 buzz from the most active users of #ASH21 who registered early with their handle!", "unwound_url": "https://twitter.com/i/lists/1575216119517962241?s=20&utm_source=twitter&utm_medium=organic_social&utm_campaign=twitter_list22"}, {"start": 141, "end": 164, "url": "https://t.co/qnUHSPY7X1", "expanded_url": "https://loom.ly/e6yd_9g", "display_url": "loom.ly/e6yd_9g", "status": 404, "unwound_url": "https://twitter.com/i/lists/1592272561840300035?s=20&utm_source=twitter&utm_medium=organic_social&utm_campaign=and_twitter_list22"}]}, "text": "Don't forget to follow our Twitter lists to keep up with the #ASH22 buzz!\n\n\ud83d\udcccTop Hashtag Users: https://t.co/HVtex9Aoes\n\ud83d\udcccAND Editorial Board: https://t.co/qnUHSPY7X1", "conversation_id": "1594727341086965763", "created_at": "2022-11-21T16:20:02.000Z", "edit_history_tweet_ids": ["1594727344857649152"], "author_id": "84072624", "lang": "en", "id": "1594727344857649152"}, {"source": "Loomly", "entities": {"annotations": [{"start": 21, "end": 34, "probability": 0.9217, "type": "Other", "normalized_text": "ASH News Daily"}, {"start": 224, "end": 228, "probability": 0.6385, "type": "Other", "normalized_text": " #ASH"}], "hashtags": [{"start": 225, "end": 231, "tag": "ASH22"}], "urls": [{"start": 170, "end": 193, "url": "https://t.co/C7KViQbw9G", "expanded_url": "https://loom.ly/ye9vPmM", "display_url": "loom.ly/ye9vPmM", "images": [{"url": "https://pbs.twimg.com/news_img/1600682123903606784/vvixSRx2?format=png&name=orig", "width": 627, "height": 353}, {"url": "https://pbs.twimg.com/news_img/1600682123903606784/vvixSRx2?format=png&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Your Social Media Guide to #ASH22 | ASH News Daily | American Society of Hematology", "description": "The 64th ASH Annual Meeting and Exposition is the best place to reconnect with old colleagues, establish new collaborations, and discover the latest in hematology. Whether you're joining us in New Orleans, or using the meeting\u2019s virtual platform, participating in the scientific conversation on social media is an essential part of the #ASH22 experience! By using social media during the annual meeting, you can immerse yours elf in scientific discourse around your favorite sessions, get updates from the", "unwound_url": "https://ashpublications.org/ashnewsdaily/news/6587/your-social-media-guide-to-ash22?utm_source=organic_social&utm_medium=twitter&utm_campaign=and_preview_22"}, {"start": 277, "end": 300, "url": "https://t.co/1jBWV7eMDk", "expanded_url": "https://twitter.com/ASH_hematology/status/1594727341086965763/photo/1", "display_url": "pic.twitter.com/1jBWV7eMDk", "media_key": "3_1594727338746544128"}]}, "text": "The preview issue of ASH News Daily (AND) is out NOW! Check out our social media article to find tips &amp; tricks on how to join the scientific conversation online \ud83e\uddd1\u200d\ud83d\udcbb: https://t.co/C7KViQbw9G\n\nBe sure to use these featured #ASH22 hashtags for all your meeting-related posts! https://t.co/1jBWV7eMDk", "conversation_id": "1594727341086965763", "created_at": "2022-11-21T16:20:01.000Z", "edit_history_tweet_ids": ["1594727341086965763"], "author_id": "84072624", "lang": "en", "id": "1594727341086965763"}, {"source": "Loomly", "text": "\ud83c\udd95in Blood Advances: Study finds that coping strategies among caregivers for those undergoing #stemcell transplants can affect levels of anxiety &amp; depression, as well as impact quality of life. Read more during #CaregiverAwarenessMonth: \n https://t.co/naV6t2hLNa https://t.co/M6Is9SEAJQ", "conversation_id": "1593697464925949953", "entities": {"hashtags": [{"start": 93, "end": 102, "tag": "stemcell"}, {"start": 214, "end": 238, "tag": "CaregiverAwarenessMonth"}], "urls": [{"start": 242, "end": 265, "url": "https://t.co/naV6t2hLNa", "expanded_url": "https://loom.ly/XdvpnhY", "display_url": "loom.ly/XdvpnhY", "status": 200, "title": "Caregivers\u2019 Coping Strategies Tied to Anxiety, Depression and Quality of Life - Hematology.org", "description": "Caregivers\u2019 Coping Strategies Tied to Anxiety, Depression and Quality of Life", "unwound_url": "https://www.hematology.org/newsroom/press-releases/2022/caregivers-coping-strategies?utm_source=organic_social&utm_medium=twitter&utm_campaign=ba_pr_caregivers"}, {"start": 266, "end": 289, "url": "https://t.co/M6Is9SEAJQ", "expanded_url": "https://twitter.com/ASH_hematology/status/1593697464925949953/video/1", "display_url": "pic.twitter.com/M6Is9SEAJQ", "media_key": "7_1593697356377194504"}]}, "created_at": "2022-11-18T20:07:39.000Z", "edit_history_tweet_ids": ["1593697464925949953"], "author_id": "84072624", "lang": "en", "id": "1593697464925949953"}, {"entities": {"mentions": [{"start": 3, "end": 18, "username": "MikkaelSekeres", "id": "390846254"}, {"start": 49, "end": 64, "username": "ASH_hematology", "id": "84072624"}], "annotations": [{"start": 116, "end": 120, "probability": 0.6793, "type": "Other", "normalized_text": "to #A"}], "hashtags": [{"start": 119, "end": 125, "tag": "ASH22"}]}, "source": "TweetDeck", "referenced_tweets": [{"type": "retweeted", "id": "1593379871698337792"}], "text": "RT @MikkaelSekeres: What a great meeting of the \u2066@ASH_hematology\u2069 Committee on Communications! Bringing super ideas to #ASH22, with a cameo\u2026", "conversation_id": "1593626147912392705", "created_at": "2022-11-18T15:24:16.000Z", "edit_history_tweet_ids": ["1593626147912392705"], "author_id": "84072624", "lang": "en", "id": "1593626147912392705"}, {"source": "Loomly", "entities": {"annotations": [{"start": 86, "end": 127, "probability": 0.6855, "type": "Other", "normalized_text": "Sickle Cell Disease Comprehensive Care Act"}], "hashtags": [{"start": 181, "end": 192, "tag": "ConquerSCD"}, {"start": 259, "end": 276, "tag": "Fight4Hematology"}], "urls": [{"start": 235, "end": 258, "url": "https://t.co/ZabqgBEOdH", "expanded_url": "https://loom.ly/yV2Btpw", "display_url": "loom.ly/yV2Btpw", "status": 200, "title": "Cosponsor the Sickle Cell Disease Comprehensive Care Act - Hematology.org", "description": "Cosponsor the Sickle Cell Disease Comprehensive Care Act", "unwound_url": "https://www.hematology.org/advocacy/reach-out-to-congress/cosponsor-the-sickle-cell-disease-comprehensive-care-act?utm_source=twitter&utm_medium=organic_social&utm_campaign=scdcca_cosponsor"}, {"start": 277, "end": 300, "url": "https://t.co/TPidHk02KE", "expanded_url": "https://twitter.com/ASH_hematology/status/1593378996116680705/photo/1", "display_url": "pic.twitter.com/TPidHk02KE", "media_key": "3_1593378993977364481"}]}, "text": "We've led a group 50 organizations in sending a letter urging Congress to include the Sickle Cell Disease Comprehensive Care Act in any end-of-year omnibus bill. Join us &amp; help #ConquerSCD by contacting your representative today:  https://t.co/ZabqgBEOdH\n#Fight4Hematology https://t.co/TPidHk02KE", "conversation_id": "1593378996116680705", "created_at": "2022-11-17T23:02:10.000Z", "edit_history_tweet_ids": ["1593378996116680705"], "author_id": "84072624", "lang": "en", "id": "1593378996116680705"}, {"source": "Loomly", "entities": {"annotations": [{"start": 181, "end": 185, "probability": 0.5303, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 5, "end": 23, "tag": "ThrowbackThursday"}, {"start": 180, "end": 186, "tag": "ASH22"}], "urls": [{"start": 235, "end": 258, "url": "https://t.co/IHHGJNDjVv", "expanded_url": "https://twitter.com/ASH_hematology/status/1593246370718097410/photo/1", "display_url": "pic.twitter.com/IHHGJNDjVv", "media_key": "3_1593246359716757506"}]}, "text": "It's #ThrowbackThursday &amp; we want to hear about your favorite memory from a past ASH annual meeting! Reply with your story and/or photo &amp; get ready to make new memories at #ASH22 \ud83d\udcf8 Here's one of our favorites from last year \ud83e\udd1f\ud83c\udfb8 https://t.co/IHHGJNDjVv", "conversation_id": "1593246370718097410", "created_at": "2022-11-17T14:15:10.000Z", "edit_history_tweet_ids": ["1593246370718097410"], "author_id": "84072624", "lang": "en", "id": "1593246370718097410"}, {"source": "Loomly", "entities": {"annotations": [{"start": 23, "end": 30, "probability": 0.5992, "type": "Other", "normalized_text": "ASH Self"}, {"start": 154, "end": 156, "probability": 0.4456, "type": "Other", "normalized_text": "CME"}, {"start": 158, "end": 160, "probability": 0.3924, "type": "Organization", "normalized_text": "MOC"}], "hashtags": [{"start": 231, "end": 242, "tag": "hematology"}, {"start": 268, "end": 274, "tag": "MedEd"}], "urls": [{"start": 244, "end": 267, "url": "https://t.co/XklL8j7FU1", "expanded_url": "https://loom.ly/YKdAhfo", "display_url": "loom.ly/YKdAhfo", "images": [{"url": "https://pbs.twimg.com/news_img/1593036036744957952/GctTvYS5?format=jpg&name=orig", "width": 520, "height": 675}, {"url": "https://pbs.twimg.com/news_img/1593036036744957952/GctTvYS5?format=jpg&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "American Society of Hematology Self-Assessment Program", "description": "Northwestern University Chicago, Illinois University of Florida Gainesville, Florida Johns Hopkins University Baltimore, Maryland Banner MD Anderson Cancer Center Gilbert, Arizona American Society of Hematology Washington, DC DOI: https://doi.org/10.1182/ashsap8 Publisher: American Society of Hematology Washington,", "unwound_url": "https://ashpublications.org/books/book/8/American-Society-of-Hematology-Self-Assessment?utm_source=SAP_Twitter&utm_medium=SAP_Organic"}, {"start": 275, "end": 298, "url": "https://t.co/9hAFl8eQCq", "expanded_url": "https://twitter.com/ASH_hematology/status/1592983790388854784/video/1", "display_url": "pic.twitter.com/9hAFl8eQCq", "media_key": "7_1592983737494552577"}]}, "text": "The 8th edition of the ASH Self-Assessment Program is here! Get your print or digital copy to prepare for board certification, recertification, obtaining CME/MOC credits, or simply to stay up to date with the latest innovations in #hematology: https://t.co/XklL8j7FU1\n#MedEd https://t.co/9hAFl8eQCq", "conversation_id": "1592983790388854784", "created_at": "2022-11-16T20:51:46.000Z", "edit_history_tweet_ids": ["1592983790388854784"], "author_id": "84072624", "lang": "en", "id": "1592983790388854784"}, {"source": "Loomly", "entities": {"annotations": [{"start": 18, "end": 45, "probability": 0.4651, "type": "Other", "normalized_text": "ASH Congressional Fellowship"}, {"start": 64, "end": 75, "probability": 0.9531, "type": "Place", "normalized_text": "Capitol Hill"}], "urls": [{"start": 190, "end": 213, "url": "https://t.co/y6s3Zuhs3L", "expanded_url": "https://loom.ly/HVvzzNg", "display_url": "loom.ly/HVvzzNg", "status": 200, "title": "ASH Congressional Fellowship", "description": "The ASH Congressional Fellowship aims to provide education about the policymaking process, including Congress\u00e2\u20ac\u2122 relationship to the hematology community, as well as an opportunity to educate Congressional members and staff about hematology.", "unwound_url": "https://www.hematology.org/advocacy/congressional-fellowship?utm_source=twitter&utm_medium=organic_social&utm_campaign=congressional_fellowship_2023"}, {"start": 214, "end": 237, "url": "https://t.co/ccq6O65A8K", "expanded_url": "https://twitter.com/ASH_hematology/status/1592579245410521089/video/1", "display_url": "pic.twitter.com/ccq6O65A8K", "media_key": "7_1592578735898873858"}]}, "text": "Apply now for the ASH Congressional Fellowship &amp; join us on Capitol Hill! Learn more about how you can help shape health care &amp; hematology policy through this year-long program \ud83e\ude78\ud83d\udcc3\ud83d\udd8a\ufe0f https://t.co/y6s3Zuhs3L https://t.co/ccq6O65A8K", "conversation_id": "1592579245410521089", "created_at": "2022-11-15T18:04:15.000Z", "edit_history_tweet_ids": ["1592579245410521089"], "author_id": "84072624", "lang": "en", "id": "1592579245410521089"}, {"source": "Loomly", "entities": {"annotations": [{"start": 37, "end": 43, "probability": 0.9735, "type": "Other", "normalized_text": "YouTube"}, {"start": 171, "end": 174, "probability": 0.5122, "type": "Other", "normalized_text": "MMsm"}], "hashtags": [{"start": 170, "end": 175, "tag": "MMsm"}, {"start": 176, "end": 189, "tag": "HealthEquity"}], "urls": [{"start": 190, "end": 213, "url": "https://t.co/zpuAbEWoc6", "expanded_url": "https://loom.ly/NmxuiBE", "display_url": "loom.ly/NmxuiBE", "images": [{"url": "https://pbs.twimg.com/news_img/1592216321323782146/e3BIa-qj?format=jpg&name=orig", "width": 168, "height": 94}, {"url": "https://pbs.twimg.com/news_img/1592216321323782146/e3BIa-qj?format=jpg&name=150x150", "width": 94, "height": 94}], "status": 200, "title": "IMPACT Audio Lessons: Impacting Multiple Myeloma Patients in African American Communities", "description": "\u4f5c\u6210\u3057\u305f\u52d5\u753b\u3092\u53cb\u3060\u3061\u3001\u5bb6\u65cf\u3001\u4e16\u754c\u4e2d\u306e\u4eba\u305f\u3061\u3068\u5171\u6709", "unwound_url": "https://www.youtube.com/playlist?list=PL4C8vBKsIWMq_ruFYoF1RxIOiYfQF3_o3&utm_source=twitter&utm_medium=organic_social&utm_campaign=impact_audio"}]}, "text": "Check out our \"IMPACT Audio Lessons\" YouTube playlist &amp; learn how to address barriers due to racial disparities in African Americans living with multiple myeloma \ud83c\udfa7\u2b07\ufe0f #MMsm #HealthEquity\nhttps://t.co/zpuAbEWoc6", "conversation_id": "1592216318362558465", "created_at": "2022-11-14T18:02:06.000Z", "edit_history_tweet_ids": ["1592216318362558465"], "author_id": "84072624", "lang": "en", "id": "1592216318362558465"}, {"entities": {"mentions": [{"start": 3, "end": 15, "username": "AMarshallMD", "id": "987798415"}, {"start": 85, "end": 100, "username": "ASH_hematology", "id": "84072624"}], "annotations": [{"start": 137, "end": 138, "probability": 0.4821, "type": "Other", "normalized_text": "Wo"}], "hashtags": [{"start": 72, "end": 83, "tag": "Hematology"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "retweeted", "id": "1590759972794953729"}], "text": "RT @AMarshallMD: Attention Advanced Practice Providers (NPs and PAs) in #Hematology! @ASH_hematology needs YOUR input on your practice, #Wo\u2026", "conversation_id": "1591169103074832384", "created_at": "2022-11-11T20:40:51.000Z", "edit_history_tweet_ids": ["1591169103074832384"], "author_id": "84072624", "lang": "en", "id": "1591169103074832384"}, {"source": "Loomly", "entities": {"annotations": [{"start": 102, "end": 125, "probability": 0.6358, "type": "Other", "normalized_text": "ASH Minority Recruitment"}, {"start": 214, "end": 222, "probability": 0.4565, "type": "Organization", "normalized_text": "ASHAwards"}], "hashtags": [{"start": 213, "end": 223, "tag": "ASHAwards"}], "urls": [{"start": 189, "end": 212, "url": "https://t.co/4LIEo9OlHU", "expanded_url": "https://loom.ly/Dw3KiY0", "display_url": "loom.ly/Dw3KiY0", "status": 200, "title": "ASH Minority Recruitment Initiative", "description": "The ASH Minority Recruitment Initiative (MRI) was created in 2003 to increase the participation of underrepresented minorities training in hematology-related fields and to increase the number of minority hematologists with academic and research appointments. The Minority Hematology Fellow Award (MHFA) encourages junior researchers to pursue careers in academic hematology by providing research funding and mentorship over a two-to-three year period. Listen, as MRI Career Development Mentor and The Hematologi", "unwound_url": "https://www.hematology.org/awards/minority-recruitment?utm_source=MRI_Twitter&utm_medium=MRI_Organic"}, {"start": 224, "end": 247, "url": "https://t.co/8jx9Vr6Rb0", "expanded_url": "https://twitter.com/ASH_hematology/status/1590752872643194882/photo/1", "display_url": "pic.twitter.com/8jx9Vr6Rb0", "media_key": "3_1590752870206521346"}]}, "text": "Are you an underrepresented minority training in a hematology-related field? Find support through the ASH Minority Recruitment Initiative with mentorship, funding, &amp; more! Learn more:  https://t.co/4LIEo9OlHU\n#ASHAwards https://t.co/8jx9Vr6Rb0", "conversation_id": "1590752872643194882", "created_at": "2022-11-10T17:06:54.000Z", "edit_history_tweet_ids": ["1590752872643194882"], "author_id": "84072624", "lang": "en", "id": "1590752872643194882"}, {"entities": {"mentions": [{"start": 5, "end": 18, "username": "BloodJournal", "id": "3407436940"}], "annotations": [{"start": 51, "end": 57, "probability": 0.7574, "type": "Other", "normalized_text": "TcellRX"}], "hashtags": [{"start": 50, "end": 58, "tag": "TcellRX"}, {"start": 112, "end": 122, "tag": "pediatric"}, {"start": 137, "end": 141, "tag": "ALL"}], "urls": [{"start": 154, "end": 177, "url": "https://t.co/oOZsHfBK0F", "expanded_url": "https://loom.ly/QlXTVhI", "display_url": "loom.ly/QlXTVhI", "status": 200, "title": "CAR T-Cell Therapy Outcomes Similar Across Different Socioeconomic Levels - Hematology.org", "description": "CAR T-Cell Therapy Outcomes Similar Across Different Socioeconomic Levels", "unwound_url": "https://www.hematology.org/newsroom/press-releases/2022/car-t-cell-therapy-outcomes-similar-across-different-socioeconomic-levels?utm_source=twitter&utm_medium=organic_social&utm_campaign=bloodpr11922"}, {"start": 178, "end": 201, "url": "https://t.co/7wxMAbByga", "expanded_url": "https://twitter.com/ASH_hematology/status/1590750674870235137/video/1", "display_url": "pic.twitter.com/7wxMAbByga", "media_key": "7_1590750622692909057"}]}, "source": "Loomly", "text": "\ud83c\udd95 in @BloodJournal: Study finds no differences in #TcellRX outcomes across different socioeconomic levels among #pediatric patients with #ALL. Read more: https://t.co/oOZsHfBK0F https://t.co/7wxMAbByga", "conversation_id": "1590750674870235137", "created_at": "2022-11-10T16:58:10.000Z", "edit_history_tweet_ids": ["1590750674870235137"], "author_id": "84072624", "lang": "en", "id": "1590750674870235137"}, {"entities": {"mentions": [{"start": 3, "end": 12, "username": "ManniMD1", "id": "1269642863924609025"}, {"start": 40, "end": 55, "username": "ASH_hematology", "id": "84072624"}], "annotations": [{"start": 56, "end": 65, "probability": 0.7465, "type": "Other", "normalized_text": "News Daily"}]}, "source": "TweetDeck", "referenced_tweets": [{"type": "retweeted", "id": "1590440063263182851"}], "text": "RT @ManniMD1: I am excited to be on the @ASH_hematology News Daily editorial board, and will be covering/attending the meeting this year.\u2026", "conversation_id": "1590458785130156032", "created_at": "2022-11-09T21:38:18.000Z", "edit_history_tweet_ids": ["1590458785130156032"], "author_id": "84072624", "lang": "en", "id": "1590458785130156032"}, {"entities": {"mentions": [{"start": 3, "end": 19, "username": "ASHClinicalNews", "id": "2842612449"}], "annotations": [{"start": 47, "end": 49, "probability": 0.9813, "type": "Organization", "normalized_text": "FDA"}], "hashtags": [{"start": 46, "end": 50, "tag": "FDA"}, {"start": 75, "end": 80, "tag": "drug"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "retweeted", "id": "1588533591155560449"}], "text": "RT @ASHClinicalNews: A clinical hold from the #FDA is a normal part of the #drug development process, functioning as a quality assurance st\u2026", "conversation_id": "1590379634310676481", "created_at": "2022-11-09T16:23:47.000Z", "edit_history_tweet_ids": ["1590379634310676481"], "author_id": "84072624", "lang": "en", "id": "1590379634310676481"}, {"source": "Loomly", "entities": {"annotations": [{"start": 20, "end": 22, "probability": 0.614, "type": "Other", "normalized_text": "ASH"}, {"start": 160, "end": 162, "probability": 0.6062, "type": "Other", "normalized_text": "ASH"}], "hashtags": [{"start": 115, "end": 128, "tag": "blooddisease"}], "urls": [{"start": 258, "end": 281, "url": "https://t.co/LIA906cldC", "expanded_url": "https://loom.ly/MsEpwWY", "display_url": "loom.ly/MsEpwWY", "status": 200, "title": "ASH Membership", "description": "Become part of a global network of more than 17,000 hematologists working to conquer blood diseases. Join ASH and experience membership benefits that will support your professional development each step of the way.", "unwound_url": "https://www.hematology.org/membership?utm_source=organic_social&utm_medium=twitter&utm_campaign=membership"}, {"start": 282, "end": 305, "url": "https://t.co/noo8VRQoS8", "expanded_url": "https://twitter.com/ASH_hematology/status/1590347231063789570/photo/1", "display_url": "pic.twitter.com/noo8VRQoS8", "media_key": "3_1590347227985321985"}]}, "text": "Start or renew your ASH membership &amp; engage in a diverse community of 18,000+ hematologists working to conquer #blooddisease worldwide! Enjoy benefits like ASH product discounts, access to exclusive ASH programs, &amp; annual meeting deals \ud83e\ude78 Learn more: https://t.co/LIA906cldC https://t.co/noo8VRQoS8", "conversation_id": "1590347231063789570", "created_at": "2022-11-09T14:15:01.000Z", "edit_history_tweet_ids": ["1590347231063789570"], "author_id": "84072624", "lang": "en", "id": "1590347231063789570"}, {"source": "Loomly", "entities": {"annotations": [{"start": 64, "end": 66, "probability": 0.5362, "type": "Other", "normalized_text": "ASH"}, {"start": 102, "end": 109, "probability": 0.4922, "type": "Other", "normalized_text": "American"}], "hashtags": [{"start": 9, "end": 20, "tag": "hematology"}], "urls": [{"start": 255, "end": 278, "url": "https://t.co/3jMwfYe0ZN", "expanded_url": "https://loom.ly/XsGg4FY", "display_url": "loom.ly/XsGg4FY", "status": 200, "title": "Early-Career Investigator Awards and Training Programs", "description": "Awards and training programs provided by ASH help to enhance knowledge, research, and expertise of early- and mid-career hematologists.", "unwound_url": "https://www.hematology.org/awards/career-enhancement-and-training?utm_source=LATPVTP_Twitter&utm_medium=LATPVTP_Organic"}, {"start": 279, "end": 302, "url": "https://t.co/KlzX2dcDoj", "expanded_url": "https://twitter.com/ASH_hematology/status/1589951260907610113/photo/1", "display_url": "pic.twitter.com/KlzX2dcDoj", "media_key": "3_1589951258034683905"}]}, "text": "Increase #hematology capacity at your home institution with the ASH Visitor Training Program or Latin American Training Program \ud83e\ude7a\ud83c\udf0e Submit your application to receive training &amp; mentorship to strengthen hematology care &amp; management in your region: https://t.co/3jMwfYe0ZN https://t.co/KlzX2dcDoj", "conversation_id": "1589951260907610113", "created_at": "2022-11-08T12:01:35.000Z", "edit_history_tweet_ids": ["1589951260907610113"], "author_id": "84072624", "lang": "en", "id": "1589951260907610113"}, {"source": "Loomly", "entities": {"annotations": [{"start": 0, "end": 2, "probability": 0.5018, "type": "Organization", "normalized_text": "ASH"}, {"start": 62, "end": 64, "probability": 0.571, "type": "Other", "normalized_text": "ASH"}, {"start": 242, "end": 252, "probability": 0.4886, "type": "Other", "normalized_text": "Amyloidosis"}], "urls": [{"start": 179, "end": 202, "url": "https://t.co/xmqfRvzMsq", "expanded_url": "https://loom.ly/I7nePGQ", "display_url": "loom.ly/I7nePGQ", "status": 200, "title": "ASH VTE Guidelines: Pediatrics", "description": "Pediatric VTE is considered a severe problem because of the potential for associated mortality and significant complications including PE, and cerebrovascular events, as well as post-thrombotic syndrome. Over recent years there has been a dramatic increase in available information, knowledge, and expertise in relation to appropriate diagnosis, prevention, and clinical management of VTE in neonates and children. The purpose of these guidelines is to provide evidence-based recommendations about the management of VTE in this population.", "unwound_url": "https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/pediatrics?utm_source=organic_social&utm_medium=twitter&utm_campaign=VTE_guidelines_openings"}, {"start": 257, "end": 280, "url": "https://t.co/pG2oIk0eS5", "expanded_url": "https://loom.ly/lso8JAM", "display_url": "loom.ly/lso8JAM", "status": 200, "title": "ASH Clinical Practice Guidelines on Amyloidosis - Hematology.org", "description": "ASH Clinical Practice Guidelines on Amyloidosis", "unwound_url": "https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/amyloidosis-guidelines?utm_source=organic_social&utm_medium=twitter&utm_campaign=amyloidosis_guidelines_openings"}, {"start": 281, "end": 304, "url": "https://t.co/CaaoXZPiJ7", "expanded_url": "https://twitter.com/ASH_hematology/status/1589710114566520832/photo/1", "display_url": "pic.twitter.com/CaaoXZPiJ7", "media_key": "3_1589710111144132609"}]}, "text": "ASH is seeking panel member nominations for new &amp; updated ASH Clinical Practice Guidelines topics. Nominate yourself or a colleague today!\n\n\ud83e\ude7a ASH VTE Guidelines: Pediatrics - https://t.co/xmqfRvzMsq\n\n\ud83e\ude7a ASH Clinical Practice Guidelines on Amyloidosis -  https://t.co/pG2oIk0eS5 https://t.co/CaaoXZPiJ7", "conversation_id": "1589710114566520832", "created_at": "2022-11-07T20:03:21.000Z", "edit_history_tweet_ids": ["1589710114566520832"], "author_id": "84072624", "lang": "en", "id": "1589710114566520832"}, {"source": "Loomly", "entities": {"annotations": [{"start": 44, "end": 53, "probability": 0.7458, "type": "Other", "normalized_text": "ASH Summit"}, {"start": 90, "end": 97, "probability": 0.6089, "type": "Other", "normalized_text": "Diseases"}, {"start": 239, "end": 248, "probability": 0.6671, "type": "Other", "normalized_text": "MedTwitter"}], "hashtags": [{"start": 142, "end": 156, "tag": "immunotherapy"}, {"start": 231, "end": 237, "tag": "MedEd"}, {"start": 238, "end": 249, "tag": "MedTwitter"}], "urls": [{"start": 207, "end": 230, "url": "https://t.co/a7H5A7fLlp", "expanded_url": "https://loom.ly/zvhUkF4", "display_url": "loom.ly/zvhUkF4", "status": 200, "title": "ASH Summit on Immunotherapies for Hematologic Diseases", "description": "The ASH Summit on Immunotherapies for Hematologic Diseases will examine preclinical and clinical factors influencing the effective development, regulation, and implementation of immunotherapies for hematologic diseases.", "unwound_url": "https://www.hematology.org/meetings/summit-on-emerging-immunotherapies-for-hematologic-diseases?utm_source=ImmunoSummit_Twitter&utm_medium=ImmunoSummit_Organic"}, {"start": 250, "end": 273, "url": "https://t.co/ExjzmxJZhi", "expanded_url": "https://twitter.com/ASH_hematology/status/1588524047557591042/photo/1", "display_url": "pic.twitter.com/ExjzmxJZhi", "media_key": "3_1588524042679615489"}]}, "text": "Registration is now \ud83d\udfe2OPEN for this spring's ASH Summit on Immunotherapies for Hematologic Diseases! Join us to learn about the science behind #immunotherapy &amp; how to implement this innovative treatment: https://t.co/a7H5A7fLlp\n#MedEd #MedTwitter https://t.co/ExjzmxJZhi", "conversation_id": "1588524047557591042", "created_at": "2022-11-04T13:30:20.000Z", "edit_history_tweet_ids": ["1588524047557591042"], "author_id": "84072624", "lang": "en", "id": "1588524047557591042"}, {"entities": {"mentions": [{"start": 70, "end": 82, "username": "FranceFound", "id": "518697437"}, {"start": 84, "end": 90, "username": "ASTCT", "id": "1379457751"}, {"start": 98, "end": 110, "username": "ProjectECHO", "id": "1511493282"}], "annotations": [{"start": 29, "end": 36, "probability": 0.7592, "type": "Other", "normalized_text": "CARTcell"}, {"start": 276, "end": 285, "probability": 0.7055, "type": "Other", "normalized_text": "MedTwitter"}], "hashtags": [{"start": 28, "end": 37, "tag": "CARTcell"}, {"start": 268, "end": 274, "tag": "MedEd"}, {"start": 275, "end": 286, "tag": "MedTwitter"}], "urls": [{"start": 244, "end": 267, "url": "https://t.co/gVNLIcpxRY", "expanded_url": "https://loom.ly/Y9tRWoI", "display_url": "loom.ly/Y9tRWoI", "status": 200, "title": "9155 CAR T-Cell Therapy Consults: Navigating a New Landscape", "description": "Free Continuing Medical Education for Health Care Professionals", "unwound_url": "https://www.francefoundation.com/9155-car-t-cell-therapy-consults-navigating-a-new-landscape"}, {"start": 287, "end": 310, "url": "https://t.co/RyPBXjGlvt", "expanded_url": "https://twitter.com/ASH_hematology/status/1588517897516769294/photo/1", "display_url": "pic.twitter.com/RyPBXjGlvt", "media_key": "3_1588517894278758401"}]}, "source": "Loomly", "text": "Looking to learn more about #CARTcell therapies? We've partnered with @FranceFound, @ASTCT, &amp; @ProjectECHO to bring you a \ud83c\udd95 webinar covering when &amp; how to use these innovative therapies! Register now for this month's sessions on B-ALL: https://t.co/gVNLIcpxRY\n#MedEd #MedTwitter https://t.co/RyPBXjGlvt", "conversation_id": "1588517897516769294", "created_at": "2022-11-04T13:05:54.000Z", "edit_history_tweet_ids": ["1588517897516769294"], "author_id": "84072624", "lang": "en", "id": "1588517897516769294"}, {"entities": {"mentions": [{"start": 3, "end": 15, "username": "AMarshallMD", "id": "987798415"}, {"start": 87, "end": 102, "username": "ASH_hematology", "id": "84072624"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "retweeted", "id": "1582426782770565120"}], "text": "RT @AMarshallMD: Medicine is a team sport! \u26bd\ufe0f\n\nHematologists \ud83e\ude78- do you work with APPs? @ASH_hematology needs your input! We want your \ud83e\udde0 \ud83e\udd14 o\u2026", "conversation_id": "1588194731678474241", "created_at": "2022-11-03T15:41:45.000Z", "edit_history_tweet_ids": ["1588194731678474241"], "author_id": "84072624", "lang": "en", "id": "1588194731678474241"}, {"source": "Loomly", "entities": {"annotations": [{"start": 5, "end": 9, "probability": 0.7673, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 4, "end": 10, "tag": "ASH22"}], "urls": [{"start": 51, "end": 74, "url": "https://t.co/f2Fz9tOGWo", "expanded_url": "https://loom.ly/DFffhxk", "display_url": "loom.ly/DFffhxk", "status": 200, "title": "ASH Annual Meeting Abstracts", "description": "Abstracts submitted for oral and poster presentations at the ASH annual meeting represent important, novel research in the field and are considered the best of the thousands of abstracts submitted. Typically, more than 5,000 scientific abstracts are submitted each year and more than 3,000 abstracts are accepted for oral and poster presentations through an extensive peer review process. The Plenary Scientific Sess ion, which includes the top six abstracts as selected by the Program Committee, is traditional", "unwound_url": "https://www.hematology.org/meetings/annual-meeting/abstracts?utm_source=organic_social&utm_medium=twitter&utm_campaign=ash22_abstracts"}, {"start": 159, "end": 182, "url": "https://t.co/dS3Sj29Vw7", "expanded_url": "https://twitter.com/ASH_hematology/status/1588157073782718467/photo/1", "display_url": "pic.twitter.com/dS3Sj29Vw7", "media_key": "3_1588157072008482817"}]}, "text": "The #ASH22 abstracts are now LIVE! Check them out: https://t.co/f2Fz9tOGWo\n\nLet us know which abstract you\u2019re most excited about with a reply or quote tweet \ud83e\udd29 https://t.co/dS3Sj29Vw7", "conversation_id": "1588157073782718467", "created_at": "2022-11-03T13:12:07.000Z", "edit_history_tweet_ids": ["1588157073782718467"], "author_id": "84072624", "lang": "en", "id": "1588157073782718467"}, {"source": "Loomly", "entities": {"annotations": [{"start": 48, "end": 50, "probability": 0.3642, "type": "Organization", "normalized_text": "ASH"}, {"start": 55, "end": 67, "probability": 0.4284, "type": "Place", "normalized_text": "Latin America"}, {"start": 73, "end": 81, "probability": 0.9656, "type": "Place", "normalized_text": "S\u00e3o Paulo"}, {"start": 84, "end": 89, "probability": 0.9641, "type": "Place", "normalized_text": "Brazil"}, {"start": 159, "end": 163, "probability": 0.6683, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 158, "end": 164, "tag": "ASH22"}], "urls": [{"start": 204, "end": 227, "url": "https://t.co/qKvvYZZcOi", "expanded_url": "https://loom.ly/smoqjms", "display_url": "loom.ly/smoqjms", "status": 200, "title": "2023 Highlights of ASH\u00ae", "description": "Get a synopsis of the top hematology research presented at the latest ASH annual meeting and learn how it can help improve your patient management and care strategies at Highlights of ASH.", "unwound_url": "https://www.hematology.org/meetings/highlights?utm_source=twitter&utm_medium=organic_social&utm_campaign=HOA_2023"}, {"start": 228, "end": 251, "url": "https://t.co/4g5vnyxXsT", "expanded_url": "https://twitter.com/ASH_hematology/status/1587792466723364865/photo/1", "display_url": "pic.twitter.com/4g5vnyxXsT", "media_key": "3_1587792464341045254"}]}, "text": "We're back in person for the 2023 Highlights of ASH in Latin America, in S\u00e3o Paulo, Brazil! Register today to attend &amp; learn how the latest research from #ASH22 can help improve your care strategies: https://t.co/qKvvYZZcOi https://t.co/4g5vnyxXsT", "conversation_id": "1587792466723364865", "created_at": "2022-11-02T13:03:18.000Z", "edit_history_tweet_ids": ["1587792466723364865"], "author_id": "84072624", "lang": "en", "id": "1587792466723364865"}, {"source": "Loomly", "entities": {"annotations": [{"start": 40, "end": 42, "probability": 0.4311, "type": "Organization", "normalized_text": "ASH"}, {"start": 47, "end": 58, "probability": 0.8521, "type": "Place", "normalized_text": "Asia-Pacific"}, {"start": 64, "end": 68, "probability": 0.9288, "type": "Place", "normalized_text": "Hanoi"}, {"start": 71, "end": 77, "probability": 0.9785, "type": "Place", "normalized_text": "Vietnam"}, {"start": 138, "end": 142, "probability": 0.4245, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 137, "end": 143, "tag": "ASH22"}], "urls": [{"start": 145, "end": 168, "url": "https://t.co/qKvvYZZcOi", "expanded_url": "https://loom.ly/smoqjms", "display_url": "loom.ly/smoqjms", "status": 200, "title": "2023 Highlights of ASH\u00ae", "description": "Get a synopsis of the top hematology research presented at the latest ASH annual meeting and learn how it can help improve your patient management and care strategies at Highlights of ASH.", "unwound_url": "https://www.hematology.org/meetings/highlights?utm_source=twitter&utm_medium=organic_social&utm_campaign=HOA_2023"}, {"start": 169, "end": 192, "url": "https://t.co/iqEQxT4khJ", "expanded_url": "https://twitter.com/ASH_hematology/status/1587777019865186304/photo/1", "display_url": "pic.twitter.com/iqEQxT4khJ", "media_key": "3_1587777017495298048"}]}, "text": "Register now for the 2023 Highlights of ASH in Asia-Pacific, in Hanoi, Vietnam \ud83e\ude78 Join us in person to get a recap of all the action from #ASH22: https://t.co/qKvvYZZcOi https://t.co/iqEQxT4khJ", "conversation_id": "1587777019865186304", "created_at": "2022-11-02T12:01:55.000Z", "edit_history_tweet_ids": ["1587777019865186304"], "author_id": "84072624", "lang": "en", "id": "1587777019865186304"}, {"source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1587444035546914817"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 47, "end": 60, "probability": 0.6153, "type": "Other", "normalized_text": "The consortium"}, {"start": 86, "end": 91, "probability": 0.9352, "type": "Place", "normalized_text": "Africa"}, {"start": 104, "end": 107, "probability": 0.5918, "type": "Other", "normalized_text": "cell"}, {"start": 180, "end": 182, "probability": 0.4818, "type": "Other", "normalized_text": "SCD"}], "urls": [{"start": 260, "end": 283, "url": "https://t.co/jV817y3x5p", "expanded_url": "https://loom.ly/HNW5aWE", "display_url": "loom.ly/HNW5aWE", "images": [{"url": "https://pbs.twimg.com/news_img/1587444041494532096/ZXz5qNFb?format=png&name=orig", "width": 120, "height": 154}, {"url": "https://pbs.twimg.com/news_img/1587444041494532096/ZXz5qNFb?format=png&name=150x150", "width": 120, "height": 120}], "status": 200, "title": "consortium on newborn screening in Africa for sickle cell disease: study rationale and methodology", "description": "Key Points. CONSA is an ASH-led 7-country sub-Saharan consortium for implementation research on newborn SCD screening and early clinical interventionThe primary", "unwound_url": "https://ashpublications.org/bloodadvances/article/doi/10.1182/bloodadvances.2022007698/486808/The-consortium-on-newborn-screening-in-Africa-for?utm_source=organic_social&utm_medium=twitter&utm_campaign=CONSA_2_anniv"}]}, "text": "In honor of this anniversary, we've published \"The consortium on newborn screening in Africa for sickle cell disease: study rationale and methodology.\" Read about how early infant SCD screening &amp; entry into continuous care can help reduce child mortality: https://t.co/jV817y3x5p", "conversation_id": "1587444025199575040", "created_at": "2022-11-01T13:58:46.000Z", "edit_history_tweet_ids": ["1587444037442834434"], "author_id": "84072624", "lang": "en", "id": "1587444037442834434"}, {"source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1587444029842751488"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 11, "end": 28, "probability": 0.5646, "type": "Other", "normalized_text": "WorldSickleCellDay"}, {"start": 83, "end": 85, "probability": 0.3456, "type": "Other", "normalized_text": "SCD"}, {"start": 118, "end": 120, "probability": 0.419, "type": "Place", "normalized_text": "ASH"}], "hashtags": [{"start": 10, "end": 29, "tag": "WorldSickleCellDay"}, {"start": 82, "end": 86, "tag": "SCD"}], "urls": [{"start": 200, "end": 223, "url": "https://t.co/nPgfzoIW6H", "expanded_url": "https://twitter.com/ASH_hematology/status/1587444035546914817/photo/1", "display_url": "pic.twitter.com/nPgfzoIW6H", "media_key": "3_1587443779878981632"}]}, "text": "This past #WorldSickleCellDay, CONSA sites celebrated &amp; educated within their #SCD communities. With funding from ASH, these groups were able to hold health fairs, screenings, &amp; trainings \ud83e\ude78 \ud83e\ude7a https://t.co/nPgfzoIW6H", "conversation_id": "1587444025199575040", "created_at": "2022-11-01T13:58:46.000Z", "edit_history_tweet_ids": ["1587444035546914817"], "author_id": "84072624", "lang": "en", "id": "1587444035546914817"}], "includes": {"users": [{"id": "84072624", "name": "ASH", "username": "ASH_hematology"}, {"id": "603145861", "name": "Athalia Pyzer, MD PhD", "username": "HowellJollyBody"}, {"id": "1375416370524000260", "name": "Madelon de Jong", "username": "maadulon"}, {"id": "1064662683407003648", "name": "Laurel A. Menapace, MD", "username": "LaurelMenapace"}, {"id": "32760936", "name": "Jonathan Keats, PhD", "username": "PedalheadPHX"}, {"id": "89017265", "name": "A. Emre E\u015fkazan, MD \ud83e\ude78\ud83d\udd2c", "username": "eskazanae"}, {"id": "1291680846156529664", "name": "Shuchi Agrawal Singh", "username": "ShuchiChromaBio"}, {"id": "1144997352148787201", "name": "Amer Zeidan MBBS,MHS \u200f\u0639\u0627\u0645\u0631 \u0632\u064a\u062f\u0627\u0646", "username": "Dr_AmerZeidan"}, {"id": "1145441671129292801", "name": "Alberto L\u00f3pez-Garcia MD #ASH22", "username": "DrAlbertoLG"}, {"id": "754664467015892992", "name": "Akshay Sharma MD", "username": "AkshaySharmaMD"}, {"id": "1026289734904164353", "name": "Fr\u00e9d\u00e9rique St-Pierre", "username": "FStPierreMD"}], "tweets": [{"entities": {"mentions": [{"start": 156, "end": 172, "username": "DrChrisHourigan", "id": "811643018025504768"}], "annotations": [{"start": 22, "end": 26, "probability": 0.699, "type": "Other", "normalized_text": "ASH22"}, {"start": 177, "end": 183, "probability": 0.5109, "type": "Organization", "normalized_text": "ASHFOMO"}], "hashtags": [{"start": 21, "end": 27, "tag": "ASH22"}, {"start": 176, "end": 184, "tag": "ASHFOMO"}]}, "source": "Twitter for iPhone", "text": "Unable to make it to #ASH22 due to an ambitious kidney stone launching a failed bid for freedom. Hopefully the pre-recording of my talk is alright! Joining @DrChrisHourigan in #ASHFOMO \ud83e\udd7a\ud83e\udd7a\ud83e\udd7a", "conversation_id": "1601243155109650437", "created_at": "2022-12-09T15:51:32.000Z", "edit_history_tweet_ids": ["1601243155109650437"], "author_id": "603145861", "lang": "en", "id": "1601243155109650437"}, {"entities": {"mentions": [{"start": 44, "end": 59, "username": "ASH_hematology", "id": "84072624"}], "annotations": [{"start": 19, "end": 25, "probability": 0.7263, "type": "Other", "normalized_text": "ASH2022"}], "urls": [{"start": 65, "end": 88, "url": "https://t.co/KBB8oaWB0Q", "expanded_url": "https://twitter.com/CarrawayHetty/status/1601245405911683073/photo/1", "display_url": "pic.twitter.com/KBB8oaWB0Q", "media_key": "3_1601245400027090947"}]}, "source": "Twitter for iPhone", "text": "Everyone ready for ASH2022!!? Let\u2019s Go!! \u2665\ufe0f\u2066@ASH_hematology\u2069 \ud83e\udd13\ud83e\udd13\ud83e\udd13 https://t.co/KBB8oaWB0Q", "conversation_id": "1601245405911683073", "created_at": "2022-12-09T16:00:29.000Z", "edit_history_tweet_ids": ["1601245405911683073"], "author_id": "3168040672", "lang": "en", "id": "1601245405911683073"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1601216743568965633"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 44, "end": 53, "probability": 0.5915, "type": "Other", "normalized_text": "Hematology"}, {"start": 58, "end": 62, "probability": 0.5346, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 43, "end": 54, "tag": "Hematology"}, {"start": 57, "end": 63, "tag": "ASH22"}, {"start": 64, "end": 79, "tag": "clinicaltrials"}, {"start": 80, "end": 97, "tag": "clinicalresearch"}]}, "text": "Advancing Decentralized Clinical Trials in #Hematology | #ASH22 #clinicaltrials #clinicalresearch", "conversation_id": "1601216719137153026", "created_at": "2022-12-09T14:06:36.000Z", "edit_history_tweet_ids": ["1601216746349891596"], "author_id": "84072624", "lang": "en", "id": "1601216746349891596"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1601216740742103041"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 0, "end": 7, "probability": 0.4366, "type": "Other", "normalized_text": "Germline"}, {"start": 81, "end": 85, "probability": 0.405, "type": "Other", "normalized_text": "ASH22"}, {"start": 88, "end": 92, "probability": 0.4965, "type": "Other", "normalized_text": "BMFSM"}, {"start": 95, "end": 99, "probability": 0.5641, "type": "Organization", "normalized_text": "mdssm"}, {"start": 102, "end": 106, "probability": 0.5647, "type": "Organization", "normalized_text": "mpnsm"}], "hashtags": [{"start": 80, "end": 86, "tag": "ASH22"}, {"start": 87, "end": 93, "tag": "BMFSM"}, {"start": 94, "end": 100, "tag": "mdssm"}, {"start": 101, "end": 107, "tag": "mpnsm"}]}, "text": "Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure | #ASH22 #BMFSM #mdssm #mpnsm", "conversation_id": "1601216719137153026", "created_at": "2022-12-09T14:06:35.000Z", "edit_history_tweet_ids": ["1601216743568965633"], "author_id": "84072624", "lang": "en", "id": "1601216743568965633"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1601216737017561088"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 34, "end": 40, "probability": 0.6144, "type": "Other", "normalized_text": "to Stay"}, {"start": 45, "end": 49, "probability": 0.5309, "type": "Other", "normalized_text": "ASH22"}, {"start": 52, "end": 57, "probability": 0.3951, "type": "Other", "normalized_text": "CRISPR"}, {"start": 73, "end": 76, "probability": 0.5335, "type": "Other", "normalized_text": "SCGE"}], "hashtags": [{"start": 16, "end": 27, "tag": "Hematology"}, {"start": 44, "end": 50, "tag": "ASH22"}, {"start": 51, "end": 58, "tag": "CRISPR"}, {"start": 59, "end": 71, "tag": "geneediting"}, {"start": 72, "end": 77, "tag": "SCGE"}]}, "text": "Gene Editing in #Hematology: Here to Stay | #ASH22 #CRISPR #geneediting #SCGE", "conversation_id": "1601216719137153026", "created_at": "2022-12-09T14:06:34.000Z", "edit_history_tweet_ids": ["1601216740742103041"], "author_id": "84072624", "lang": "en", "id": "1601216740742103041"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1601216734127702016"}], "in_reply_to_user_id": "84072624", "text": "Myeloid Development | #ASH22 #AMLsm #CML", "conversation_id": "1601216719137153026", "entities": {"hashtags": [{"start": 22, "end": 28, "tag": "ASH22"}, {"start": 29, "end": 35, "tag": "AMLsm"}, {"start": 36, "end": 40, "tag": "CML"}]}, "created_at": "2022-12-09T14:06:33.000Z", "edit_history_tweet_ids": ["1601216737017561088"], "author_id": "84072624", "lang": "ht", "id": "1601216737017561088"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1601216731317403652"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 71, "end": 76, "probability": 0.7153, "type": "Other", "normalized_text": "Cancer"}, {"start": 81, "end": 85, "probability": 0.5662, "type": "Other", "normalized_text": "ASH22"}, {"start": 101, "end": 104, "probability": 0.7332, "type": "Other", "normalized_text": "MMSM"}, {"start": 107, "end": 114, "probability": 0.5503, "type": "Other", "normalized_text": "leukemia"}], "hashtags": [{"start": 80, "end": 86, "tag": "ASH22"}, {"start": 87, "end": 99, "tag": "bloodcancer"}, {"start": 100, "end": 105, "tag": "MMSM"}, {"start": 106, "end": 115, "tag": "leukemia"}, {"start": 116, "end": 125, "tag": "genomics"}]}, "text": "Translational Molecular Diagnostics: Genomic Reclassification of Blood Cancer | #ASH22 #bloodcancer #MMSM #leukemia #genomics", "conversation_id": "1601216719137153026", "created_at": "2022-12-09T14:06:33.000Z", "edit_history_tweet_ids": ["1601216734127702016"], "author_id": "84072624", "lang": "en", "id": "1601216734127702016"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1601216728465383424"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 94, "end": 98, "probability": 0.5539, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 93, "end": 99, "tag": "ASH22"}, {"start": 100, "end": 113, "tag": "epidemiology"}, {"start": 114, "end": 127, "tag": "publichealth"}]}, "text": "Epidemiology: Leveraging Digital Technology to Modernize and Enhance Observational Studies | #ASH22 #epidemiology #publichealth", "conversation_id": "1601216719137153026", "created_at": "2022-12-09T14:06:32.000Z", "edit_history_tweet_ids": ["1601216731317403652"], "author_id": "84072624", "lang": "en", "id": "1601216731317403652"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1601216725600673792"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 91, "end": 99, "probability": 0.5037, "type": "Other", "normalized_text": "CAR_TCell"}], "hashtags": [{"start": 83, "end": 89, "tag": "ASH22"}, {"start": 90, "end": 100, "tag": "CAR_TCell"}]}, "text": "Bedside to Bench: Dissecting Emergent CAR T-cell Toxicities Beyond CRS and ICANS | #ASH22 #CAR_TCell", "conversation_id": "1601216719137153026", "created_at": "2022-12-09T14:06:31.000Z", "edit_history_tweet_ids": ["1601216728465383424"], "author_id": "84072624", "lang": "en", "id": "1601216728465383424"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1601216722584879106"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 24, "end": 28, "probability": 0.6258, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 23, "end": 29, "tag": "ASH22"}, {"start": 30, "end": 41, "tag": "hematology"}, {"start": 42, "end": 55, "tag": "healthyaging"}, {"start": 56, "end": 70, "tag": "patientsafety"}]}, "text": "Hematology and Aging | #ASH22 #hematology #healthyaging #patientsafety", "conversation_id": "1601216719137153026", "created_at": "2022-12-09T14:06:31.000Z", "edit_history_tweet_ids": ["1601216725600673792"], "author_id": "84072624", "lang": "en", "id": "1601216725600673792"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1601216719137153026"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 48, "end": 52, "probability": 0.5616, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 47, "end": 53, "tag": "ASH22"}, {"start": 54, "end": 72, "tag": "bleedingdisorders"}, {"start": 73, "end": 84, "tag": "hemophilia"}]}, "text": "Interplay between Coagulation and Malignancy | #ASH22 #bleedingdisorders #hemophilia", "conversation_id": "1601216719137153026", "created_at": "2022-12-09T14:06:30.000Z", "edit_history_tweet_ids": ["1601216722584879106"], "author_id": "84072624", "lang": "en", "id": "1601216722584879106"}, {"source": "Loomly", "entities": {"annotations": [{"start": 5, "end": 9, "probability": 0.6771, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 4, "end": 10, "tag": "ASH22"}], "urls": [{"start": 111, "end": 134, "url": "https://t.co/ahlfV8WYCa", "expanded_url": "https://twitter.com/ASH_hematology/status/1601216719137153026/photo/1", "display_url": "pic.twitter.com/ahlfV8WYCa", "media_key": "3_1601216716851257345"}]}, "text": "The #ASH22 Scientific Workshops are happening today from 2:00-5:00 p.m. CT! Check out the discussion topics \ud83e\uddf5\ud83d\udc47 https://t.co/ahlfV8WYCa", "conversation_id": "1601216719137153026", "created_at": "2022-12-09T14:06:29.000Z", "edit_history_tweet_ids": ["1601216719137153026"], "author_id": "84072624", "lang": "en", "id": "1601216719137153026"}, {"entities": {"mentions": [{"start": 98, "end": 113, "username": "ASH_hematology", "id": "84072624"}], "annotations": [{"start": 14, "end": 18, "probability": 0.5825, "type": "Other", "normalized_text": "ASH22"}, {"start": 132, "end": 142, "probability": 0.9858, "type": "Place", "normalized_text": "New Orleans"}], "hashtags": [{"start": 13, "end": 19, "tag": "ASH22"}], "urls": [{"start": 281, "end": 304, "url": "https://t.co/68GbiNycXt", "expanded_url": "https://twitter.com/DavidSteensma/status/1600956349105713152/photo/1", "display_url": "pic.twitter.com/68GbiNycXt", "media_key": "3_1600955696203325440"}, {"start": 281, "end": 304, "url": "https://t.co/68GbiNycXt", "expanded_url": "https://twitter.com/DavidSteensma/status/1600956349105713152/photo/1", "display_url": "pic.twitter.com/68GbiNycXt", "media_key": "3_1600955696329138210"}, {"start": 281, "end": 304, "url": "https://t.co/68GbiNycXt", "expanded_url": "https://twitter.com/DavidSteensma/status/1600956349105713152/photo/1", "display_url": "pic.twitter.com/68GbiNycXt", "media_key": "3_1600955696614342658"}, {"start": 281, "end": 304, "url": "https://t.co/68GbiNycXt", "expanded_url": "https://twitter.com/DavidSteensma/status/1600956349105713152/photo/1", "display_url": "pic.twitter.com/68GbiNycXt", "media_key": "3_1600955696744366080"}]}, "source": "Twitter Web App", "text": "Attendees at #ASH22 might be interested in seeing the complete 4-page program from the first time @ASH_hematology held a meeting in New Orleans: 1966, the 9th annual meeting. About 1000 people came. Notable is the almost complete absence of discussion of hematological malignancy! https://t.co/68GbiNycXt", "conversation_id": "1600956349105713152", "created_at": "2022-12-08T20:51:52.000Z", "edit_history_tweet_ids": ["1600956349105713152"], "author_id": "2739065578", "lang": "en", "id": "1600956349105713152"}, {"source": "Twitter Web App", "entities": {"annotations": [{"start": 13, "end": 17, "probability": 0.7717, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 12, "end": 18, "tag": "ASH22"}]}, "text": "Where\u2019s the #ASH22 bingo card at? I\u2019ve never been so don\u2019t know what to look out for", "conversation_id": "1600567122215714833", "created_at": "2022-12-07T19:05:13.000Z", "edit_history_tweet_ids": ["1600567122215714833"], "author_id": "1375416370524000260", "lang": "en", "id": "1600567122215714833"}, {"source": "Twitter for iPhone", "text": "Has everyone received their ASH badge via mail? Mine is missing \u2026 #ASH2022 #Hematology #NewOrleans", "conversation_id": "1600654522317438977", "entities": {"hashtags": [{"start": 66, "end": 74, "tag": "ASH2022"}, {"start": 75, "end": 86, "tag": "Hematology"}, {"start": 87, "end": 98, "tag": "NewOrleans"}]}, "created_at": "2022-12-08T00:52:31.000Z", "edit_history_tweet_ids": ["1600654522317438977"], "author_id": "1064662683407003648", "lang": "en", "id": "1600654522317438977"}, {"entities": {"mentions": [{"start": 37, "end": 52, "username": "ASH_hematology", "id": "84072624"}, {"start": 103, "end": 114, "username": "jmikhaelmd", "id": "2377190652"}]}, "source": "Twitter for iPhone", "text": "Second year in a row I didn\u2019t get my @ASH_hematology meeting badge in the mail. Would not compete with @jmikhaelmd on stickers but getting ripped off again", "conversation_id": "1600632832522702848", "created_at": "2022-12-07T23:26:20.000Z", "edit_history_tweet_ids": ["1600632832522702848"], "author_id": "32760936", "lang": "en", "id": "1600632832522702848"}, {"entities": {"mentions": [{"start": 124, "end": 139, "username": "ASH_hematology", "id": "84072624"}, {"start": 140, "end": 148, "username": "NODlike", "id": "69042897"}, {"start": 149, "end": 159, "username": "majorajay", "id": "409755591"}, {"start": 160, "end": 175, "username": "AlexandraRezMD", "id": "306251536"}, {"start": 176, "end": 188, "username": "PARty4Ever_", "id": "1554090133883965441"}, {"start": 189, "end": 201, "username": "DrDariaGaut", "id": "1184306629711237120"}, {"start": 202, "end": 218, "username": "Midenightrosemh", "id": "528921331"}, {"start": 219, "end": 229, "username": "rmistry91", "id": "42084590"}, {"start": 230, "end": 240, "username": "JMStempel", "id": "1396844859282108419"}], "annotations": [{"start": 1, "end": 10, "probability": 0.4415, "type": "Other", "normalized_text": "ASHtrainee"}, {"start": 33, "end": 35, "probability": 0.5134, "type": "Place", "normalized_text": "ASH"}, {"start": 39, "end": 45, "probability": 0.4736, "type": "Other", "normalized_text": "Palooza"}], "hashtags": [{"start": 0, "end": 11, "tag": "ASHtrainee"}, {"start": 75, "end": 81, "tag": "ASH22"}], "urls": [{"start": 98, "end": 121, "url": "https://t.co/DsQNtNgQ6K", "expanded_url": "https://tinyurl.com/mwr89tp9", "display_url": "tinyurl.com/mwr89tp9", "images": [{"url": "https://pbs.twimg.com/news_img/1599114806459449344/2wS7IprP?format=jpg&name=orig", "width": 660, "height": 495}, {"url": "https://pbs.twimg.com/news_img/1599114806459449344/2wS7IprP?format=jpg&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "I\u2019ve Registered for ASH. Now What? - Hematology.org", "description": "I\u2019ve Registered for ASH. Now What?", "unwound_url": "https://www.hematology.org/education/trainees/fellows/trainee-news/2022/registered-for-ash"}, {"start": 241, "end": 264, "url": "https://t.co/PKWIzOdbNF", "expanded_url": "https://twitter.com/beckyzon/status/1599127783099494400/photo/1", "display_url": "pic.twitter.com/PKWIzOdbNF", "media_key": "3_1599127778795872256"}]}, "source": "Twitter for iPhone", "text": "#ASHtrainee make sure to come to ASH-a-Palooza. It is going to be AMAZING. #ASH22\n\nFor more info: https://t.co/DsQNtNgQ6K \n\n@ASH_hematology @NODlike @majorajay @AlexandraRezMD @PARty4Ever_ @DrDariaGaut @Midenightrosemh @rmistry91 @JMStempel https://t.co/PKWIzOdbNF", "conversation_id": "1599127783099494400", "created_at": "2022-12-03T19:45:48.000Z", "edit_history_tweet_ids": ["1599127783099494400"], "author_id": "3242517017", "lang": "en", "id": "1599127783099494400"}, {"entities": {"mentions": [{"start": 43, "end": 56, "username": "JaneWinterMD", "id": "1433149659808247813"}, {"start": 57, "end": 69, "username": "heMEGirl_MD", "id": "3608131998"}], "annotations": [{"start": 37, "end": 41, "probability": 0.4734, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 36, "end": 42, "tag": "ASH22"}], "urls": [{"start": 70, "end": 93, "url": "https://t.co/GJThGGwzM4", "expanded_url": "https://twitter.com/FStPierreMD/status/1600652194541441025/photo/1", "display_url": "pic.twitter.com/GJThGGwzM4", "media_key": "3_1600652188220637184"}]}, "source": "Twitter for iPhone", "text": "Wine and cheese with the President.\n#ASH22\n@JaneWinterMD @heMEGirl_MD https://t.co/GJThGGwzM4", "conversation_id": "1600652194541441025", "created_at": "2022-12-08T00:43:16.000Z", "edit_history_tweet_ids": ["1600652194541441025"], "author_id": "1026289734904164353", "lang": "en", "id": "1600652194541441025"}, {"source": "Twitter for iPhone", "entities": {"annotations": [{"start": 17, "end": 20, "probability": 0.6366, "type": "Place", "normalized_text": "NOLA"}, {"start": 54, "end": 60, "probability": 0.5574, "type": "Other", "normalized_text": "ASH2022"}], "hashtags": [{"start": 53, "end": 61, "tag": "ASH2022"}], "urls": [{"start": 104, "end": 127, "url": "https://t.co/DAiSGjqoct", "expanded_url": "https://twitter.com/DocsDock200/status/1600612587825143820/photo/1", "display_url": "pic.twitter.com/DAiSGjqoct", "media_key": "3_1600612579314995200"}]}, "text": "Just walked thru NOLA convention center. All set for #ASH2022. Place looks great. 80 degrees and sunny. https://t.co/DAiSGjqoct", "conversation_id": "1600612587825143820", "created_at": "2022-12-07T22:05:53.000Z", "edit_history_tweet_ids": ["1600612587825143820"], "author_id": "1586415236935991296", "lang": "en", "id": "1600612587825143820"}, {"source": "Twitter Web App", "entities": {"annotations": [{"start": 37, "end": 39, "probability": 0.8757, "type": "Organization", "normalized_text": "WHO"}, {"start": 42, "end": 45, "probability": 0.7287, "type": "Organization", "normalized_text": "IARC"}, {"start": 56, "end": 58, "probability": 0.6552, "type": "Organization", "normalized_text": "ICC"}], "hashtags": [{"start": 36, "end": 40, "tag": "WHO"}, {"start": 41, "end": 46, "tag": "IARC"}, {"start": 55, "end": 59, "tag": "ICC"}, {"start": 79, "end": 91, "tag": "hematologic"}, {"start": 92, "end": 102, "tag": "neoplasms"}]}, "text": "Though there is overlap between the #WHO #IARC and new #ICC classifications of #hematologic #neoplasms, having two classification systems means clinicians must decide how to apply them. Which system will you primarily rely on in your clinical practice going forward?", "conversation_id": "1600589369152339969", "created_at": "2022-12-07T20:33:37.000Z", "edit_history_tweet_ids": ["1600589369152339969"], "author_id": "2842612449", "lang": "en", "id": "1600589369152339969"}, {"entities": {"mentions": [{"start": 40, "end": 55, "username": "ASH_hematology", "id": "84072624"}], "annotations": [{"start": 2, "end": 9, "probability": 0.7913, "type": "Place", "normalized_text": "Istanbul"}, {"start": 14, "end": 24, "probability": 0.9409, "type": "Place", "normalized_text": "New Orleans"}], "hashtags": [{"start": 30, "end": 36, "tag": "ASH22"}], "urls": [{"start": 56, "end": 79, "url": "https://t.co/76lZwiKUU1", "expanded_url": "https://twitter.com/eskazanae/status/1599781543366443008", "display_url": "twitter.com/eskazanae/stat\u2026"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "quoted", "id": "1599781543366443008"}], "text": "\ud83d\udeeb Istanbul \u27a1\ufe0f New Orleans for #ASH22 \ud83e\udd13\ud83d\ude0e\n@ASH_hematology https://t.co/76lZwiKUU1", "conversation_id": "1600560087809941504", "created_at": "2022-12-07T18:37:16.000Z", "edit_history_tweet_ids": ["1600560087809941504"], "author_id": "89017265", "lang": "en", "id": "1600560087809941504"}, {"entities": {"mentions": [{"start": 0, "end": 15, "username": "ASH_hematology", "id": "84072624"}, {"start": 16, "end": 28, "username": "BritSocHaem", "id": "201645895"}]}, "source": "Twitter for iPhone", "referenced_tweets": [{"type": "replied_to", "id": "1600555859691585555"}], "in_reply_to_user_id": "84072624", "text": "@ASH_hematology @BritSocHaem Look forward to it.", "conversation_id": "1600555830939631618", "created_at": "2022-12-07T18:27:49.000Z", "edit_history_tweet_ids": ["1600557710218387456"], "author_id": "1291680846156529664", "lang": "en", "id": "1600557710218387456"}, {"entities": {"mentions": [{"start": 19, "end": 31, "username": "nsarellano9", "id": "1384691585011572739"}], "annotations": [{"start": 132, "end": 136, "probability": 0.4563, "type": "Other", "normalized_text": "mpnsm"}], "hashtags": [{"start": 131, "end": 137, "tag": "mpnsm"}, {"start": 169, "end": 175, "tag": "ASH22"}], "urls": [{"start": 187, "end": 210, "url": "https://t.co/HlzNLzO1yE", "expanded_url": "https://twitter.com/ASH_hematology/status/1600555865295175698/photo/1", "display_url": "pic.twitter.com/HlzNLzO1yE", "media_key": "3_1600555726027489280"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600555859691585555"}], "in_reply_to_user_id": "84072624", "text": "Finally, we've got @nsarellano9! This graduate student from @ElflLabUChicago is attending this year's meeting to share her work on #mpnsm \ud83d\udc69\ud83c\udffb\u200d\u2695\ufe0f\ud83d\udd2c Check out her plans for #ASH22 below!\n8/9 https://t.co/HlzNLzO1yE", "conversation_id": "1600555830939631618", "created_at": "2022-12-07T18:20:29.000Z", "edit_history_tweet_ids": ["1600555865295175698"], "author_id": "84072624", "lang": "en", "id": "1600555865295175698"}, {"entities": {"mentions": [{"start": 27, "end": 43, "username": "ShuchiChromaBio", "id": "1291680846156529664"}, {"start": 69, "end": 81, "username": "BritSocHaem", "id": "201645895"}], "annotations": [{"start": 65, "end": 67, "probability": 0.3153, "type": "Other", "normalized_text": "ASH"}, {"start": 103, "end": 107, "probability": 0.566, "type": "Other", "normalized_text": "Award"}, {"start": 114, "end": 118, "probability": 0.4571, "type": "Other", "normalized_text": "Singh"}, {"start": 149, "end": 153, "probability": 0.6199, "type": "Other", "normalized_text": "HOXA9"}, {"start": 199, "end": 201, "probability": 0.363, "type": "Organization", "normalized_text": "AML"}, {"start": 234, "end": 237, "probability": 0.7096, "type": "Place", "normalized_text": "NOLA"}], "hashtags": [{"start": 148, "end": 154, "tag": "HOXA9"}, {"start": 198, "end": 202, "tag": "AML"}, {"start": 265, "end": 271, "tag": "ASH22"}], "urls": [{"start": 278, "end": 301, "url": "https://t.co/zbVdCBildz", "expanded_url": "https://twitter.com/ASH_hematology/status/1600555859691585555/photo/1", "display_url": "pic.twitter.com/zbVdCBildz", "media_key": "3_1600555613939023881"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600555855308414976"}], "in_reply_to_user_id": "84072624", "text": "From across the pond, it's @ShuchiChromaBio! As recipient of the ASH-@BritSocHaem Abstract Achievement Award, Dr. Singh will be sharing her work on #HOXA9 &amp; the importance of differentiation in #AML \ud83e\uddec Find out why she\u2019s coming to NOLA for all the excitement of #ASH22\u2935\ufe0f\n7/9 https://t.co/zbVdCBildz", "conversation_id": "1600555830939631618", "created_at": "2022-12-07T18:20:28.000Z", "edit_history_tweet_ids": ["1600555859691585555"], "author_id": "84072624", "lang": "en", "id": "1600555859691585555"}, {"entities": {"mentions": [{"start": 14, "end": 26, "username": "Djeffreedom", "id": "343131539"}], "annotations": [{"start": 32, "end": 38, "probability": 0.6464, "type": "Other", "normalized_text": "Edwards"}, {"start": 82, "end": 84, "probability": 0.4019, "type": "Other", "normalized_text": "TCD"}, {"start": 172, "end": 174, "probability": 0.3465, "type": "Organization", "normalized_text": "SCD"}], "hashtags": [{"start": 81, "end": 85, "tag": "TCD"}, {"start": 113, "end": 124, "tag": "sicklecell"}, {"start": 142, "end": 159, "tag": "healthinequities"}, {"start": 171, "end": 175, "tag": "SCD"}, {"start": 270, "end": 276, "tag": "ASH22"}], "urls": [{"start": 283, "end": 306, "url": "https://t.co/Lp2Ne5L3M4", "expanded_url": "https://twitter.com/ASH_hematology/status/1600555855308414976/photo/1", "display_url": "pic.twitter.com/Lp2Ne5L3M4", "media_key": "3_1600555501091274817"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600555849855950848"}], "in_reply_to_user_id": "84072624", "text": "Next, we have @Djeffreedom! Dr. Edwards will be presenting on his work improving #TCD screening in children with #sicklecell &amp; addressing #healthinequities within the #SCD community at the Promoting Minorities in Hematology event \u2764\ufe0f\ud83e\udd1d\ud83c\udffd See why he can\u2019t wait to be at #ASH22\u2935\ufe0f\n6/9 https://t.co/Lp2Ne5L3M4", "conversation_id": "1600555830939631618", "created_at": "2022-12-07T18:20:27.000Z", "edit_history_tweet_ids": ["1600555855308414976"], "author_id": "84072624", "lang": "en", "id": "1600555855308414976"}, {"entities": {"mentions": [{"start": 44, "end": 56, "username": "chancolonne", "id": "16681509"}, {"start": 85, "end": 98, "username": "hsanz_org_au", "id": "1055695780676169729"}], "annotations": [{"start": 17, "end": 22, "probability": 0.7252, "type": "Place", "normalized_text": "Sydney"}, {"start": 25, "end": 33, "probability": 0.9706, "type": "Place", "normalized_text": "Australia"}, {"start": 108, "end": 124, "probability": 0.7076, "type": "Other", "normalized_text": "Achievement Award"}], "hashtags": [{"start": 201, "end": 212, "tag": "hematology"}, {"start": 264, "end": 270, "tag": "ASH22"}], "urls": [{"start": 276, "end": 299, "url": "https://t.co/Y2Qe6jA8yw", "expanded_url": "https://twitter.com/ASH_hematology/status/1600555849855950848/photo/1", "display_url": "pic.twitter.com/Y2Qe6jA8yw", "media_key": "3_1600555348926119967"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600555844814315520"}], "in_reply_to_user_id": "84072624", "text": "All the way from Sydney, Australia, we have @chancolonne! She's been awarded the ASH-@hsanz_org_au Abstract Achievement Award for her research on a new subtype of erythroblasts \ud83d\udd2c \ud83e\ude78 Read about why this #hematology expert is traveling across the world to experience #ASH22!\n5/9 https://t.co/Y2Qe6jA8yw", "conversation_id": "1600555830939631618", "created_at": "2022-12-07T18:20:26.000Z", "edit_history_tweet_ids": ["1600555849855950848"], "author_id": "84072624", "lang": "en", "id": "1600555849855950848"}, {"entities": {"mentions": [{"start": 11, "end": 27, "username": "MayaAbdallah_MD", "id": "1117914517567098880"}], "annotations": [{"start": 58, "end": 67, "probability": 0.5108, "type": "Other", "normalized_text": "ASHTrainee"}, {"start": 186, "end": 190, "probability": 0.4992, "type": "Other", "normalized_text": "ASH22"}, {"start": 235, "end": 247, "probability": 0.5557, "type": "Other", "normalized_text": "SHEmatologist"}], "hashtags": [{"start": 57, "end": 68, "tag": "ASHTrainee"}, {"start": 185, "end": 191, "tag": "ASH22"}, {"start": 234, "end": 248, "tag": "SHEmatologist"}], "urls": [{"start": 275, "end": 298, "url": "https://t.co/GaAVkXEErl", "expanded_url": "https://twitter.com/ASH_hematology/status/1600555844814315520/photo/1", "display_url": "pic.twitter.com/GaAVkXEErl", "media_key": "3_1600555235755409440"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600555840385204230"}], "in_reply_to_user_id": "84072624", "text": "Next up is @MayaAbdallah_MD! This standing member of the #ASHTrainee Council has just joined our Communications Committee &amp; is a \u2728certified social media superstar\u2728 Read her special #ASH22 message to learn about what sessions this #SHEmatologist is excited to attend!\n4/9 https://t.co/GaAVkXEErl", "conversation_id": "1600555830939631618", "created_at": "2022-12-07T18:20:24.000Z", "edit_history_tweet_ids": ["1600555844814315520"], "author_id": "84072624", "lang": "en", "id": "1600555844814315520"}, {"entities": {"mentions": [{"start": 34, "end": 48, "username": "Andresnoyolaa", "id": "1936057358"}], "annotations": [{"start": 13, "end": 21, "probability": 0.7613, "type": "Place", "normalized_text": "Monterrey"}, {"start": 24, "end": 25, "probability": 0.4108, "type": "Place", "normalized_text": "MX"}, {"start": 108, "end": 123, "probability": 0.6031, "type": "Other", "normalized_text": "ASH HONORS Award"}], "hashtags": [{"start": 159, "end": 171, "tag": "celltherapy"}, {"start": 178, "end": 195, "tag": "healthinequities"}, {"start": 263, "end": 269, "tag": "ASH22"}], "urls": [{"start": 283, "end": 306, "url": "https://t.co/9oOzkLu4ML", "expanded_url": "https://twitter.com/ASH_hematology/status/1600555840385204230/photo/1", "display_url": "pic.twitter.com/9oOzkLu4ML", "media_key": "3_1600555120407855133"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600555835331342336"}], "in_reply_to_user_id": "84072624", "text": "Hailing from Monterrey, MX , it's @andresnoyolaa! As a medical student, his outstanding work earned him the ASH HONORS Award to help carry out his research in #celltherapy &amp; #healthinequities \ud83d\udc89\ud83c\udfe5 See why he's eager to help build international community in his #ASH22 message!\n3/9 https://t.co/9oOzkLu4ML", "conversation_id": "1600555830939631618", "created_at": "2022-12-07T18:20:23.000Z", "edit_history_tweet_ids": ["1600555840385204230"], "author_id": "84072624", "lang": "en", "id": "1600555840385204230"}, {"entities": {"mentions": [{"start": 10, "end": 19, "username": "beckyzon", "id": "3242517017"}], "annotations": [{"start": 26, "end": 35, "probability": 0.6756, "type": "Other", "normalized_text": "ASHTrainee"}, {"start": 150, "end": 156, "probability": 0.692, "type": "Other", "normalized_text": "heparin"}, {"start": 166, "end": 181, "probability": 0.6591, "type": "Other", "normalized_text": "thrombocytopenia"}, {"start": 223, "end": 227, "probability": 0.4945, "type": "Other", "normalized_text": ". Zon"}], "hashtags": [{"start": 25, "end": 36, "tag": "ASHTrainee"}, {"start": 259, "end": 265, "tag": "ASH22"}], "urls": [{"start": 273, "end": 296, "url": "https://t.co/b42rmtSCpL", "expanded_url": "https://twitter.com/ASH_hematology/status/1600555835331342336/photo/1", "display_url": "pic.twitter.com/b42rmtSCpL", "media_key": "3_1600554965310783488"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1600555830939631618"}], "in_reply_to_user_id": "84072624", "text": "First up, @beckyzon! Our #ASHTrainee Council Chair will be presenting on implementation of electronic health alerts to improve care for patients with heparin-induced thrombocytopenia \u2695\ufe0f\ud83d\udda5\ufe0f Check out a special message from Dr. Zon below on why she's pumped for #ASH22!  \n2/9 https://t.co/b42rmtSCpL", "conversation_id": "1600555830939631618", "created_at": "2022-12-07T18:20:22.000Z", "edit_history_tweet_ids": ["1600555835331342336"], "author_id": "84072624", "lang": "en", "id": "1600555835331342336"}, {"source": "Twitter Web App", "entities": {"annotations": [{"start": 68, "end": 72, "probability": 0.64, "type": "Other", "normalized_text": "ASH22"}, {"start": 178, "end": 188, "probability": 0.9894, "type": "Place", "normalized_text": "New Orleans"}], "hashtags": [{"start": 67, "end": 73, "tag": "ASH22"}, {"start": 97, "end": 108, "tag": "hematology"}], "urls": [{"start": 275, "end": 298, "url": "https://t.co/WGIwYK34th", "expanded_url": "https://twitter.com/ASH_hematology/status/1600555830939631618/photo/1", "display_url": "pic.twitter.com/WGIwYK34th", "media_key": "3_1600554823052673054"}]}, "text": "Drumroll, please...\ud83e\udd41\ud83e\udd41\ud83e\udd41 We'd like to introduce you to our Voices of #ASH22! These rising stars in #hematology are traveling from around the globe to attend this year's meeting in New Orleans \u269c\ufe0f Check out the \ud83e\uddf5\ud83d\udc47 to find out why they're all excited to get in on the action!\n1/9 https://t.co/WGIwYK34th", "conversation_id": "1600555830939631618", "created_at": "2022-12-07T18:20:21.000Z", "edit_history_tweet_ids": ["1600555830939631618"], "author_id": "84072624", "lang": "en", "id": "1600555830939631618"}, {"entities": {"mentions": [{"start": 0, "end": 15, "username": "ASH_hematology", "id": "84072624"}], "annotations": [{"start": 132, "end": 138, "probability": 0.4146, "type": "Other", "normalized_text": "ASH2013"}, {"start": 152, "end": 156, "probability": 0.3984, "type": "Other", "normalized_text": "MDSsm"}, {"start": 168, "end": 182, "probability": 0.9521, "type": "Person", "normalized_text": "Peter Greenberg"}, {"start": 252, "end": 260, "probability": 0.7035, "type": "Other", "normalized_text": "Hollywood"}], "hashtags": [{"start": 131, "end": 139, "tag": "ASH2013"}, {"start": 151, "end": 157, "tag": "MDSsm"}, {"start": 273, "end": 281, "tag": "ASH2022"}, {"start": 282, "end": 288, "tag": "ASH22"}], "urls": [{"start": 289, "end": 312, "url": "https://t.co/3LtEphMhDt", "expanded_url": "https://twitter.com/Dr_AmerZeidan/status/1600528627086622726/photo/1", "display_url": "pic.twitter.com/3LtEphMhDt", "media_key": "3_1600528623248760833"}]}, "source": "Twitter for iPhone", "in_reply_to_user_id": "84072624", "text": "@ASH_hematology meetings are not only about research/education, but also to build connections &amp; meet people you look up to. In #ASH2013 I ran into #MDSsm legend Dr Peter Greenberg &amp; I couldn\u2019t hold excitement to ask for a photo with him like a Hollywood celebrity! #ASH2022 #ASH22 https://t.co/3LtEphMhDt", "conversation_id": "1600528627086622726", "created_at": "2022-12-07T16:32:15.000Z", "edit_history_tweet_ids": ["1600528627086622726"], "author_id": "1144997352148787201", "lang": "en", "id": "1600528627086622726"}, {"entities": {"mentions": [{"start": 81, "end": 96, "username": "ASH_hematology", "id": "84072624"}], "annotations": [{"start": 35, "end": 39, "probability": 0.6582, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 34, "end": 40, "tag": "ASH22"}], "urls": [{"start": 97, "end": 120, "url": "https://t.co/Y9gGAR98JA", "expanded_url": "https://twitter.com/DrAlbertoLG/status/1600412235116912640/photo/1", "display_url": "pic.twitter.com/Y9gGAR98JA", "media_key": "3_1600412226439073794"}]}, "source": "Twitter for iPhone", "text": "I finally got everything ready to #ASH22 annual meeting. And you, are you ready? @ASH_hematology https://t.co/Y9gGAR98JA", "conversation_id": "1600412235116912640", "created_at": "2022-12-07T08:49:45.000Z", "edit_history_tweet_ids": ["1600412235116912640"], "author_id": "1145441671129292801", "lang": "en", "id": "1600412235116912640"}, {"entities": {"mentions": [{"start": 0, "end": 13, "username": "rosslevinemd", "id": "2700794490"}], "annotations": [{"start": 66, "end": 70, "probability": 0.6473, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 65, "end": 71, "tag": "ASH22"}]}, "source": "Twitter for iPhone", "referenced_tweets": [{"type": "replied_to", "id": "1600469365878452224"}], "in_reply_to_user_id": "2700794490", "text": "@rosslevinemd Thanks for sharing this link. I totally missed it. #ASH22", "conversation_id": "1600469018825019393", "created_at": "2022-12-07T12:55:37.000Z", "edit_history_tweet_ids": ["1600474108130603008"], "author_id": "754664467015892992", "lang": "en", "id": "1600474108130603008"}, {"entities": {"mentions": [{"start": 43, "end": 58, "username": "NUHemOncFellow", "id": "1527734252112162819"}, {"start": 59, "end": 75, "username": "NorthwesternMed", "id": "21438665"}, {"start": 76, "end": 88, "username": "LurieCancer", "id": "1006862749"}, {"start": 89, "end": 102, "username": "JaneWinterMD", "id": "1433149659808247813"}, {"start": 103, "end": 115, "username": "heMEGirl_MD", "id": "3608131998"}], "annotations": [{"start": 14, "end": 16, "probability": 0.4307, "type": "Other", "normalized_text": "ASH"}, {"start": 21, "end": 25, "probability": 0.6388, "type": "Other", "normalized_text": "ASH22"}, {"start": 28, "end": 40, "probability": 0.6135, "type": "Other", "normalized_text": "Hemoncfellows"}], "hashtags": [{"start": 20, "end": 26, "tag": "ASH22"}, {"start": 27, "end": 41, "tag": "Hemoncfellows"}], "urls": [{"start": 116, "end": 139, "url": "https://t.co/0xDubHWueC", "expanded_url": "https://twitter.com/FStPierreMD/status/1600512703038119936/photo/1", "display_url": "pic.twitter.com/0xDubHWueC", "media_key": "3_1600512690136440837"}]}, "source": "Twitter for iPhone", "text": "On our way to ASH!!\n#ASH22\n#Hemoncfellows \n@NUHemOncFellow @NorthwesternMed @LurieCancer @JaneWinterMD @heMEGirl_MD https://t.co/0xDubHWueC", "conversation_id": "1600512703038119936", "created_at": "2022-12-07T15:28:59.000Z", "edit_history_tweet_ids": ["1600512703038119936"], "author_id": "1026289734904164353", "lang": "en", "id": "1600512703038119936"}, {"source": "Loomly", "entities": {"annotations": [{"start": 33, "end": 37, "probability": 0.6155, "type": "Other", "normalized_text": "ASH22"}, {"start": 107, "end": 123, "probability": 0.7413, "type": "Other", "normalized_text": "Olatoyosi Odenike"}, {"start": 134, "end": 148, "probability": 0.5368, "type": "Other", "normalized_text": "David A. Garcia"}, {"start": 192, "end": 202, "probability": 0.5108, "type": "Other", "normalized_text": "HemeTwitter"}], "hashtags": [{"start": 32, "end": 38, "tag": "ASH22"}, {"start": 179, "end": 190, "tag": "hematology"}, {"start": 191, "end": 203, "tag": "HemeTwitter"}], "urls": [{"start": 155, "end": 178, "url": "https://t.co/EklAlXikhg", "expanded_url": "https://loom.ly/eiNXe7s", "display_url": "loom.ly/eiNXe7s", "images": [{"url": "https://pbs.twimg.com/news_img/1599752191522508801/CeuWW33P?format=jpg&name=orig", "width": 150, "height": 150}, {"url": "https://pbs.twimg.com/news_img/1599752191522508801/CeuWW33P?format=jpg&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Providing Cutting-Edge, Practical Programming | ASH Clinical News | American Society of Hematology", "description": "As co-chairs of the Education Program, what were your goals in putting the program together? Dr. Odenike: We wanted to make sure that the program was as contemporary and as comprehensive as possible. We are in a very fast-paced, ever-changing world in hematology, and we wanted to make sure the audience was brought up to speed on some of the most exciting developments in today\u2019s era. Dr. Garcia: I would totally agree with that, and I would add that while the ASH Annual Meeting Education Program already", "unwound_url": "https://ashpublications.org/ashclinicalnews/news/6541/Providing-Cutting-Edge-Practical-Programming?searchresult=1"}]}, "text": "Check out what's to come in the #ASH22 Education Program in our exclusive interview with program co-chairs Olatoyosi Odenike, MD, and David A. Garcia, MD! https://t.co/EklAlXikhg #hematology #HemeTwitter", "conversation_id": "1599811273528590336", "created_at": "2022-12-05T17:01:45.000Z", "edit_history_tweet_ids": ["1599811273528590336"], "author_id": "2842612449", "lang": "en", "id": "1599811273528590336"}, {"source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1598791543573385243"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 190, "end": 192, "probability": 0.5113, "type": "Organization", "normalized_text": "GPS"}], "urls": [{"start": 251, "end": 274, "url": "https://t.co/4drhbuESor", "expanded_url": "https://loom.ly/GpFJdp0", "display_url": "loom.ly/GpFJdp0", "status": 200, "title": "ASH Annual Meeting App", "description": "The ASH annual meeting app includes the complete ASH annual meeting program, the full text of all annual meeting abstracts, and more. Download the app for iOS or Android devices.", "unwound_url": "https://www.hematology.org/meetings/annual-meeting/attendee-resources/mobile-app?utm_source=organic_social&utm_medium=twitter&utm_campaign=mobileapp_22"}, {"start": 275, "end": 298, "url": "https://t.co/u1uXwfq03A", "expanded_url": "https://twitter.com/ASH_hematology/status/1598791621587439634/video/1", "display_url": "pic.twitter.com/u1uXwfq03A", "media_key": "7_1598791394608484379"}]}, "text": "Get access to everything you need, including the complete annual meeting program, the full text of all annual meeting abstracts, &amp; other general information with our mobile app \ud83d\udcf2 with a GPS-enabled tool to help you navigate the convention center!\nhttps://t.co/4drhbuESor https://t.co/u1uXwfq03A", "conversation_id": "1598791474325630976", "created_at": "2022-12-02T21:30:01.000Z", "edit_history_tweet_ids": ["1598791621587439634"], "author_id": "84072624", "lang": "en", "id": "1598791621587439634"}, {"source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1598791474325630976"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 54, "end": 58, "probability": 0.6847, "type": "Other", "normalized_text": "ASH22"}, {"start": 156, "end": 166, "probability": 0.9941, "type": "Place", "normalized_text": "New Orleans"}], "hashtags": [{"start": 53, "end": 59, "tag": "ASH22"}], "urls": [{"start": 63, "end": 86, "url": "https://t.co/XiyabRBax2", "expanded_url": "https://loom.ly/Lmicp4c", "display_url": "loom.ly/Lmicp4c", "status": 200, "title": "ASH Annual Meeting Health and Safety Protocols - Hematology.org", "description": "The safety of meeting attendees is ASH\u2019s top priority, and we believe the most effective way to ensure the safety of all attendees is for them to be vaccinated against COVID-19. Please note that proof of vaccination will be required for all in-person meeting attendees prior to traveling to Atlanta.", "unwound_url": "https://www.hematology.org/meetings/annual-meeting/attendee-resources/health-and-safety-protocols?utm_source=organic_social&utm_medium=twitter&utm_campaign=healthandsafety_22"}, {"start": 282, "end": 305, "url": "https://t.co/70DOcnGmTs", "expanded_url": "https://twitter.com/ASH_hematology/status/1598791543573385243/video/1", "display_url": "pic.twitter.com/70DOcnGmTs", "media_key": "7_1598791336777420815"}]}, "text": "Below are some key health &amp; safety protocols for #ASH22 \u23ef\ufe0f https://t.co/XiyabRBax2\n\nDon't forget to upload your proof of vaccination before arriving in New Orleans and enroll in medical evacuation and quarantine support coverage (free for non-industry attendees) by December 4! https://t.co/70DOcnGmTs", "conversation_id": "1598791474325630976", "created_at": "2022-12-02T21:29:42.000Z", "edit_history_tweet_ids": ["1598791543573385243"], "author_id": "84072624", "lang": "en", "id": "1598791543573385243"}, {"source": "Twitter Web App", "entities": {"annotations": [{"start": 14, "end": 23, "probability": 0.3941, "type": "Other", "normalized_text": "Bourbon St"}, {"start": 127, "end": 131, "probability": 0.5796, "type": "Other", "normalized_text": "ASH22"}, {"start": 202, "end": 219, "probability": 0.7517, "type": "Other", "normalized_text": "Know Before You Go"}], "hashtags": [{"start": 126, "end": 132, "tag": "ASH22"}], "urls": [{"start": 248, "end": 271, "url": "https://t.co/eJ8zJHb7HQ", "expanded_url": "https://loom.ly/DwBfDis", "display_url": "loom.ly/DwBfDis", "status": 200, "title": "Know Before You Go - Hematology.org", "description": "Know Before You Go", "unwound_url": "https://www.hematology.org/meetings/annual-meeting/know-before-you-go?utm_source=organic_social&utm_medium=twitter&utm_campaign=kbyg_22"}, {"start": 272, "end": 295, "url": "https://t.co/G4oDWobwHm", "expanded_url": "https://twitter.com/ASH_hematology/status/1598791474325630976/video/1", "display_url": "pic.twitter.com/G4oDWobwHm", "media_key": "7_1598790770240196608"}]}, "text": "Get ready for Bourbon St., beignets, &amp; a bloody good time! We\u2019ve got everything you need to know to make the most of your #ASH22 experience \ud83d\ude4c Check out the thread below for a breakdown\ud83e\uddf5\u2935\ufe0f\n\nHit our \"Know Before You Go\" page for a one-stop-shop: https://t.co/eJ8zJHb7HQ https://t.co/G4oDWobwHm", "conversation_id": "1598791474325630976", "created_at": "2022-12-02T21:29:26.000Z", "edit_history_tweet_ids": ["1598791474325630976"], "author_id": "84072624", "lang": "en", "id": "1598791474325630976"}, {"entities": {"mentions": [{"start": 4, "end": 19, "username": "ASH_hematology", "id": "84072624"}], "annotations": [{"start": 154, "end": 156, "probability": 0.3623, "type": "Organization", "normalized_text": "SCD"}, {"start": 188, "end": 192, "probability": 0.4848, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 96, "end": 107, "tag": "sicklecell"}, {"start": 153, "end": 157, "tag": "SCD"}, {"start": 187, "end": 193, "tag": "ASH22"}], "urls": [{"start": 207, "end": 230, "url": "https://t.co/7JsyEvpwOP", "expanded_url": "https://bit.ly/ASH22SCD", "display_url": "bit.ly/ASH22SCD", "images": [{"url": "https://pbs.twimg.com/news_img/1598378911213228033/7nZls2ly?format=jpg&name=orig", "width": 1200, "height": 600}, {"url": "https://pbs.twimg.com/news_img/1598378911213228033/7nZls2ly?format=jpg&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Sickle Cell Disease Coalition", "description": "The Sickle Cell Disease Coalition was formed to amplify the voice of the sickle cell disease stakeholder community to improve outcomes for individuals with SCD.", "unwound_url": "http://www.scdcoalition.org/updates/november-17-2022.html#AnnualMeeting"}]}, "source": "Twitter Web App", "text": "The @ASH_hematology Annual Meeting is just around the corner, and we are excited to learn about #sicklecell education and research. To see a list of all #SCD related sessions planned for #ASH22, click here: https://t.co/7JsyEvpwOP", "conversation_id": "1598378909569060896", "created_at": "2022-12-01T18:10:03.000Z", "edit_history_tweet_ids": ["1598378909569060896"], "author_id": "900068688140873729", "lang": "en", "id": "1598378909569060896"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1597652159822168067"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 0, "end": 2, "probability": 0.5728, "type": "Organization", "normalized_text": "ASH"}, {"start": 113, "end": 146, "probability": 0.4902, "type": "Person", "normalized_text": "Ernest N. Morial Convention Center"}], "hashtags": [{"start": 157, "end": 163, "tag": "ASH22"}]}, "text": "ASH Choosing Wisely Campaign: 2022 ASH Choosing Wisely Champions \n\ud83d\udcc5 Monday, December 12\n\ud83d\udd51 12:15 \u2013 1:15 p.m. CT\n\ud83d\udccd Ernest N. Morial Convention Center, 243-245\n#ASH22", "conversation_id": "1597652156479332352", "created_at": "2022-11-29T18:02:13.000Z", "edit_history_tweet_ids": ["1597652162804424705"], "author_id": "84072624", "lang": "en", "id": "1597652162804424705"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1597652156479332352"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 0, "end": 2, "probability": 0.587, "type": "Other", "normalized_text": "ASH"}, {"start": 87, "end": 120, "probability": 0.4444, "type": "Other", "normalized_text": "Ernest N. Morial Convention Center"}], "hashtags": [{"start": 131, "end": 137, "tag": "ASH22"}]}, "text": "ASH Guideline Implementation Champions \n\ud83d\udcc5 Sunday, December 11\n\ud83d\udd51 9:30 \u2013 11:00 a.m. CT\n\ud83d\udccd Ernest N. Morial Convention Center, 353-355\n#ASH22", "conversation_id": "1597652156479332352", "created_at": "2022-11-29T18:02:12.000Z", "edit_history_tweet_ids": ["1597652159822168067"], "author_id": "84072624", "lang": "en", "id": "1597652159822168067"}, {"source": "Loomly", "entities": {"annotations": [{"start": 24, "end": 36, "probability": 0.5219, "type": "Other", "normalized_text": "ASHGuidelines"}, {"start": 158, "end": 162, "probability": 0.4558, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 23, "end": 37, "tag": "ASHGuidelines"}, {"start": 44, "end": 63, "tag": "QualityImprovement"}, {"start": 157, "end": 163, "tag": "ASH22"}], "urls": [{"start": 164, "end": 187, "url": "https://t.co/bg1SpMASPC", "expanded_url": "https://twitter.com/ASH_hematology/status/1597652156479332352/photo/1", "display_url": "pic.twitter.com/bg1SpMASPC", "media_key": "3_1597652154281590784"}]}, "text": "Don't miss this year's #ASHGuidelines &amp; #QualityImprovement sessions at the annual meeting \ud83e\ude7a\ud83c\udfe5 Check out this \ud83e\uddf5\u2b07\ufe0f to find more info on each presentation!\n#ASH22 https://t.co/bg1SpMASPC", "conversation_id": "1597652156479332352", "created_at": "2022-11-29T18:02:11.000Z", "edit_history_tweet_ids": ["1597652156479332352"], "author_id": "84072624", "lang": "en", "id": "1597652156479332352"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1595508546979958793"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 98, "end": 104, "probability": 0.7515, "type": "Place", "normalized_text": "Orleans"}, {"start": 106, "end": 114, "probability": 0.9392, "type": "Place", "normalized_text": "Riverside"}], "hashtags": [{"start": 117, "end": 123, "tag": "ASH22"}]}, "text": "Women in Hematology Networking Dinner \n\ud83d\udcc5 Monday, December 12 \n\ud83d\udd51 7:30 \u2013 9:30 p.m. CT \n\ud83d\udccd Hilton New Orleans Riverside \n#ASH22", "conversation_id": "1595508537584939008", "created_at": "2022-11-23T20:04:16.000Z", "edit_history_tweet_ids": ["1595508550222155787"], "author_id": "84072624", "lang": "en", "id": "1595508550222155787"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1595508543972868096"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 126, "end": 159, "probability": 0.5278, "type": "Other", "normalized_text": "Ernest N. Morial Convention Center"}], "hashtags": [{"start": 162, "end": 168, "tag": "ASH22"}]}, "text": "Maternal Health in Hematology \u2013 Current Resources and Future Advocacy \n\ud83d\udcc5 Monday, December 12 \n\ud83d\udd51 10:30 a.m. \u2013 12:00 p.m. CT \n\ud83d\udccd Ernest N. Morial Convention Center \n#ASH22", "conversation_id": "1595508537584939008", "created_at": "2022-11-23T20:04:15.000Z", "edit_history_tweet_ids": ["1595508546979958793"], "author_id": "84072624", "lang": "en", "id": "1595508546979958793"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1595508540856467456"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 89, "end": 123, "probability": 0.5944, "type": "Place", "normalized_text": "New Orleans Warehouse Arts District"}], "hashtags": [{"start": 126, "end": 132, "tag": "ASH22"}]}, "text": "Health Equity Rounds Lunch\n\ud83d\udcc5 Sunday, December 11\n\ud83d\udd51 11:30 a.m. \u2013 12:30 p.m. CT \n\ud83d\udccd Marriot New Orleans Warehouse Arts District \n#ASH22", "conversation_id": "1595508537584939008", "created_at": "2022-11-23T20:04:14.000Z", "edit_history_tweet_ids": ["1595508543972868096"], "author_id": "84072624", "lang": "en", "id": "1595508543972868096"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1595508537584939008"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 128, "end": 134, "probability": 0.5326, "type": "Place", "normalized_text": "Orleans"}, {"start": 136, "end": 144, "probability": 0.5342, "type": "Place", "normalized_text": "Riverside"}], "hashtags": [{"start": 146, "end": 152, "tag": "ASH22"}]}, "text": "Promoting Minorities in Hematology Presentations &amp; Reception \n\ud83d\udcc5 Saturday, December 10 \n\ud83d\udd51 6:30 \u2013 9:00 p.m. CT  \n\ud83d\udccd Hilton New Orleans Riverside\n#ASH22", "conversation_id": "1595508537584939008", "created_at": "2022-11-23T20:04:13.000Z", "edit_history_tweet_ids": ["1595508540856467456"], "author_id": "84072624", "lang": "en", "id": "1595508540856467456"}, {"source": "Loomly", "entities": {"annotations": [{"start": 16, "end": 20, "probability": 0.695, "type": "Other", "normalized_text": "ASH22"}, {"start": 201, "end": 206, "probability": 0.6355, "type": "Other", "normalized_text": "ASHDEI"}], "hashtags": [{"start": 15, "end": 21, "tag": "ASH22"}, {"start": 200, "end": 207, "tag": "ASHDEI"}]}, "text": "Joining us for #ASH22? Learn about how differences in identity impact outcomes &amp; how to mitigate those differences to achieve equitable outcomes for all individuals with hematologic conditions at #ASHDEI sessions &amp; events. Check out the \ud83e\uddf5\u2b07\ufe0f", "conversation_id": "1595508537584939008", "created_at": "2022-11-23T20:04:13.000Z", "edit_history_tweet_ids": ["1595508537584939008"], "author_id": "84072624", "lang": "en", "id": "1595508537584939008"}, {"source": "Sprout Social", "entities": {"annotations": [{"start": 67, "end": 78, "probability": 0.8345, "type": "Other", "normalized_text": "Hemophilia B"}, {"start": 98, "end": 126, "probability": 0.7468, "type": "Other", "normalized_text": "Factor IX prophylaxis therapy"}, {"start": 176, "end": 185, "probability": 0.5085, "type": "Other", "normalized_text": "hemorrhage"}], "urls": [{"start": 245, "end": 268, "url": "https://t.co/LR6v9KXxM8", "expanded_url": "https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treat-adults-hemophilia-b", "display_url": "fda.gov/news-events/pr\u2026", "images": [{"url": "https://pbs.twimg.com/news_img/1600551083033915392/pUSxw1jl?format=png&name=orig", "width": 1200, "height": 675}, {"url": "https://pbs.twimg.com/news_img/1600551083033915392/pUSxw1jl?format=png&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "FDA Approves First Gene Therapy to Treat Adults with Hemophilia B", "description": "The FDA approved Hemgenix, a gene therapy for the treatment of adults with Hemophilia B.", "unwound_url": "https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treat-adults-hemophilia-b"}, {"start": 269, "end": 292, "url": "https://t.co/lN8iue1mXK", "expanded_url": "https://twitter.com/US_FDA/status/1595155113987174401/video/1", "display_url": "pic.twitter.com/lN8iue1mXK", "media_key": "13_1595155069669937156"}]}, "text": "Today, we approved a gene therapy for the treatment of adults with Hemophilia B who currently use Factor IX prophylaxis therapy, or have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous bleeding episodes. https://t.co/LR6v9KXxM8 https://t.co/lN8iue1mXK", "conversation_id": "1595155113987174401", "created_at": "2022-11-22T20:39:50.000Z", "edit_history_tweet_ids": ["1595155113987174401"], "author_id": "208120290", "lang": "en", "id": "1595155113987174401"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1595447708059246592"}], "in_reply_to_user_id": "84072624", "text": "Step 2: Verify your vaccination status \u2705\n\nSafe Expo: https://t.co/6czslTGDAw\n\nCLEAR: https://t.co/iSzDuRN3yc (code: ASHMEETING22)\n#ASH22", "conversation_id": "1595447703898447872", "entities": {"hashtags": [{"start": 130, "end": 136, "tag": "ASH22"}], "urls": [{"start": 53, "end": 76, "url": "https://t.co/6czslTGDAw", "expanded_url": "https://loom.ly/N-T1j4A", "display_url": "loom.ly/N-T1j4A", "status": 200, "unwound_url": "https://mgl.ud.net/fmi/webd/ash22_vax"}, {"start": 85, "end": 108, "url": "https://t.co/iSzDuRN3yc", "expanded_url": "https://loom.ly/rvRgQJM", "display_url": "loom.ly/rvRgQJM", "images": [{"url": "https://pbs.twimg.com/news_img/1600116236288868352/vnVHoUsM?format=jpg&name=orig", "width": 3120, "height": 1638}, {"url": "https://pbs.twimg.com/news_img/1600116236288868352/vnVHoUsM?format=jpg&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Unlock the power of our mobile app | CLEAR", "description": "The CLEAR app helps you find your nearest CLEAR locations, manage your membership, link your accounts to experience our latest technology, and more \u2013 all in one easy place.", "unwound_url": "https://www.clearme.com/mobileapp"}]}, "created_at": "2022-11-23T16:02:31.000Z", "edit_history_tweet_ids": ["1595447711448567808"], "author_id": "84072624", "lang": "en", "id": "1595447711448567808"}, {"source": "Loomly", "referenced_tweets": [{"type": "replied_to", "id": "1595447703898447872"}], "in_reply_to_user_id": "84072624", "text": "Step 1: Enroll in free (for non-industry attendees) medical evacuation by December 4 to be covered in case of emergent medical issues of any kind that require transportation to a hospital in another location for care: https://t.co/RqT2WS9j3Z\n#ASH22", "conversation_id": "1595447703898447872", "entities": {"hashtags": [{"start": 242, "end": 248, "tag": "ASH22"}], "urls": [{"start": 218, "end": 241, "url": "https://t.co/RqT2WS9j3Z", "expanded_url": "https://loom.ly/I77eQs4", "display_url": "loom.ly/I77eQs4", "status": 200, "title": "American Society of Hematology - Covac Global", "description": "Covac Global revolutionized medical evacuation without the burden of hospitalization requirements. Our in-house medical staff and worldwide medical transport teams stand ready to bring our members back to their home or hospital of choice without first being hospitalized at the location of injury or illness. Our indemnified membership covers medical transportation for medical emergencies (including obstetric issues, accidents, illness, etc.). Our teams stand ready 24/7 to provide our members support.", "unwound_url": "https://covacglobal.com/american-society-of-hematology-2/"}]}, "created_at": "2022-11-23T16:02:30.000Z", "edit_history_tweet_ids": ["1595447708059246592"], "author_id": "84072624", "lang": "en", "id": "1595447708059246592"}, {"source": "Loomly", "entities": {"annotations": [{"start": 0, "end": 2, "probability": 0.7056, "type": "Organization", "normalized_text": "ASH"}, {"start": 52, "end": 56, "probability": 0.589, "type": "Other", "normalized_text": "ASH22"}, {"start": 71, "end": 81, "probability": 0.9936, "type": "Place", "normalized_text": "New Orleans"}, {"start": 173, "end": 180, "probability": 0.9776, "type": "Other", "normalized_text": "COVID-19"}], "hashtags": [{"start": 51, "end": 57, "tag": "ASH22"}], "urls": [{"start": 203, "end": 226, "url": "https://t.co/Jv9RGUtLPY", "expanded_url": "https://loom.ly/_mT5VbQ", "display_url": "loom.ly/_mT5VbQ", "status": 200, "title": "ASH Annual Meeting Health and Safety Protocols - Hematology.org", "description": "The safety of meeting attendees is ASH\u2019s top priority, and we believe the most effective way to ensure the safety of all attendees is for them to be vaccinated against COVID-19. Please note that proof of vaccination will be required for all in-person meeting attendees prior to traveling to Atlanta.", "unwound_url": "https://www.hematology.org/meetings/annual-meeting/attendee-resources/health-and-safety-protocols?utm_source=organic_social&utm_medium=twitter&utm_campaign=am_22_healthandsafety"}, {"start": 279, "end": 302, "url": "https://t.co/uwpwB8LjyA", "expanded_url": "https://twitter.com/ASH_hematology/status/1595447703898447872/photo/1", "display_url": "pic.twitter.com/uwpwB8LjyA", "media_key": "3_1595447700870266881"}]}, "text": "ASH wants to ensure the health &amp; safety of all #ASH22 attendees in New Orleans \u269c\ufe0f Do your part by reviewing this year's protocols on vaccinations, masking requirements, COVID-19 testing, &amp; more: https://t.co/Jv9RGUtLPY \n\nCheck out the \ud83e\uddf5\u2b07\ufe0f for a protocol prep tweetorial! https://t.co/uwpwB8LjyA", "conversation_id": "1595447703898447872", "created_at": "2022-11-23T16:02:29.000Z", "edit_history_tweet_ids": ["1595447703898447872"], "author_id": "84072624", "lang": "en", "id": "1595447703898447872"}, {"entities": {"mentions": [{"start": 39, "end": 48, "username": "n_gangat", "id": "2833103654"}, {"start": 115, "end": 130, "username": "ASH_hematology", "id": "84072624"}], "annotations": [{"start": 25, "end": 36, "probability": 0.4733, "type": "Organization", "normalized_text": "ASHNewsDaily"}, {"start": 93, "end": 97, "probability": 0.5674, "type": "Other", "normalized_text": "ASH22"}, {"start": 103, "end": 112, "probability": 0.6143, "type": "Other", "normalized_text": "NewOrleans"}], "hashtags": [{"start": 24, "end": 37, "tag": "ASHNewsDaily"}, {"start": 92, "end": 98, "tag": "ASH22"}, {"start": 102, "end": 113, "tag": "NewOrleans"}], "urls": [{"start": 137, "end": 160, "url": "https://t.co/oW9RJZ9fQf", "expanded_url": "https://ashpublications.org/ashnewsdaily/news/6570/Now-Is-the-Time-ASH22-in-New-Orleans/", "display_url": "ashpublications.org/ashnewsdaily/n\u2026", "status": 200, "title": "Now Is the Time: #ASH22 in New Orleans | ASH News Daily | American Society of Hematology", "description": "Dr. Naseema Gangat (@n_gangat) graduated from medical school at Aga Khan University in Karachi, Pakistan, and attended Mayo Clinic College of Medicine for her internal medicine residency and hematology/oncology fellowship. She continues to call the Mayo Clinic and Rochester, Minnesota, home and is currently a professor of medicine in the division of hematology. 2022 marks Dr. Gangat\u2019s third serving on the ASH News Daily editorial board \u2014 she was an Author in 2018, became Editor in 2021, and clearly is", "unwound_url": "https://ashpublications.org/ashnewsdaily/news/6570/Now-Is-the-Time-ASH22-in-New-Orleans/"}, {"start": 163, "end": 186, "url": "https://t.co/GCqbHCOZTx", "expanded_url": "https://twitter.com/JoselleCookMD/status/1593774060764266496/photo/1", "display_url": "pic.twitter.com/GCqbHCOZTx", "media_key": "3_1593774057840861184"}]}, "source": "Twitter for Android", "text": "The Classiest editor of #ASHNewsDaily, @n_gangat highlights the awesome events coming up at #ASH22 in #NewOrleans. @ASH_hematology. \ud83d\udc49\ud83c\udffe\ud83d\udc49\ud83c\udffe https://t.co/oW9RJZ9fQf . https://t.co/GCqbHCOZTx", "conversation_id": "1593774060764266496", "created_at": "2022-11-19T01:12:01.000Z", "edit_history_tweet_ids": ["1593774060764266496"], "author_id": "904726197224996868", "lang": "en", "id": "1593774060764266496"}, {"source": "Loomly", "entities": {"annotations": [{"start": 21, "end": 34, "probability": 0.9217, "type": "Other", "normalized_text": "ASH News Daily"}, {"start": 224, "end": 228, "probability": 0.6385, "type": "Other", "normalized_text": " #ASH"}], "hashtags": [{"start": 225, "end": 231, "tag": "ASH22"}], "urls": [{"start": 170, "end": 193, "url": "https://t.co/C7KViQbw9G", "expanded_url": "https://loom.ly/ye9vPmM", "display_url": "loom.ly/ye9vPmM", "images": [{"url": "https://pbs.twimg.com/news_img/1600682123903606784/vvixSRx2?format=png&name=orig", "width": 627, "height": 353}, {"url": "https://pbs.twimg.com/news_img/1600682123903606784/vvixSRx2?format=png&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Your Social Media Guide to #ASH22 | ASH News Daily | American Society of Hematology", "description": "The 64th ASH Annual Meeting and Exposition is the best place to reconnect with old colleagues, establish new collaborations, and discover the latest in hematology. Whether you're joining us in New Orleans, or using the meeting\u2019s virtual platform, participating in the scientific conversation on social media is an essential part of the #ASH22 experience! By using social media during the annual meeting, you can immerse yours elf in scientific discourse around your favorite sessions, get updates from the", "unwound_url": "https://ashpublications.org/ashnewsdaily/news/6587/your-social-media-guide-to-ash22?utm_source=organic_social&utm_medium=twitter&utm_campaign=and_preview_22"}, {"start": 277, "end": 300, "url": "https://t.co/1jBWV7eMDk", "expanded_url": "https://twitter.com/ASH_hematology/status/1594727341086965763/photo/1", "display_url": "pic.twitter.com/1jBWV7eMDk", "media_key": "3_1594727338746544128"}]}, "text": "The preview issue of ASH News Daily (AND) is out NOW! Check out our social media article to find tips &amp; tricks on how to join the scientific conversation online \ud83e\uddd1\u200d\ud83d\udcbb: https://t.co/C7KViQbw9G\n\nBe sure to use these featured #ASH22 hashtags for all your meeting-related posts! https://t.co/1jBWV7eMDk", "conversation_id": "1594727341086965763", "created_at": "2022-11-21T16:20:01.000Z", "edit_history_tweet_ids": ["1594727341086965763"], "author_id": "84072624", "lang": "en", "id": "1594727341086965763"}, {"entities": {"mentions": [{"start": 29, "end": 44, "username": "ASH_hematology", "id": "84072624"}], "annotations": [{"start": 96, "end": 100, "probability": 0.6141, "type": "Other", "normalized_text": "to #A"}, {"start": 130, "end": 132, "probability": 0.3496, "type": "Other", "normalized_text": " by"}], "hashtags": [{"start": 99, "end": 105, "tag": "ASH22"}], "urls": [{"start": 223, "end": 246, "url": "https://t.co/3MeZt3asaj", "expanded_url": "https://twitter.com/MikkaelSekeres/status/1593379871698337792/photo/1", "display_url": "pic.twitter.com/3MeZt3asaj", "media_key": "3_1593379860084391937"}]}, "source": "Twitter for iPhone", "text": "What a great meeting of the \u2066@ASH_hematology\u2069 Committee on Communications! Bringing super ideas to #ASH22, with a cameo appearance by Red, who tells us he\u2019s bringing 2 buddies to the annual meeting! \n                   \ud83e\ude78\ud83e\ude78\ud83e\ude78 https://t.co/3MeZt3asaj", "conversation_id": "1593379871698337792", "created_at": "2022-11-17T23:05:39.000Z", "edit_history_tweet_ids": ["1593379871698337792"], "author_id": "390846254", "lang": "en", "id": "1593379871698337792"}, {"entities": {"mentions": [{"start": 68, "end": 83, "username": "ASH_hematology", "id": "84072624"}, {"start": 199, "end": 208, "username": "APSHOorg", "id": "2318955973"}], "annotations": [{"start": 56, "end": 65, "probability": 0.5058, "type": "Other", "normalized_text": "Hematology"}, {"start": 212, "end": 216, "probability": 0.414, "type": "Organization", "normalized_text": "APSHO"}, {"start": 266, "end": 275, "probability": 0.7667, "type": "Other", "normalized_text": "MedTwitter"}], "hashtags": [{"start": 55, "end": 66, "tag": "Hematology"}, {"start": 119, "end": 135, "tag": "WorkLifeBalance"}, {"start": 265, "end": 276, "tag": "MedTwitter"}]}, "source": "Twitter Web App", "text": "Attention Advanced Practice Providers (NPs and PAs) in #Hematology! @ASH_hematology needs YOUR input on your practice, #WorkLifeBalance and best practices for working with docs! Survey sent TODAY by @APSHOorg so APSHO members please help us in this important work! #MedTwitter", "conversation_id": "1590759972794953729", "created_at": "2022-11-10T17:35:07.000Z", "edit_history_tweet_ids": ["1590759972794953729"], "author_id": "987798415", "lang": "en", "id": "1590759972794953729"}, {"entities": {"mentions": [{"start": 26, "end": 41, "username": "ASH_hematology", "id": "84072624"}], "annotations": [{"start": 42, "end": 51, "probability": 0.7395, "type": "Other", "normalized_text": "News Daily"}, {"start": 164, "end": 170, "probability": 0.4696, "type": "Other", "normalized_text": "myeloma"}, {"start": 236, "end": 240, "probability": 0.5625, "type": "Other", "normalized_text": "ASH22"}, {"start": 255, "end": 258, "probability": 0.5415, "type": "Other", "normalized_text": "mmsm"}], "hashtags": [{"start": 235, "end": 241, "tag": "ASH22"}, {"start": 254, "end": 259, "tag": "mmsm"}]}, "source": "Twitter Web App", "text": "I am excited to be on the @ASH_hematology News Daily editorial board, and will be covering/attending the meeting this year.\n\nIn this \ud83e\uddf5, I will highlight the top 10 myeloma abstracts that most influence my thought and practice from the #ASH22 meeting!  \n\n#mmsm", "conversation_id": "1590440063263182851", "created_at": "2022-11-09T20:23:54.000Z", "edit_history_tweet_ids": ["1590440063263182851"], "author_id": "1269642863924609025", "lang": "en", "id": "1590440063263182851"}, {"source": "Twitter Web App", "entities": {"annotations": [{"start": 26, "end": 28, "probability": 0.9822, "type": "Organization", "normalized_text": "FDA"}], "hashtags": [{"start": 25, "end": 29, "tag": "FDA"}, {"start": 54, "end": 59, "tag": "drug"}]}, "text": "A clinical hold from the #FDA is a normal part of the #drug development process, functioning as a quality assurance step for new products that need a closer look. Are you wary of prescribing therapies that have been on hold at one point or another?", "conversation_id": "1588533591155560449", "created_at": "2022-11-04T14:08:16.000Z", "edit_history_tweet_ids": ["1588533591155560449"], "author_id": "2842612449", "lang": "en", "id": "1588533591155560449"}, {"entities": {"mentions": [{"start": 70, "end": 85, "username": "ASH_hematology", "id": "84072624"}, {"start": 220, "end": 230, "username": "VincentRK", "id": "24261916"}, {"start": 231, "end": 241, "username": "NTConnell", "id": "33371180"}, {"start": 242, "end": 254, "username": "MedEdDocOnc", "id": "1392442042857496580"}, {"start": 255, "end": 264, "username": "PKouides", "id": "859376315442581504"}], "annotations": [{"start": 172, "end": 174, "probability": 0.3602, "type": "Other", "normalized_text": "ASH"}, {"start": 209, "end": 218, "probability": 0.5853, "type": "Other", "normalized_text": "MedTwitter"}], "hashtags": [{"start": 208, "end": 219, "tag": "MedTwitter"}]}, "source": "Twitter for iPhone", "text": "Medicine is a team sport! \u26bd\ufe0f\n\nHematologists \ud83e\ude78- do you work with APPs? @ASH_hematology needs your input! We want your \ud83e\udde0 \ud83e\udd14 on best collaborative \ud83e\udd1dpractice!\n\n\u2705 your email for ASH survey, we offer \ud83d\udcb5 for your \u23f0!\n\n#MedTwitter @VincentRK @NTConnell @MedEdDocOnc @PKouides", "conversation_id": "1582426782770565120", "created_at": "2022-10-18T17:41:59.000Z", "edit_history_tweet_ids": ["1582426782770565120"], "author_id": "987798415", "lang": "en", "id": "1582426782770565120"}, {"source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1587444029842751488"}], "in_reply_to_user_id": "84072624", "entities": {"annotations": [{"start": 11, "end": 28, "probability": 0.5646, "type": "Other", "normalized_text": "WorldSickleCellDay"}, {"start": 83, "end": 85, "probability": 0.3456, "type": "Other", "normalized_text": "SCD"}, {"start": 118, "end": 120, "probability": 0.419, "type": "Place", "normalized_text": "ASH"}], "hashtags": [{"start": 10, "end": 29, "tag": "WorldSickleCellDay"}, {"start": 82, "end": 86, "tag": "SCD"}], "urls": [{"start": 200, "end": 223, "url": "https://t.co/nPgfzoIW6H", "expanded_url": "https://twitter.com/ASH_hematology/status/1587444035546914817/photo/1", "display_url": "pic.twitter.com/nPgfzoIW6H", "media_key": "3_1587443779878981632"}]}, "text": "This past #WorldSickleCellDay, CONSA sites celebrated &amp; educated within their #SCD communities. With funding from ASH, these groups were able to hold health fairs, screenings, &amp; trainings \ud83e\ude78 \ud83e\ude7a https://t.co/nPgfzoIW6H", "conversation_id": "1587444025199575040", "created_at": "2022-11-01T13:58:46.000Z", "edit_history_tweet_ids": ["1587444035546914817"], "author_id": "84072624", "lang": "en", "id": "1587444035546914817"}, {"entities": {"mentions": [{"start": 27, "end": 39, "username": "juliemakani", "id": "285732545"}, {"start": 53, "end": 61, "username": "WHOAFRO", "id": "544389588"}], "annotations": [{"start": 19, "end": 23, "probability": 0.6344, "type": "Organization", "normalized_text": "CONSA"}, {"start": 62, "end": 64, "probability": 0.5561, "type": "Other", "normalized_text": "SCD"}], "urls": [{"start": 257, "end": 280, "url": "https://t.co/lZq9pyY5jP", "expanded_url": "https://loom.ly/o_10Wx0", "display_url": "loom.ly/o_10Wx0", "images": [{"url": "https://pbs.twimg.com/news_img/1587444033827356675/0mQS-adI?format=png&name=orig", "width": 450, "height": 583}, {"url": "https://pbs.twimg.com/news_img/1587444033827356675/0mQS-adI?format=png&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Consortium on Newborn Screening in Africa - Hematology.org", "description": "Consortium on Newborn Screening in Africa", "unwound_url": "https://www.hematology.org/global-initiatives/consortium-on-newborn-screening-in-africa?utm_source=organic_social&utm_medium=twitter&utm_campaign=CONSA_2_anniv"}]}, "source": "Twitter Web App", "referenced_tweets": [{"type": "replied_to", "id": "1587444027263172608"}], "in_reply_to_user_id": "84072624", "text": "During the summer, CONSA's @juliemakani spoke at the @WHOAFRO SCD Campaign Launch \ud83c\udf0d\u2695\ufe0f She educated attendees on our newborn screening efforts, the importance of government involvement, &amp; how African countries can learn from these endeavors. Learn more: https://t.co/lZq9pyY5jP", "conversation_id": "1587444025199575040", "created_at": "2022-11-01T13:58:44.000Z", "edit_history_tweet_ids": ["1587444029842751488"], "author_id": "84072624", "lang": "en", "id": "1587444029842751488"}]}, "meta": {"next_token": "7140dibdnow9c7btw423x79v7o9q807lgmzml6mdg8bp3", "result_count": 100, "newest_id": "1601306662794559488", "oldest_id": "1587444035546914817"}, "neighbors": ["84072624", "1433149659808247813", "2842612449"]}